UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________________________
FORM 10-K/A
(Amendment No. 1)
___________________________________
þ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2014 OR
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 1-11037
___________________________________
Praxair, Inc.
___________________________________
Praxair, Inc. | ||
39 Old Ridgebury Road | State of incorporation: Delaware | |
Danbury, Connecticut 06810-5113 | IRS identification number: 06-124 9050 | |
Tel. (203) 837-2000 | ||
Securities registered pursuant to Section 12(b) of the Act:
Title of each class: | Registered on: | |
Common Stock ($0.01 par value) | New York Stock Exchange | |
Securities registered pursuant to Section 12(g) of the Act: None
___________________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes þ No ¨
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No þ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. þ
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer þ Accelerated filer ¨ Non- accelerated filer ¨ Smaller reporting company ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No þ
The aggregate market value of the voting and non-voting common stock held by non-affiliates as of June 30, 2014, was approximately $39 billion (based on the closing sale price of the stock on that date as reported on the New York Stock Exchange).
At January 31, 2015, 288,789,175 shares of common stock of Praxair, Inc. were outstanding.
Documents incorporated by reference:
Portions of the Proxy Statement of Praxair, Inc., for its 2015 Annual Meeting of Shareholders, are incorporated in Part III of this report.
EXPLANATORY NOTE
We are filing this Amendment to our Form 10-K for the fiscal year ended December 31, 2014, filed with the Securities and Exchange Commission on February 25, 2015, solely to correct a typographical error on page 53 in the Report of Independent Registered Public Accounting Firm signed by PricewaterhouseCoopers LLP. This report inadvertently referred to the Company’s internal control over financial reporting as of December 31, 2013, but should have referred to the Company’s internal control over financial reporting as of December 31, 2014. Except for this correction, there have been no changes in any of the financial or other information contained in the report. For convenience, the entire Form 10-K, as amended, is being re-filed.
PRAXAIR, INC.
ANNUAL REPORT ON FORM 10-K
For the fiscal year ended December 31, 2014
TABLE OF CONTENTS
Page | ||
Part I | ||
Item 1: | ||
Item 1A: | ||
Item 1B: | ||
Item 2: | ||
Item 3: | ||
Item 4: | ||
Part II | ||
Item 5: | ||
Item 6: | ||
Item 7: | ||
Item 7A: | ||
Item 8: | ||
Item 9: | ||
Item 9A: | ||
Item 9B: | ||
Part III | ||
Item 10: | ||
Item 11: | ||
Item 12: | ||
Item 13: | ||
Item 14: | ||
Part IV | ||
Item 15: | ||
2
Praxair, Inc. and Subsidiaries
PART I
ITEM 1. BUSINESS
General
Praxair, Inc. (Praxair or the company) was founded in 1907 and became an independent publicly traded company in 1992. Praxair was the first company in the United States to produce oxygen from air using a cryogenic process and continues to be a major technological innovator in the industrial gases industry.
Praxair is the largest industrial gas supplier in North and South America, is rapidly growing in Asia, and has strong, well-established businesses in Europe. Praxair’s primary products in its industrial gases business are atmospheric gases (oxygen, nitrogen, argon, rare gases) and process gases (carbon dioxide, helium, hydrogen, electronic gases, specialty gases, acetylene). The company also designs, engineers, and builds equipment that produces industrial gases primarily for internal use. The company’s surface technologies segment, operated through Praxair Surface Technologies, Inc., supplies wear-resistant and high-temperature corrosion-resistant metallic and ceramic coatings and powders. Praxair’s sales were $12,273 million, $11,925 million, and $11,224 million for 2014, 2013, and 2012, respectively. Refer to Note 18 to the consolidated financial statements for additional information related to Praxair’s reportable segments.
Praxair serves a diverse group of industries including healthcare, petroleum refining, computer-chip manufacturing, beverage carbonation, fiber-optics, steel making, aerospace, chemicals and water treatment. In 2014, 94% of sales were generated in four geographic segments (North America, Europe, South America and Asia) primarily from the sale of industrial gases, with the balance generated from the surface technologies segment. Praxair provides a competitive advantage to its customers by continuously developing new products and applications, which allow them to improve their productivity, energy efficiency and environmental performance.
Industrial Gases Products and Manufacturing Processes
Atmospheric gases are the highest volume products produced by Praxair. Using air as its raw material, Praxair produces oxygen, nitrogen and argon through several air separation processes of which cryogenic air separation is the most prevalent. As a pioneer in the industrial gases industry, Praxair is a leader in developing a wide range of proprietary and patented applications and supply systems technology. Praxair also led the development and commercialization of non-cryogenic air separation technologies for the production of industrial gases. These technologies open important new markets and optimize production capacity for the company by lowering the cost of supplying industrial gases. These technologies include proprietary vacuum pressure swing adsorption (“VPSA”) and membrane separation to produce gaseous oxygen and nitrogen, respectively. Praxair also manufactures precious metal and ceramic sputtering targets used primarily in the production of semiconductors.
Process gases, including carbon dioxide, hydrogen, carbon monoxide, helium, specialty gases and acetylene are produced by methods other than air separation. Most carbon dioxide is purchased from by-product sources, including chemical plants, refineries and industrial processes and is recovered from carbon dioxide wells. Carbon dioxide is processed in Praxair’s plants to produce commercial and food-grade carbon dioxide. Hydrogen and carbon monoxide are produced by either steam methane reforming of natural gas or by purifying by-product sources obtained from the chemical and petrochemical industries. Most of the helium sold by Praxair is sourced from certain helium-rich natural gas streams in the United States, with additional supplies being acquired from outside the United States. Acetylene can be produced from calcium carbide and water. Praxair purchases a significant percentage as a chemical by-product.
Industrial Gases Distribution
There are three basic distribution methods for industrial gases: (i) on-site or tonnage; (ii) merchant or bulk liquid; and (iii) packaged or cylinder gases. These distribution methods are often integrated, with products from all three supply modes coming from the same plant. The method of supply is generally determined by the lowest cost means of meeting the customer’s needs, depending upon factors such as volume requirements, purity, pattern of usage, and the form in which the product is used (as a gas or as a cryogenic liquid). Additionally, Praxair provides a number of services, such as maintenance of equipment, which are ancillary to the process of supplying product to customers.
On-site. Customers that require the largest volumes of product (typically oxygen, nitrogen and hydrogen) and that have a relatively constant demand pattern are supplied by cryogenic and process gas on-site plants. Praxair constructs plants on or adjacent to these customers’ sites and supplies the product directly to customers by pipeline. On-site product supply contracts generally are total requirement contracts with terms typically ranging from 10-20 years and containing minimum purchase requirements and price escalation provisions. Many of the cryogenic on-site plants also produce liquid products for the merchant market. Therefore, plants are typically not dedicated to a single customer. Advanced air
3
separation processes allow on-site delivery to customers with smaller volume requirements. Customers using these systems usually enter into requirement contracts with terms typically ranging from 5-15 years.
Merchant. The merchant business is generally associated with distributable liquid oxygen, nitrogen, argon, carbon dioxide, hydrogen and helium. The deliveries generally are made from Praxair’s plants by tanker trucks to storage containers at the customer's site which are owned and maintained by Praxair and leased to the customer. Due to distribution cost, merchant oxygen and nitrogen generally have a relatively small distribution radius from the plants at which they are produced. Merchant argon, hydrogen and helium can be shipped much longer distances. The customer agreements used in the merchant business are usually three-to five-year requirement contracts.
Packaged Gases. Customers requiring small volumes are supplied products in metal containers called cylinders, under medium to high pressure. Packaged gases include atmospheric gases, carbon dioxide, hydrogen, helium, acetylene and related. Praxair also produces and distributes in cylinders a wide range of specialty gases and mixtures. Cylinders may be delivered to the customer’s site or picked up by the customer at a packaging facility or retail store. Packaged gases are generally sold under one to three-year supply contracts and through purchase orders.
A substantial amount of the cylinder gases sold in the United States is distributed by independent distributors that buy merchant gases in liquid form and repackage the products in their facilities. Packaged gas distributors, including Praxair, also distribute hardgoods and welding equipment purchased from independent manufacturers. Over time, Praxair has acquired a number of independent industrial gases and welding products distributors at various locations in the United States and continues to sell merchant gases to other independent distributors. Between its own distribution business, joint ventures and sales to independent distributors, Praxair is represented in 48 states, the District of Columbia and Puerto Rico.
Surface Technologies
Praxair Surface Technologies is a leading worldwide supplier of coatings services and thermal spray consumables to customers in the aircraft, energy, printing, primary metals, petrochemical, textile, and other industries. Its coatings are used to provide wear resistance, corrosion protection, thermal insulation, and many other surface-enhancing functions which serve to extend component life, enable optimal performance, and reduce operating costs. It also manufactures a complete line of electric arc, plasma and wire spray, and high-velocity oxy-fuel ("HVOF") equipment.
Inventories – Praxair carries inventories of merchant and cylinder gases, hardgoods and coatings materials to supply products to its customers on a reasonable delivery schedule. On-site plants and pipeline complexes have limited inventory. Inventory obsolescence is not material to Praxair’s business.
Customers – Praxair is not dependent upon a single customer or a few customers.
International – Praxair is a global enterprise with approximately 58% of its 2014 sales outside of the United States. It conducts industrial gases business through consolidated companies in Argentina, Bahrain, Belgium, Bolivia, Brazil, Canada, Chile, China, Colombia, Costa Rica, Denmark, Dominican Republic, France, Germany, Ghana, India, Italy, Japan, Mexico, the Netherlands, Norway, Paraguay, Peru, Portugal, Puerto Rico, Russia, South Korea, Spain, Sweden, Taiwan, Thailand, United Arab Emirates, the United Kingdom, Uruguay and Venezuela. Societa Italiana Acetilene & Derivati S.p.A. ("S.I.A.D."), an Italian company accounted for as an equity company, also has established positions in Austria, Bosnia, Bulgaria, Croatia, the Czech Republic, Hungary, Romania, Russia, Serbia, Slovakia, Slovenia and Ukraine. Refrigeration and Oxygen Company Limited ("ROC"), a Middle Eastern company accounted for as an equity company, has operations in the United Arab Emirates, Kuwait and Qatar. Praxair’s surface technologies segment has operations in Brazil, Canada, China, France, Germany, India, Italy, Japan, Singapore, South Korea and the United Kingdom.
Praxair’s international business is subject to risks customarily encountered in foreign operations, including fluctuations in foreign currency exchange rates, import and export controls, and other economic, political and regulatory policies of local governments. Also, see Item 1A. “Risk Factors” and Item 7A. “Quantitative and Qualitative Disclosures About Market Risk.”
Seasonality – Praxair’s business is generally not subject to seasonal fluctuations to any significant extent.
Research and Development – Praxair’s research and development is directed toward developing new and improved methods for the production and distribution of industrial gases and the development of new markets and applications for these gases. This results in the development of new advanced air separation and hydrogen process technologies and the frequent introduction of new industrial gas applications. Research and development for industrial gases is principally conducted at Tonawanda, New York; Burr Ridge, Illinois; Shanghai, China; and Bangalore, India.
Praxair conducts research and development for its surface technologies to improve the quality and durability of coatings and the use of specialty powders for new applications and industries. Surface technologies research is conducted at Indianapolis, Indiana.
4
Patents and Trademarks – Praxair owns or licenses a large number of United States and foreign patents that relate to a wide variety of products and processes. Praxair’s patents expire at various times over the next 20 years. While these patents and licenses are considered important to our individual businesses, Praxair does not consider its business as a whole to be materially dependent upon any one particular patent, or patent license, or family of patents. Praxair also owns a large number of valuable trademarks. Only the "Praxair" trademark is important to our business as a whole.
Raw Materials and Energy Costs – Energy is the single largest cost item in the production and distribution of industrial gases. Most of Praxair’s energy requirements are in the form of electricity, natural gas and diesel fuel for distribution.
The supply of energy has not been a significant issue in the geographic areas where the company conducts business. However, energy availability and price is unpredictable and may pose unforeseen future risks.
For carbon dioxide, carbon monoxide, helium, hydrogen, specialty gases and surface technologies, raw materials are largely purchased from outside sources. Praxair has contracts or commitments for, or readily available sources of, most of these raw materials; however, their long-term availability and prices are subject to market conditions.
Competition – Praxair operates within a highly competitive environment. Some of its competitors are larger in size and capital base than Praxair. Competition is based on price, product quality, delivery, reliability, technology and service to customers.
Major competitors in the industrial gases industry both in the United States and worldwide include Air Products and Chemicals, Inc., Airgas Inc., L’Air Liquide S.A., and Linde AG. Principal competitors for the surface technologies business are Chromalloy Gas Turbine Corporation, a subsidiary of Sequa Corporation, Bodycote, PLC, and OC Oerlikon Corp AG. There are other surface coating competitors that compete on a local geography basis.
Employees and Labor Relations – As of December 31, 2014, Praxair had 27,780 employees worldwide. Of this number, 10,570 are employed in the United States. Praxair has collective bargaining agreements with unions at numerous locations throughout the world, which expire at various dates. Praxair considers relations with its employees to be good.
Environment – Information required by this item is incorporated herein by reference to the section captioned “Management’s Discussion and Analysis – Environmental Matters” in Item 7 of this 10-K.
Available Information – The company makes its periodic and current reports available, free of charge, on or through its website, www.praxair.com, as soon as practicable after such material is electronically filed with, or furnished to, the Securities and Exchange Commission ("SEC"). Investors may also access from the company website other investor information such as press releases and presentations. Information on the company’s website is not incorporated by reference herein.
In addition, the public may read and copy any materials filed with the SEC at the SEC’s Public Reference Room located at 100 F Street NE, Washington, D.C. 20549. The public may also obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains a website, www.sec.gov, that contains reports, proxy information statements and other information regarding issuers that file electronically.
Executive Officers – The following Executive Officers have been elected by the Board of Directors and serve at the pleasure of the Board. It is expected that the Board will elect officers annually following each annual meeting of shareholders.
Stephen F. Angel, 59, is Chief Executive Officer of Praxair, Inc. since January 1, 2007, and Chairman since May 1, 2007. Before becoming the Chief Executive Officer, Mr. Angel served as President and Chief Operating Officer from March to December 2006, and as Executive Vice President from 2001 to March 2006. Prior to joining Praxair in 2001, Mr. Angel spent 22 years in a variety of management positions with General Electric. Mr. Angel is a director of PPG Industries, Inc. where he serves on the Officers-Directors Compensation Committee, and is the Chairman of the Technology and Environment Committee. He is also a member of The Business Council, the U.S. - Brazil CEO Forum, a member of the Board of the U.S. - China Business Council, and is a former director of the American Chemistry Council.
Guillermo Bichara, 40, was appointed Vice President, General Counsel and Corporate Secretary of Praxair, Inc. effective January 1, 2015. Prior to this, from 2013-2014, he was Associate General Counsel and Assistant Secretary. From 2011-2013, Mr. Bichara served as Associate General Counsel with responsibility for Praxair Europe, Praxair Mexico and corporate transactions. He was Vice President and General Counsel of Praxair Asia from 2007-2011, and joined Praxair in 2006 as director of legal affairs at Praxair Mexico. Prior to joining Praxair, Mr. Bichara served as corporate counsel at CEMEX, Mexico's global leader in the building materials industry, and was a foreign associate and counsel, respectively, at the law firms of Skadden, Arps, Slate, Meagher & Flom and White & Case.
5
Elizabeth T. Hirsch, 61, is Vice President and Controller of Praxair, Inc. since December 2010. Prior to becoming Controller, she served as Praxair’s Director of Investor Relations since 2002 and as Vice President of Investor Relations since October 2010. She joined Praxair in 1995 as Director of Corporate Finance and later served as Assistant Treasurer. Previously, she had fifteen years of experience in corporate banking, primarily at Manufacturers Hanover Trust Company.
Karen L. Keegans, 49, was appointed Vice President and Chief Human Resources officer in 2014. Ms. Keegans joined Praxair in 2012 as vice president, HR, North America, from Monsanto where she had spent the previous five years. While at Monsanto, Ms. Keegans had increasing HR leadership roles, gaining global exposure across all business areas and was most recently VP, HR, Global Manufacturing.
Eduardo F. Menezes, 51, was promoted to Executive Vice President from Senior Vice President effective March 1, 2012. He oversees Praxair’s businesses in Europe, Mexico, and South America, and Praxair’s U.S. and global hydrogen operations. From 2010 to March 2011, he was a Vice President of Praxair with responsibility for the North American Industrial Gases business. From 2007 to 2010, he was President of Praxair Europe. He served as Managing Director of Praxair’s business in Mexico from 2004 to 2007, as Vice President and General Manager for Praxair Distribution, Inc. from 2003 to 2004 and as Vice President, U.S. West Region, for North American Industrial Gases, from 2000 to 2003.
Anne K. Roby, age 50, was named Senior Vice President on January 1, 2014, responsible for Global Supply Systems, R&D, Global Market Development, Global Operations Excellence, Global Procurement, Sustainability and Safety, Health and Environment. From 2011-2013, she served as President of Praxair Asia, responsible for Praxair’s industrial gases business in China, India, South Korea and Thailand as well as the electronics market globally. In 2010, Ms. Roby became President of Praxair Electronics, after having served as Vice President, Global Sales, for Praxair from 2009-2010. Prior to this, she was Vice President of the U.S. South Region from 2006-2009. Ms. Roby joined Praxair in 1991 as a development associate in the Company’s R&D organization and was promoted to other positions of increasing responsibility.
Scott E. Telesz, 47, was promoted to Executive Vice President from Senior Vice President, effective March 1, 2012. He is responsible for Praxair’s U.S. Industrial Gases (USIG) organization, and it’s business in Canada, Praxair Distribution, Praxair Surface Technologies, NUCO2, and Helium-Rare Gases. Before joining Praxair in 2010, he was a Vice President from 2007 to 2010 of SABIC Innovative Plastics, a major division of Riyadh-based Saudi Basic Industries Corporation, a global manufacturer of chemicals, fertilizers, plastics and metals. From 1998 to 2007, he held a variety of general management positions with General Electric, and from 1989 to 1998, Mr. Telesz held several positions, including Engagement Manager, in the United States and Australia, with McKinsey & Company.
Matthew J. White, 42, was appointed Senior Vice President and Chief Financial Officer effective January 1, 2014. Prior to this, Mr. White was President of Praxair Canada from 2011-2014. Mr. White joined Praxair in 2004 as finance director of Praxair’s largest business unit, North American Industrial Gases. In 2008, he became Vice President and Controller of Praxair, then was named Vice President and Treasurer in 2010. Before joining Praxair, Mr. White was vice president, finance, at Fisher Scientific and before that he held various financial positions, including group controller, at GenTek, a manufacturing and performance chemicals company.
ITEM 1A. RISK FACTORS
Due to the size and geographic reach of the company’s operations, a wide range of factors, many of which are outside of the company’s control, could materially affect the company’s future operations and financial performance. Management believes the following risks may significantly impact the company:
General Economic Conditions – Weakening economic conditions in markets in which the company does business may adversely impact the company’s financial results and/or cash flows.
Praxair serves a diverse group of industries across more than 50 countries, which generally leads to financial stability through various business cycles. However, a broad decline in general economic or business conditions in the industries served by its customers could adversely affect the demand for Praxair’s products and impair the ability of our customers to satisfy their obligations to the company, resulting in uncollected receivables and/or unanticipated contract terminations or project delays. In addition, many of the company’s customers are in businesses that are cyclical in nature, such as the chemicals, electronics, metals and refining industries. Downturns in these industries may adversely impact the company during these cycles. Additionally, such conditions could impact the utilization of the company’s manufacturing capacity which may require the company to recognize impairment losses on tangible assets such as property, plant and equipment as well as intangible assets such as intellectual property or goodwill.
6
Cost and Availability of Raw Materials and Energy – Increases in the cost of energy and raw materials and/or disruption in the supply of these materials could result in lost sales or reduced profitability.
Energy is the single largest cost item in the production and distribution of industrial gases. Most of Praxair’s energy requirements are in the form of electricity, natural gas and diesel fuel for distribution. Praxair attempts to minimize the financial impact of variability in these costs through the management of customer contracts and reducing demand through operational productivity and energy efficiency. Large customer contracts typically have escalation and pass-through clauses to recover energy and feedstock costs. Such attempts may not successfully mitigate cost variability which could negatively impact its financial condition or results of operations. The supply of energy has not been a significant issue in the geographic areas where it conducts business. However, regional energy conditions are unpredictable and may pose future risk.
For carbon dioxide, carbon monoxide, helium, hydrogen, specialty gases and surface technologies, raw materials are largely purchased from outside sources. Where feasible, Praxair sources several of these gases, including carbon dioxide, hydrogen and calcium carbide, as chemical or industrial byproducts. In addition, Praxair has contracts or commitments for, or readily available sources of, most of these raw materials; however, their long-term availability and prices are subject to market conditions. A disruption in supply of such raw materials could impact the company’s ability to meet contractual supply commitments.
International Events and Circumstances – The company’s international operations are subject to the risks of doing business abroad and international events and circumstances may adversely impact its business, financial condition or results of operations.
Praxair has substantial international operations which are subject to risks including devaluations in currency exchange rates, transportation delays and interruptions, political and economic instability and disruptions, restrictions on the transfer of funds, the imposition of duties and tariffs, import and export controls, changes in governmental policies, labor unrest, possible nationalization and/or expropriation of assets, domestic and international tax laws and compliance with governmental regulations. These events could have an adverse effect on the international operations in the future by reducing the demand for its products, decreasing the prices at which it can sell its products, reducing the U.S. dollar value of revenue from international operations or otherwise having an adverse effect on its business. Also, the Company is monitoring developments regarding the collectability of government receivables from healthcare sales to public hospitals in Spain and Italy where economic conditions have been challenging and uncertain. Historically, collection of such government receivables has extended beyond the contractual terms of sale; however, payment has always been received. At December 31, 2014, government receivables in Spain and Italy totaled about $60 million.
Global Financial Markets Conditions – Macroeconomic factors may impact the company’s ability to obtain financing or increase the cost of obtaining financing which may adversely impact the company’s financial results and/or cash flows.
Volatility and disruption in the U.S. and global credit and equity markets, from time to time, could make it more difficult for Praxair to obtain financing for its operations and/or could increase the cost of obtaining financing. In addition, the company’s borrowing costs can be affected by short and long-term debt ratings assigned by independent rating agencies which are based, in significant part, on the company’s performance as measured by certain criteria such as interest coverage and leverage ratios. A decrease in these debt ratings could increase the cost of borrowing or make it more difficult to obtain financing. While the impact of volatility in the global credit markets cannot be predicted with certainty, the company believes that it has sufficient operating flexibility, cash reserves, and funding sources to maintain adequate amounts of liquidity to meet its business needs around the world.
Competitor Actions – The inability to effectively compete could adversely impact results of operations.
Praxair operates within a highly competitive environment worldwide. Competition is based on price, product quality, delivery, reliability, technology and service to customers. Competitors’ behavior related to these areas could potentially have significant impacts on the company’s financial results.
Governmental Regulations – The company is subject to a variety of United States and foreign government regulations. Changes in these regulations could have an adverse impact on the business, financial position and results of operations.
The company is subject to regulations in the following areas, among others:
• | Environmental protection including climate change; |
• | Domestic and international tax laws and currency controls; |
• | Safety; |
• | Securities laws (e.g., SEC and generally accepted accounting principles in the United States); |
7
• | Trade and import/ export restrictions; |
• | Antitrust matters; |
• | Global anti-bribery laws, including the U.S. Foreign Corrupt Practices Act; |
• | Healthcare reimbursement regulations; and |
• | Conflict minerals |
Changes in these or other regulatory areas may impact the company’s profitability, may require the company to spend additional resources to comply with the regulations, or may restrict the company’s ability to compete effectively in the marketplace. Noncompliance with such laws and regulations could result in penalties or sanctions that could have an adverse impact on the company’s financial results. Environmental protection is discussed further below.
Praxair is subject to various environmental and occupational health and safety laws and regulations, including those governing the discharge of pollutants into the air or water, the storage, handling and disposal of chemicals, hazardous substances and wastes, the remediation of contamination, the regulation of greenhouse gas emissions, and other potential climate change initiatives. Violations of these laws could result in substantial penalties, third party claims for property damage or personal injury, or sanctions. The company may also be subject to liability for the investigation and remediation of environmental contamination at properties that it owns or operates and at other properties where Praxair or its predecessors have operated or arranged for the disposal of hazardous wastes. Although management does not believe that any such liabilities will have a material adverse impact on its financial position and results of operations, management cannot provide assurance that such costs will not increase in the future or will not become material. See the section captioned “Management’s Discussion and Analysis – Environmental Matters” in Item 7 of this Form 10-K.
Catastrophic Events – Catastrophic events could disrupt the operations of the company and/or its customers and suppliers and may have a significant adverse impact on the results of operations.
The occurrence of catastrophic events or natural disasters such as extreme weather, including hurricanes and floods;health epidemics; acts of war or terrorism; could disrupt or delay the company’s ability to produce and distribute its products to customers and could potentially expose the company to third-party liability claims. In addition, such events could impact the company’s customers and suppliers resulting in temporary or long-term outages and/or the limitation of supply of energy and other raw materials used in normal business operations. To mitigate these risks, Praxair evaluates the direct and indirect business risks,: consults with vendors, insurance providers and industry experts; makes investments in suitably resilient design and technology, and conducts regular reviews of the business risks with management. Despite these steps, however, these situations are outside the company’s control and may have a significant adverse impact on the company’s financial results.
Retaining Qualified Personnel – The inability to attract and retain qualified personnel may adversely impact the company’s business.
If Praxair fails to attract, hire and retain qualified personnel, the company may not be able to develop, market or sell its products or successfully manage its business. Praxair is dependent upon its highly skilled, experienced and efficient workforce to be successful. Much of Praxair’s competitive advantage is based on the expertise and experience of its key personnel regarding its marketing, technology, manufacturing and distribution infrastructure, systems and products. The inability to attract and hire qualified individuals or the loss of key employees in very skilled areas could have a negative effect on the company’s financial results.
Technological Advances – If the company fails to keep pace with technological advances in the industry or if new technology initiatives do not become commercially accepted, customers may not continue to buy the company’s products and results of operations could be adversely affected.
Praxair’s research and development is directed toward developing new and improved methods for the production and distribution of industrial gases and the development of new markets and applications for the use of these gases. This results in the frequent introduction of new industrial gas applications and the development of new advanced air separation process technologies. The company also conducts research and development for its surface technologies to improve the quality and durability of coatings and the use of specialty powders for new applications and industries. As a result of these efforts, the company develops new and proprietary technologies and employs necessary measures to protect such technologies within the global geographies in which the company operates. These technologies help Praxair to create a competitive advantage and to provide a platform for the company to grow its business. If Praxair’s research and development activities do not keep pace with competitors or if it does not create new technologies that benefit customers, future results of operations could be adversely affected.
8
Litigation and Governmental Investigations – The outcomes of litigation and governmental investigations may affect the company’s financial results.
Praxair is subject to various lawsuits and governmental investigations arising out of the normal course of business that may result in adverse outcomes. These actions are based upon alleged environmental, tax, antitrust and personal injury claims, among others. Adverse outcomes in some or all of the claims pending may result in significant monetary damages or injunctive relief that could adversely affect its ability to conduct business. While management currently believes that resolving all of these matters, individually or in the aggregate, will not have a material adverse impact on the company’s financial position or liquidity, the litigation and other claims Praxair faces are subject to inherent uncertainties and management’s view of these matters may change in the future. There exists the possibility of a material adverse impact on the company’s results of operations for the period in which the effect of an unfavorable final outcome becomes probable and reasonably estimable.
Tax Liabilities – Potential tax liabilities could adversely impact the company’s financial position and results of operations.
Praxair is subject to income and other taxes in both the United States and numerous foreign jurisdictions. The determination of the company’s worldwide provision for income taxes and other tax liabilities requires judgment and is based on diverse legislative and regulatory structures that exist in the various jurisdictions where the company operates. Although management believes its estimates are reasonable, the ultimate tax outcome may differ from the amounts recorded in its financial statements and may materially affect the company’s financial results for the period when such determination is made. See Notes 5 and 17 to the consolidated financial statements of this Form 10-K.
Pension Liabilities – Risks related to our pension benefit plans may adversely impact our results of operations and cash flows.
Pension benefits represent significant financial obligations that will be ultimately settled in the future with employees who meet eligibility requirements. Because of the uncertainties involved in estimating the timing and amount of future payments and asset returns, significant estimates are required to calculate pension expense and liabilities related to the company’s plans. The company utilizes the services of independent actuaries, whose models are used to facilitate these calculations. Several key assumptions are used in the actuarial models to calculate pension expense and liability amounts recorded in the consolidated financial statements. In particular, significant changes in actual investment returns on pension assets, discount rates, or legislative or regulatory changes could impact future results of operations and required pension contributions. For information regarding the potential impacts regarding significant assumptions used to estimate pension expense, including discount rates and the expected long-term rates of return on plan assets. See “Critical Accounting Policies – Pension Benefits” included in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 of this Form 10-K.
Operational Risks – Operational risks may adversely impact the company’s business or results of operations.
Praxair’s operating results are dependent on the continued operation of its production facilities and its ability to meet customer contract requirements and other needs. Insufficient or excess capacity threatens the company’s ability to generate competitive profit margins and may expose the company to liabilities related to contract commitments. Operating results are also dependent on the company’s ability to complete new construction projects on time, on budget and in accordance with performance requirements. Failure to do so may expose the business to loss of revenue, potential litigation and loss of business reputation.
Also inherent in the management of the company’s production facilities and delivery systems, including storage, vehicle transportation and pipelines, are operational risks that require continuous training, oversight and control. Material operating failures at production, storage facilities or pipelines, including fire, toxic release and explosions, or the occurrence of vehicle transportation accidents could result in loss of life, damage to the environment, loss of production and/or extensive property damage, all of which may negatively impact the company’s financial results.
Information Technology Systems – The Company may be subject to information technology system ("IT") failures, network disruptions and breaches in data security.
Praxair relies on IT systems and networks for business and operational activities, and also stores and processes sensitive business and proprietary information in these systems and networks. These systems are susceptible to outages due to fire, flood, power loss, telecommunications failures, viruses, break-ins and similar events, or breaches of security. Management has taken steps to address these risks and concerns by implementing advanced security technologies, internal controls, network and data center resiliency and recovery process. Despite these steps, however, operational failures and breaches of security from increasingly sophisticated cyber threats could lead to the loss or disclosure of confidential information, result in regulatory actions and have a material adverse impact on Praxair's operations, reputation and financial results.
9
Acquisitions and Joint Ventures – The inability to effectively integrate acquisitions or collaborate with joint venture partners could adversely impact the company’s financial position and results of operations.
Praxair has evaluated, and expects to continue to evaluate, a wide array of potential strategic acquisitions and joint ventures. Many of these transactions, if consummated, could be material to its financial condition and results of operations. In addition, the process of integrating an acquired company, business or group of assets may create unforeseen operating difficulties and expenditures. Although historically the company has been successful with its acquisition strategy and execution, the areas where the company may face risks include:
• | The need to implement or remediate controls, procedures and policies appropriate for a larger public company at companies that prior to the acquisition lacked these controls, procedures and policies; |
• | Diversion of management time and focus from operating existing business to acquisition integration challenges; |
• | Cultural challenges associated with integrating employees from the acquired company into the existing organization; |
• | The need to integrate each company’s accounting, management information, human resource and other administrative systems to permit effective management; |
• | Difficulty with the assimilation of acquired operations and products; |
• | Failure to achieve targeted synergies; and |
• | Inability to retain key employees and business relationships of acquired companies. |
Foreign acquisitions and joint ventures involve unique risks in addition to those mentioned above, including those related to integration of operations across different cultures and languages, currency risks and the particular economic, political and regulatory risks associated with specific countries. Also, the anticipated benefit of the company’s acquisitions may not materialize. Future acquisitions or dispositions could result in potentially dilutive issuances of equity securities, the incurrence of debt, contingent liabilities or amortization expenses, or impairments of goodwill, any of which could adversely impact the company’s financial results.
ITEM 1B. UNRESOLVED STAFF COMMENTS
Praxair has received no written SEC staff comments regarding any of its Exchange Act reports which remain unresolved.
ITEM 2. PROPERTIES
Praxair’s worldwide headquarters are located in leased office space in Danbury, Connecticut. Other principal administrative offices are owned in Tonawanda, New York, and leased in Rio de Janeiro, Brazil; Shanghai, China and Madrid, Spain.
Praxair designs, engineers, manufactures and operates facilities that produce and distribute industrial gases. These industrial gas production facilities and certain components are designed and/or manufactured at its facilities in Tonawanda, New York; Burr Ridge, Illinois; Rio de Janeiro, Brazil; Monterrey, Mexico; Shanghai, China; and Bangalore, India. Praxair’s Italian equity affiliate, S.I.A.D., also has such capacity.
Due to the nature of Praxair’s industrial gas products, it is generally uneconomical to transport them distances greater than a few hundred miles from the production facility. As a result, Praxair operates a significant number of production facilities spread globally throughout a number of geographic regions.
The following is a description of production facilities for Praxair by segment. No significant portion of these assets was leased at December 31, 2014. Generally, these facilities are fully utilized and are sufficient to meet our manufacturing needs.
North America
The North America segment operates production facilities in the U.S., Canada and Mexico, approximately 245 of which are cryogenic air separation plants, hydrogen plants and carbon dioxide plants. There are five major pipeline complexes in North America located in Northern Indiana, Houston, along the Gulf Coast of Texas, Detroit and Louisiana. Also located throughout North America are packaged gas facilities, specialty gas plants, helium plants and other smaller plant facilities.
10
Europe
The Europe segment has production facilities primarily in Italy, Spain, Germany, the Benelux region, Scandinavia and Russia which include approximately 60 cryogenic air separation plants. There are three major pipeline complexes in Europe located in Northern Spain and the Rhine and Saar regions of Germany. These pipeline complexes are primarily supplied by cryogenic air separation plants. Also located throughout Europe are specialty gas plants, packaged gas facilities and other smaller plant facilities.
South America
The South America segment operates more than 50 cryogenic air separation plants, primarily located in Brazil. Many of these plants support a major pipeline complex in Southern Brazil. Also located throughout South America are carbon dioxide plants, packaged gas facilities and other smaller plant facilities.
Asia
The Asia segment has production facilities located primarily in China, Korea, India and Thailand, approximately 50 of which are cryogenic air separation plants. Also located throughout Asia are noncryogenic air separation, carbon dioxide, hydrogen, packaged gas and other production facilities.
Surface Technologies
The surface technologies segment provides coating services and manufactures coating equipment at approximately 45 sites. The majority of these sites are located in the United States and Europe, with smaller operations in Asia, Brazil, India and headquarters located in Indianapolis, Indiana.
ITEM 3. LEGAL PROCEEDINGS
Information required by this item is incorporated herein by reference to the section captioned “Notes to Consolidated Financial Statements – 17 Commitments and Contingencies” in Item 8 of this 10-K.
ITEM 4. MINE SAFETY DISCLOSURES
Not Applicable
11
PART II
ITEM 5. | MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES |
The principal market for the company’s common stock (ticker symbol: PX) is the New York Stock Exchange ("NYSE"). At December 31, 2014 there were 13,286 shareholders of record.
NYSE quarterly stock price and dividend information
Market Price | Trading High | Trading Low | Close | Dividend Per Share | |||||||||||
2014 | |||||||||||||||
First Quarter | $ | 135.24 | $ | 121.22 | $ | 130.97 | $ | 0.65 | |||||||
Second Quarter | $ | 134.84 | $ | 126.47 | $ | 132.84 | $ | 0.65 | |||||||
Third Quarter | $ | 134.06 | $ | 126.58 | $ | 129.00 | $ | 0.65 | |||||||
Fourth Quarter | $ | 132.95 | $ | 117.32 | $ | 129.56 | $ | 0.65 | |||||||
2013 | |||||||||||||||
First Quarter | $ | 114.64 | $ | 109.08 | $ | 111.54 | $ | 0.60 | |||||||
Second Quarter | $ | 120.16 | $ | 107.69 | $ | 115.16 | $ | 0.60 | |||||||
Third Quarter | $ | 124.41 | $ | 113.20 | $ | 120.21 | $ | 0.60 | |||||||
Fourth Quarter | $ | 130.58 | $ | 117.54 | $ | 130.03 | $ | 0.60 | |||||||
Praxair’s annual dividend on its common stock for 2014 was $2.60 per share. On January 28, 2015, Praxair’s Board of Directors declared a dividend of $0.715 per share for the first quarter of 2015, or $2.86 per share annualized, which may be changed as Praxair’s earnings and business prospects warrant. The declaration of dividends is a business decision made by the Board of Directors based on Praxair’s earnings and financial condition and other factors the Board of Directors considers relevant.
Purchases of Equity Securities – Certain information regarding purchases made by or on behalf of the company or any affiliated purchaser (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended) of its common stock during the three months ended December 31, 2014 is provided below:
Period | Total Number of Shares Purchased (Thousands) | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Program (1) (Thousands) | Approximate Dollar Value of Shares that May Yet be Purchased Under the Program (2) (Millions) | |||||||||
October 2014 | 927 | $ | 123.97 | 927 | $ | 1,223 | |||||||
November 2014 | 709 | $ | 126.75 | 709 | $ | 1,134 | |||||||
December 2014 | 750 | $ | 127.33 | 750 | $ | 1,038 | |||||||
Fourth Quarter 2014 | 2,386 | $ | 125.85 | 2,386 | $ | 1,038 | |||||||
________________________
(1) | On January 28, 2014, the Company’s board of directors approved the repurchase of $1.5 billion of its common stock ("2014 program") which could take place from time to time on the open market (which could include the use of 10b5-1 trading plans) or through negotiated transactions, subject to market and business conditions. |
(2) | As of December 31, 2014, the Company had purchased $462 million of its common stock pursuant to the 2014 program, leaving an additional $1,038 million remaining authorized under the 2014 program. The 2014 program does not have any stated expiration date. |
12
Peer Performance Table – The graph below compares the most recent five-year cumulative returns of Praxair’s common stock with those of the Standard & Poor’s 500 Index ("SPX") and the S5 Materials Index ("S5MATR") which covers 30 companies, including Praxair. The figures assume an initial investment of $100 on December 31, 2009 and that all dividends have been reinvested.
2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |
PX | $100 | $121 | $138 | $145 | $175 | $179 |
SPX | $100 | $115 | $117 | $136 | $180 | $205 |
S5MATR | $100 | $122 | $110 | $126 | $159 | $170 |
13
ITEM 6. SELECTED FINANCIAL DATA
FIVE-YEAR FINANCIAL SUMMARY
(Dollar amounts in millions, except per share data)
Year Ended December 31, | 2014(a) | 2013(a) | 2012(a) | 2011(a) | 2010(a) | ||||||||||||||
From the Consolidated Statements of Income | |||||||||||||||||||
Sales | $ | 12,273 | $ | 11,925 | $ | 11,224 | $ | 11,252 | $ | 10,116 | |||||||||
Cost of sales, exclusive of depreciation and amortization | 6,962 | 6,744 | 6,396 | 6,458 | 5,754 | ||||||||||||||
Selling, general and administrative | 1,308 | 1,349 | 1,270 | 1,239 | 1,196 | ||||||||||||||
Depreciation and amortization | 1,170 | 1,109 | 1,001 | 1,003 | 925 | ||||||||||||||
Research and development | 96 | 98 | 98 | 90 | 79 | ||||||||||||||
Venezuela currency devaluation and other charges – net | 138 | 32 | 65 | 1 | 85 | ||||||||||||||
Other income (expenses) – net | 9 | 32 | 43 | 7 | 5 | ||||||||||||||
Operating profit | 2,608 | 2,625 | 2,437 | 2,468 | 2,082 | ||||||||||||||
Interest expense – net | 213 | 178 | 141 | 145 | 118 | ||||||||||||||
Income before income taxes and equity investments | 2,395 | 2,447 | 2,296 | 2,323 | 1,964 | ||||||||||||||
Income taxes | 691 | 649 | 586 | 641 | 768 | ||||||||||||||
Income before equity investments | 1,704 | 1,798 | 1,710 | 1,682 | 1,196 | ||||||||||||||
Income from equity investments | 42 | 38 | 34 | 40 | 38 | ||||||||||||||
Net income (including noncontrolling interests) | 1,746 | 1,836 | 1,744 | 1,722 | 1,234 | ||||||||||||||
Noncontrolling interests | (52 | ) | (81 | ) | (52 | ) | (50 | ) | (39 | ) | |||||||||
Net income – Praxair, Inc. | $ | 1,694 | $ | 1,755 | $ | 1,692 | $ | 1,672 | $ | 1,195 | |||||||||
Per Share Data – Praxair, Inc. Shareholders | |||||||||||||||||||
Basic earnings per share | $ | 5.79 | $ | 5.94 | $ | 5.67 | $ | 5.53 | $ | 3.90 | |||||||||
Diluted earnings per share | $ | 5.73 | $ | 5.87 | $ | 5.61 | $ | 5.45 | $ | 3.84 | |||||||||
Cash dividends per share | $ | 2.60 | $ | 2.40 | $ | 2.20 | $ | 2.00 | $ | 1.80 | |||||||||
Weighted Average Shares Outstanding (000’s) | |||||||||||||||||||
Basic shares outstanding | 292,494 | 295,523 | 298,316 | 302,237 | 306,720 | ||||||||||||||
Diluted shares outstanding | 295,608 | 298,965 | 301,845 | 306,722 | 311,395 | ||||||||||||||
Other Information and Ratios | |||||||||||||||||||
Total assets | $ | 19,802 | $ | 20,255 | $ | 18,090 | $ | 16,356 | $ | 15,274 | |||||||||
Total debt | $ | 9,258 | $ | 8,811 | $ | 7,362 | $ | 6,562 | $ | 5,557 | |||||||||
Cash flow from operations | $ | 2,868 | $ | 2,917 | $ | 2,752 | $ | 2,455 | $ | 1,905 | |||||||||
Adjusted EBITDA (b) | $ | 3,958 | $ | 3,804 | $ | 3,537 | $ | 3,512 | $ | 3,130 | |||||||||
Capital expenditures | $ | 1,689 | $ | 2,020 | $ | 2,180 | $ | 1,797 | $ | 1,388 | |||||||||
Acquisitions, net of cash acquired | $ | 206 | $ | 1,323 | $ | 280 | $ | 294 | $ | 148 | |||||||||
After-tax return on capital (b) | 12.7 | % | 12.8 | % | 13.9 | % | 14.8 | % | 14.5 | % | |||||||||
Return on equity (b) | 28.7 | % | 28.6 | % | 28.9 | % | 28.1 | % | 26.4 | % | |||||||||
Debt-to-capital ratio (b) | 59.6 | % | 54.3 | % | 51.9 | % | 51.8 | % | 47.3 | % | |||||||||
Debt-to-adjusted EBITDA (b) | 2.3 | 2.2 | 1.9 | 1.7 | 1.6 | ||||||||||||||
Shares outstanding (000’s) | 289,262 | 294,134 | 296,229 | 298,530 | 303,997 | ||||||||||||||
Number of employees | 27,780 | 27,560 | 26,539 | 26,184 | 26,261 | ||||||||||||||
________________________
(a) | Amounts for 2014 include: (i) a pre-tax charge of $131 million ($131 million after-tax, or $0.45 per diluted share) related to the Venezuela currency devaluation, (ii) a pre-tax charge of $7 million ($5 million after-tax, or $0.02 per diluted share) related to pension settlements; and (iii) a pre-tax charge of $36 million ($22 million after-tax, or $0.07 per diluted share) related to a bond redemption. |
Amounts for 2013 include: (i) a pre-tax charge of $23 million ($23 million after-tax, or $0.08 per diluted share) related to the Venezuela currency devaluation; (ii) a pre-tax charge of $9 million ($6 million after-tax, or $0.02 per diluted share) related to pension settlements; (iii) an income tax benefit of $40 million ($24 million net of noncontrolling interests, or $0.08 per diluted share) related to a realignment of the Italian legal structure; and (iv) a pre-tax charge of $18 million ($12 million after-tax, or $0.04 per diluted share) related to a bond redemption.
14
Amounts for 2012 include: (i) a pre-tax charge of $56 million, ($38 million after-tax and non-controlling interests, or $0.12 per diluted share) related to the 2012 cost reduction program; (ii) a pre-tax charge of $9 million ($6 million after-tax, or $0.02 per diluted share) related to pension settlement; and (iii) an income tax benefit of $55 million ($0.18 per diluted share) related to a loss on a liquidated subsidiary as a result of the divestiture of the U.S. Homecare business.
Amounts for 2011 include: (i) a pre-tax net gain on acquisition of $39 million ($37 million after-tax, or $0.12 per diluted share); and (ii) a pre-tax charge of $40 million ($31 million after-tax, or $0.10 per diluted share) relating to the 2011 cost reduction program.
Amounts for 2010 include: (i) an income tax charge of $250 million related to a Spanish income tax settlement ($0.80 per diluted share); (ii) a pre-tax charge of $58 million ($40 million after-tax, or $0.13 per diluted share) related to the U.S. homecare divestiture; (iii) a net repatriation tax benefit of $35 million ($0.11 per diluted share); and (iv) a pre-tax charge of $27 million ($26 million after-tax, or $0.08 per diluted share) related to the Venezuela currency devaluation.
See Notes 2, 5 and 7 to the consolidated financial statements.
(b) | Non-GAAP measures. See the “Non-GAAP Financial Measures” section in Item 7 for definitions and reconciliation to reported amounts. |
15
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion of the company’s financial condition and results of operations should be read together with its consolidated financial statements and notes to the consolidated financial statements included in Item 8 of this Form 10-K.
Page | |
Business Overview | |
Executive Summary – Financial Results & Outlook | |
Consolidated Results and Other Information | |
Segment Discussion | |
Liquidity, Capital Resources and Other Financial Data | |
Contractual Obligations | |
Off-Balance Sheet Arrangements | |
Critical Accounting Policies | |
New Accounting Standards | |
Fair Value Measurements | |
Non-GAAP Financial Measures | |
Forward-Looking Statements | |
BUSINESS OVERVIEW
Praxair is the largest industrial gases supplier in North and South America, is rapidly growing in Asia, and has strong, well-established businesses in Europe. The Company's primary products in its industrial gases business are atmospheric gases (oxygen, nitrogen, argon, rare gases) and process gases (carbon dioxide, helium, hydrogen, electronic gases, specialty gases, acetylene). The company also designs, engineers, and builds equipment that produces industrial gases primarily for internal use. The company’s surface technologies segment supplies wear-resistant and high-temperature corrosion-resistant metallic and ceramic coatings and powders. Praxair Surface Technologies supplies high-performance coatings that protect metal parts from wear, corrosion and high heat. Praxair’s industrial gas operations are managed on a geographical basis and in 2014, 94% of sales were generated in four geographic segments (North America, Europe, South America, and Asia). The surface technologies segment generated the remaining 6% of sales.
Praxair serves a diverse group of industries including healthcare, petroleum refining, computer-chip manufacturing, beverage carbonation, fiber-optics, steel making, aerospace, chemicals and water treatment. The diversity of end markets creates financial stability for Praxair in varied business cycles.
Praxair generates most of its revenues and earnings in the following 12 core geographies where the company has its strongest market positions and where distribution and production operations allow the company to deliver the highest level of service to its customers at the lowest cost.
North America | South America | Europe | Asia | |||
United States | Brazil | Spain | China | |||
Canada | Italy | India | ||||
Mexico | Germany/Benelux | Korea | ||||
Scandinavia | Thailand | |||||
Praxair manufactures and distributes its products through networks of hundreds of production plants, pipeline complexes, distribution centers and delivery vehicles. Major pipeline complexes are located in the United States, Brazil, Spain and Germany. These networks are a competitive advantage, providing the foundation of reliable product supply to the company’s customer base. The majority of Praxair’s business is conducted through long-term contracts which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers. The company has growth opportunities in all major geographies and in diverse end-markets such as energy, chemicals, metals, healthcare and food and beverage.
16
EXECUTIVE SUMMARY – FINANCIAL RESULTS & OUTLOOK
2014 Year in review
Praxair delivered solid results for the full year of 2014 despite a challenging global environment including foreign currency translation headwinds and slowing growth in most major emerging markets. Sales growth came primarily from strong volume growth in North America and Asia, higher overall pricing and acquisitions. This was partially offset by the impact of negative currency translation in most geographies due to a strengthening U.S. dollar.
• | Sales of $12,273 million were 3% above 2013 sales of $11,925 million. Excluding negative currency impacts, sales grew 6% primarily due to organic sales growth including new project start-ups and acquisitions. |
• | Reported operating profit of $2,608 million decreased 1% from $2,625 million in 2013. Adjusted operating profit of $2,746 million increased 3% from 2013, from higher volumes, pricing, and acquisitions, partially offset by negative currency effects.* |
• | Reported net income – Praxair, Inc. of $1,694 million and diluted earnings per share of $5.73 decreased from $1,755 million and $5.87, respectively, in 2013. Adjusted net income – Praxair, Inc. of $1,852 million and adjusted diluted earnings per share of $6.27 increased 5% and 6% from 2013, respectively. Earnings per share grew faster than net income primarily due to fewer shares outstanding as a result of share repurchases during the year.* |
• | Cash flow from operations was a strong $2,868 million, 23% of sales. |
• | Capital expenditures were $1,689 million, primarily for the construction of growth projects. Acquisition expenditures of $206 million primarily included the acquisition of industrial gas businesses in Italy and Asia, and packaged gas businesses in North and South America. |
2015 Outlook
• | Sales are forecasted to be in the range of $12.0 to $12.4 billion. |
• | Diluted earnings per share are forecasted to be in the range of $6.15 to $6.50. |
• | Effective tax rate of about 28%. |
• | Capital expenditures of about $1.7 billion. |
• | The company’s core business is to build, own, and operate industrial gas plants in order to supply atmospheric and process gases to customers. As such, Praxair believes that its backlog is an indicator of future sales growth. At December 31, 2014, Praxair’s backlog of 24 large projects under construction was $1.9 billion. This represents the total estimated capital cost of large plants under construction. North America and Asia each represent about one-third of the backlog. The remaining backlog resides in Europe, primarily in Russia, and in South America. These plants will supply customers in the energy, chemical, manufacturing, electronics and metals markets. |
* A reconciliation of the Adjusted amounts can be found in the "Non-GAAP Financial Measures" section in this MD&A. See Notes 2, 5 and 11 to the consolidated financial statements.
The above guidance should be read in conjunction with the section entitled “Forward-Looking Statements.”
Praxair provides quarterly updates on operating results, material trends that may affect financial performance, and financial earnings guidance via earnings releases and investor teleconferences. These materials are available on the company’s website, www.praxair.com/investors but are not incorporated herein.
17
CONSOLIDATED RESULTS AND OTHER INFORMATION
The following table provides selected data for 2014, 2013, and 2012:
Variance | |||||||||||||||||
(Dollar amounts in millions, except per share data) Year Ended December 31, | 2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | ||||||||||||
Reported Amounts: | |||||||||||||||||
Sales | $ | 12,273 | $ | 11,925 | $ | 11,224 | 3 | % | 6 | % | |||||||
Gross margin (a) | $ | 5,311 | $ | 5,181 | $ | 4,828 | 3 | % | 7 | % | |||||||
As a percent of sales | 43.3 | % | 43.4 | % | 43.0 | % | |||||||||||
Selling, general and administrative | $ | 1,308 | $ | 1,349 | $ | 1,270 | (3 | )% | 6 | % | |||||||
As a percent of sales | 10.7 | % | 11.3 | % | 11.3 | % | |||||||||||
Depreciation and amortization | $ | 1,170 | $ | 1,109 | $ | 1,001 | 6 | % | 11 | % | |||||||
Venezuela currency devaluation and other charges – net (b) | $ | 138 | $ | 32 | $ | 65 | |||||||||||
Other income (expenses) – net | $ | 9 | $ | 32 | $ | 43 | |||||||||||
Operating profit | $ | 2,608 | $ | 2,625 | $ | 2,437 | (1 | )% | 8 | % | |||||||
As a percent of sales | 21.2 | % | 22.0 | % | 21.7 | % | |||||||||||
Interest expense – net | $ | 213 | $ | 178 | $ | 141 | 20 | % | 26 | % | |||||||
Effective tax rate | 28.9 | % | 26.5 | % | 25.5 | % | |||||||||||
Income from equity investments | $ | 42 | $ | 38 | $ | 34 | 11 | % | 12 | % | |||||||
Noncontrolling interests | $ | (52 | ) | $ | (81 | ) | $ | (52 | ) | (36 | )% | 56 | % | ||||
Net income – Praxair, Inc. | $ | 1,694 | $ | 1,755 | $ | 1,692 | (3 | )% | 4 | % | |||||||
Diluted earnings per share | $ | 5.73 | $ | 5.87 | $ | 5.61 | (2 | )% | 5 | % | |||||||
Diluted shares outstanding | 295,608 | 298,965 | 301,845 | (1 | )% | (1 | )% | ||||||||||
Number of employees | 27,780 | 27,560 | 26,539 | ||||||||||||||
Adjusted Amounts (c): | |||||||||||||||||
Operating profit | $ | 2,746 | $ | 2,657 | $ | 2,502 | 3 | % | 6 | % | |||||||
As a percent of sales | 22.4 | % | 22.3 | % | 22.3 | % | |||||||||||
Interest expense – net | $ | 177 | $ | 160 | $ | 141 | 11 | % | 13 | % | |||||||
Effective tax rate | 27.5 | % | 28.0 | % | 28.0 | % | |||||||||||
Noncontrolling interests | $ | (52 | ) | $ | (65 | ) | $ | (54 | ) | ||||||||
Net income – Praxair, Inc. | $ | 1,852 | $ | 1,772 | $ | 1,681 | 5 | % | 5 | % | |||||||
Diluted earnings per share | $ | 6.27 | $ | 5.93 | $ | 5.57 | 6 | % | 6 | % | |||||||
________________________
(a) | Gross margin excludes depreciation and amortization expense. |
(b) | See Note 2 to the consolidated financial statements. |
(c) | Adjusted amounts are non-GAAP measures. A reconciliation of reported amounts to adjusted amounts can be found in the “Non-GAAP Financial Measures” section of this MD&A. See Notes 2, 5 and 7 to the consolidated financial statements. |
18
Results of Operations
The following table provides a summary of changes in consolidated sales and adjusted operating profit:
2014 vs. 2013 | 2013 vs. 2012 | |||||||||||
% Change | % Change | |||||||||||
Sales | Operating Profit | Sales | Operating Profit | |||||||||
Factors Contributing to Changes | ||||||||||||
Volume | 3 | % | 1 | % | 3 | % | 1 | % | ||||
Price | 2 | % | 8 | % | 2 | % | 8 | % | ||||
Cost pass-through | — | % | — | % | — | % | — | % | ||||
Currency | (3 | )% | (7 | )% | (2 | )% | (2 | )% | ||||
Acquisitions/Divestitures | 1 | % | 1 | % | 3 | % | 3 | % | ||||
Other | — | % | (4 | )% | — | % | (2 | )% | ||||
Reported | 3 | % | (1 | )% | 6 | % | 8 | % | ||||
Venezuela currency devaluation and other charges, net | — | % | 4 | % | — | % | (2 | )% | ||||
Adjusted | 3 | % | 3 | % | 6 | % | 6 | % | ||||
The following tables provide consolidated sales by end-market and distribution method:
% of Sales | % Change* | ||||||||||||||
2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | |||||||||||
Sales by End Markets | |||||||||||||||
Manufacturing | 24 | % | 24 | % | 25 | % | 3 | % | 2 | % | |||||
Metals | 17 | % | 17 | % | 18 | % | 4 | % | 7 | % | |||||
Energy | 14 | % | 13 | % | 11 | % | 8 | % | 10 | % | |||||
Chemicals | 10 | % | 10 | % | 10 | % | 1 | % | 9 | % | |||||
Electronics | 7 | % | 8 | % | 8 | % | — | % | 1 | % | |||||
Healthcare | 8 | % | 8 | % | 8 | % | 4 | % | 4 | % | |||||
Food & Beverage | 8 | % | 8 | % | 6 | % | 7 | % | 1 | % | |||||
Aerospace | 3 | % | 3 | % | 3 | % | 1 | % | 4 | % | |||||
Other | 9 | % | 9 | % | 11 | % | 10 | % | 1 | % | |||||
100 | % | 100 | % | 100 | % | ||||||||||
* Excludes impact of currency, natural gas/precious metals cost pass-through and acquisitions/divestitures.
% of Sales | |||||||||
2014 | 2013 | 2012 | |||||||
Sales by Distribution Method | |||||||||
On-Site | 29 | % | 27 | % | 26 | % | |||
Merchant | 34 | % | 34 | % | 33 | % | |||
Packaged Gas | 28 | % | 30 | % | 31 | % | |||
Other | 9 | % | 9 | % | 10 | % | |||
100 | % | 100 | % | 100 | % | ||||
19
2014 Compared With 2013
Sales increased 3% to $12,273 million in 2014 compared to $11,925 million in 2013. Organic sales grew 5% from higher pricing and volume growth primarily in North America and Asia due to new plant start-ups. Acquisitions, including NuCO2, several packaged gas distributors in the U.S. and the acquisition of Dominion Technology Gases Investment Limited in 2013, contributed 1% to overall sales growth. These increases were partially offset by negative currency translation impacts, resulting from the strengthening of the U.S. dollar against most currencies.
Gross margin increased $130 million, or 3%, versus 2013 in line with the increase in sales.
Selling, general and administrative ("SG&A") expenses in 2014 were $1,308 million, or 10.7% of sales, versus $1,349 million, or 11.3% of sales, for 2013. Currency impacts decreased SG&A by $36 million and other cost reductions, primarily lower pension and other post-retirement benefit expense, reduced SG&A by an additional $24 million. These reductions were partially offset by an increase due to acquisitions.
Depreciation and amortization expense increased $61 million versus 2013. This increase was primarily due to plant start-ups and asset additions, and approximately $12 million related to acquisitions, partially offset by currency effects of $27 million.
Other income (expenses) – net in 2014 was a $9 million benefit versus a $32 million benefit in 2013 (see Note 7 to the consolidated financial statements for a summary of major components). Partnership income of $16 million improved $9 million and relates primarily to a partnership joint venture in the United States, while gains from business and asset sales of $36 million were $7 million less than 2013 and was spread across all segments. Severance expense of $22 million increased $8 million from 2013, reflecting actions taken in response to current market conditions outside of the United States and included $15 million in the fourth quarter. 2013 also included a $10 million favorable litigation settlement in South America. Other components were not significant.
Reported operating profit of $2,608 million in 2014 was $17 million, or 1% lower than reported operating profit of $2,625 million in 2013. 2014 included a $131 million charge related to Venezuela currency devaluation and a $7 million charge related to a pension settlement. The 2013 period included a $23 million charge related to the Venezuela currency devaluation and $9 million charge related to a pension settlement. Refer to note 2 of the consolidated financial statements for a further discussion of these items. Adjusted operating profit of $2,746 million in 2014 was $89 million, or 3% higher than adjusted operating profit of $2,657 million in 2013. A discussion of operating profit by segment is included in the segment discussion that follows.
Reported interest expense – net in 2014 increased $35 million, versus 2013. Both the 2014 and 2013 included charges of $36 million and $18 million, respectively, relating to the early redemption of notes (see note 7 to the consolidated financial statements). Excluding these charges, adjusted interest expense increased $17 million. Higher debt levels and lower capitalized interest increased interest expense by approximately $13 million and $31 million, respectively, versus 2013. The amount of interest capitalized decreased due to lower interest rates, lower construction expenditures, and currency impacts. These increases were partially offset by the benefits of lower overall interest rates which reduced interest expense by approximately $23 million. See Note 7 to the consolidated financial statements for further information relating to interest expense.
The effective tax rate ("ETR") for 2014 was 28.9% versus 26.5% in 2013. The adjusted effective tax rate was 27.5% in 2014 versus 28.0% in 2013. The 0.5% decrease in the ETR was primarily due to increased foreign tax differentials (see Note 5 to the Consolidated financial statements).
Praxair’s significant equity investments are in the United States, China, Italy, and the Middle East. Equity income increased $4 million in 2014 related primarily to higher equity income in Europe versus 2013.
At December 31, 2014, reported noncontrolling interests consisted primarily of noncontrolling shareholders’ investments in Asia (primarily in China and India), Europe (primarily in Italy and Scandinavia), and North America (primarily within the U.S. packaged gas business). Reported noncontrolling interest in 2014 decreased $29 million from 2013. The decrease was primarily due to the minority shareholder's portion of the income tax benefit in Italy of $16 million related to a legal realignment during 2013. Excluding the Italy realignment, adjusted noncontrolling interest in 2014 was $52 million compared to $65 million in 2013. This decrease was due primarily to the acquisition of the noncontrolling interest in a U.S. packaged gas business during the first quarter of 2014.
Reported net income - Praxair, Inc. in 2014 was $1,694 million, or $61 million lower than net income - Praxair, Inc. of $1,755 million in 2013. Adjusted net income – Praxair, Inc. of $1,852 million in 2014 was $80 million, or 5% higher than adjusted net income – Praxair, Inc. of $1,772 million in 2013. This increase was primarily due to higher adjusted operating profit.
20
Reported diluted earnings per share ("EPS") of $5.73 in 2014 decreased $0.14 per diluted share, or 2% from $5.87 in 2013. Adjusted diluted EPS of $6.27 in 2014 increased $0.34 per diluted share, or 6%, from adjusted diluted EPS of $5.93 in 2013. The increase in adjusted diluted EPS was primarily due to higher adjusted net income – Praxair, Inc. and a 1.1% decrease in the number of diluted shares outstanding as a result of the company’s net repurchases of common stock during 2014.
Other comprehensive loss at December 31, 2014 of $1,257 million includes negative currency translation adjustments of $1,096 million, a negative adjustment of $164 million related to the funded status of retirement obligations and a positive adjustment of $3 million related to derivative instruments. The translation adjustments reflect the impact of translating local currency foreign subsidiary financial statements to U.S. dollars and resulted from currency movements, primarily $369 million in Europe, $331 million in South America, and $238 million in North America. The negative pension funded status adjustment resulted primarily from after-tax actuarial losses from lower discount rates and the adoption of new mortality rate assumptions, both of which increased the pension benefit obligation ("PBO"). See the “Currency” section of the MD&A, and Notes 7 and 16 to the consolidated financial statements.
The number of employees at December 31, 2014 was 27,780, reflecting an increase of 220 employees from December 31, 2013. This increase primarily reflects the impact of acquisitions during the current year.
2013 Compared With 2012
Sales increased 6% to $11,925 million during 2013 compared to $11,224 million in 2012. Higher volumes, primarily in North and South America and in Asia, higher overall pricing and growth from acquisitions were partially offset by negative currency translation impacts, primarily resulting from the strengthening of the U.S. dollar against the Brazilian Real. Cost pass-through had minimal impact due to lower precious metal prices offsetting energy cost inflation.
Gross margin increased $353 million, or 7%, versus 2012. The increase was due to higher volumes and higher pricing, resulting in an increase in the gross margin percentage to 43.4%, versus 43.0% in the prior year.
Selling, general and administrative ("SG&A") expenses in 2013 were $1,349 million, or 11.3% of sales, versus $1,270 million, or 11.3% of sales, for 2012. The increase in SG&A expense of $79 million was primarily due to the impact of acquisitions ($56 million). In addition, pension expense increased $26 million due to an increase in the amortization of net actuarial losses, primarily attributable to lower discount rates. Currency effects reduced SG&A expense by $14 million.
Depreciation and amortization expense increased $108 million versus 2012. This increase was primarily due to an increase of $42 million from acquisitions and approximately $70 million from plant start-ups and asset additions, partially offset by currency effects of $13 million.
Other income (expenses) – net in 2013 was a $32 million benefit versus a $43 million benefit in 2012. Other income was higher in 2012 primarily due to a larger favorable litigation settlements in South America. See Note 7 to the consolidated financial statements for a summary of the major components of Other income (expenses) – net.
Reported operating profit of $2,625 million in 2013 was $188 million, or 8% higher than reported operating profit of $2,437 million in 2012. As a percentage of sales, reported operating profit increased to 22.0% in 2013 from 21.7% in 2012. This is primarily due to the attainment of price increases in most geographies. The 2013 period includes a $23 million charge related to the Venezuela currency devaluation and $9 million charge related to a pension settlement. The 2012 period also included a pension settlement charge of $9 million as well as a $56 million charge for cost reduction programs. Adjusted operating profit of $2,657 million in 2013 was $155 million, or 6% higher than adjusted operating profit of $2,502 million in 2012. A discussion of operating profit by segment is included in the segment discussion that follows.
Reported interest expense – net in 2013 increased $37 million, versus 2012. The increase included an $18 million charge recognized upon the early redemption of the $400 million 5.25% Notes due in 2014. Excluding this charge, adjusted interest expense increased $19 million. Higher overall debt levels increased interest expense by about $45 million, and reduced benefits from the amortization of interest rate swap gains increased interest expense by $11 million versus 2012. Lower interest rates reduced interest expense by approximately $37 million dollars. See Note 7 to the consolidated financial statements for further information relating to interest expense.
The effective tax rate for 2013 was 26.5% versus 25.5% in 2012. 2013 included a $40 million benefit as a result of a realignment of Praxair's Italian legal structure, and 2012 included a $55 million income tax benefit related to the loss on a liquidated subsidiary (See Note 5 to the consolidated financial statements). The adjusted effective tax rate for both 2012 and 2013 was 28.0%.
21
Praxair’s significant equity investments are in the United States, China, Italy, and the Middle East. Equity income increased $4 million in 2013 related primarily to higher equity income in China.
At December 31, 2013, reported noncontrolling interests consisted primarily of noncontrolling shareholders’ investments in Asia (primarily in China and India), Europe (primarily in Italy and Scandinavia), and North America (primarily within the U.S. packaged gas business). The $29 million increase in reported noncontrolling interests in 2013 was primarily due to the minority shareholder's portion of the income tax benefit in Italy related to the company's legal realignment. Adjusted noncontrolling interest in 2013 was $65 million compared to $54 million in 2012. This increase is primarily driven by improved performance by the U.S. packed gas and Italian investments.
Reported net income - Praxair, Inc. in 2013 was $1,755 million, or $63 million above net income - Praxair, Inc. of $1,692 million in 2012. Adjusted net income – Praxair, Inc. of $1,772 million in 2013 was $91 million, or 5% higher than adjusted net income – Praxair, Inc. of $1,681 million in 2012. This increase was primarily due to higher adjusted operating profit partially offset by higher interest expense and increased income tax expense.
Reported diluted earnings per share ("EPS") of $5.87 in 2013 increased $0.26 per diluted share, or 5% from $5.61 in 2012. Adjusted diluted EPS of $5.93 in 2013 increased $0.36 per diluted share, or 6%, from adjusted diluted EPS of $5.57 in 2012. The increase in adjusted diluted EPS was primarily due to higher net income – Praxair, Inc. and a 1.0% decrease in the number of diluted shares outstanding as a result of the company’s net repurchases of common stock during 2013.
Other comprehensive loss at December 31, 2013 of $123 million includes negative currency translation adjustments of $447 million, a positive after-tax adjustment of $323 million related to the funded status of retirement obligations and a positive adjustment of $1 million related to derivative instruments. The negative translation adjustment primarily resulted from currency movements of $342 million in South America and $137 million in North America. The positive pension funded status impact is driven principally by actuarial gains and losses of $395 million. Of this amount $165 million relates to asset returns in excess of assumed returns. The remaining $230 million primarily relates to the impact of higher discount rates. See the “Currency” section of the MD&A, and Notes 7 and 16 to the consolidated financial statements.
The number of employees at December 31, 2013 was 27,560, reflecting an increase of 1,021 employees from December 31, 2012. This increase primarily reflects the impact of the NuCO2 acquisition.
Related Party Transactions
The company’s related parties are primarily unconsolidated equity affiliates. The company did not engage in any material transactions involving related parties that included terms or other aspects that differ from those which would be negotiated with independent parties.
Environmental Matters
Praxair’s principal operations relate to the production and distribution of atmospheric and other industrial gases, which historically have not had a significant impact on the environment. However, worldwide costs relating to environmental protection may continue to grow due to increasingly stringent laws and regulations, and Praxair's ongoing commitment to rigorous internal standards.
Climate Change
Praxair operates in jurisdictions that have, or are developing, laws and/or regulations to reduce or mitigate the perceived adverse effects of greenhouse gas ("GHG") emissions and faces a highly uncertain regulatory environment in this area. For example, the U.S. Environmental Protection Agency ("EPA") has promulgated rules requiring reporting of GHG emissions, and Praxair and many of its suppliers and customers are subject to these rules. EPA has also promulgated regulations to restrict GHG emissions, including final rules regulating GHG emissions from light-duty vehicles and certain large manufacturing facilities, many of which are Praxair suppliers or customers. EPA recently proposed carbon dioxide regulations for both new and existing power plants, which will require controls on GHG emissions from certain suppliers of power to Praxair’s operations. In addition to these developments in the United States, there has been regulation of GHGs in the European Union under the Emissions Trading System, which have wide implications for our customers and may impact certain operations of Praxair in Europe. Also, climate change and energy efficiency laws and policies are being widely embraced by jurisdictions throughout Latin America and Mexico.. There are also requirements for mandatory reporting in Quebec, Canada, which apply to certain Praxair operations and will be used in developing cap-and-trade regulations on GHG emissions, which are expected to impact certain Praxair facilities. China has also announced plans to launch a national carbon emissions trading system in 2016, though it does not appear the regulations will have a direct
22
impact on GHG emissions from Praxair facilities. Among other impacts, such regulations are expected to raise the costs of energy, which is a significant cost for Praxair. Nevertheless, Praxair's customer contracts routinely provide rights to recover increased electricity, natural gas, and other costs that are incurred by the company.
Praxair anticipates continued growth in its hydrogen business, as hydrogen is essential to refineries which use it to remove sulfur from transportation fuels in order to meet ambient air quality standards in the United States. Hydrogen production plants and a large number of other manufacturing and electricity-generating plants have been identified under California law as a source of carbon dioxide emissions and these plants have also become subject to recently promulgated cap-and-trade regulations in that state. Praxair believes it will be able to mitigate the costs of these regulations through the terms of its product supply contracts. However, legislation that limits GHG emissions may impact growth by increasing operating costs and/or decreasing demand.
To manage these potential business risks from potential GHG emission regulation, Praxair actively monitors current developments, evaluates the direct and indirect business risks, and takes appropriate actions. Among others, actions include: increasing relevant resources and training; consulting with vendors, insurance providers and industry experts; incorporating GHG provisions in commercial agreements; and conducting regular reviews of the business risks with management. Although there are considerable uncertainties, Praxair believes that the business risk from potential regulations can be effectively managed through its commercial contracts. Additionally, Praxair does not anticipate any material effects regarding its plant operations or business arising from potential physical risks of climate change. Also, Praxair continuously seeks opportunities to reduce its own energy use and GHG footprint through rigorous energy efficiency as well as purchasing hydrogen as a chemical byproduct where feasible..
At the same time, Praxair may benefit from business opportunities arising from governmental regulation of GHG and other emissions; rising costs of many energy and natural resources; new technologies to extract natural gas; and the development of renewable energy alternatives. Praxair continues to develop new applications technologies that can lower emissions, including GHG emissions, in Praxair's processes and help customers lower energy consumption and increase product throughput. Stricter regulation of water quality in emerging economies such as China provide a growing market for a number of gases, e.g., oxygen for wastewater treatment. Renewable fuel standards in the European Union and U.S. create a market for second-generation biofuels which are users of industrial gases such as oxygen, carbon dioxide, and hydrogen.
Costs Relating to the Protection of the Environment
Environmental protection costs in 2014 included approximately $12 million in capital expenditures and $29 million of expenses. Praxair anticipates that future annual environmental protection expenditures will be similar to 2014, subject to any significant changes in existing laws and regulations. Based on historical results and current estimates, management does not believe that environmental expenditures will have a material adverse effect on the consolidated financial position, the consolidated results of operations or cash flows in any given year.
Legal Proceedings
See Note 17 to the consolidated financial statements for information concerning legal proceedings.
Retirement Benefits
Pensions
The net periodic benefit cost for the U.S. and International pension plans was $82 million in 2014, $119 million in 2013 and $93 million in 2012. Consolidated net periodic benefit cost included settlement charges of $7 million, $9 million and $10 million in 2014, 2013 and 2012, respectively.
The funded status (pension benefit obligation ("PBO") less the fair value of plan assets) for the U.S. plans was a deficit of $443 million as December 31, 2014 versus a deficit of $171 million at December 31, 2013. This increase was due to lower discount rates and new mortality assumptions which both increased the PBO.
Global pension contributions were $18 million in 2014, $52 million in 2013 and $184 million in 2012. At a minimum, Praxair contributes to its pension plans to comply with local regulatory requirements (e.g., ERISA in the United States). Discretionary contributions in excess of the local minimum requirements are made based on many factors, including long-term projections of the plans' funded status, the economic environment, potential risk of overfunding, pension insurance costs and alternative uses of the cash. Changes to these factors can impact the timing of discretionary
23
contributions from year to year. Estimated required contributions for 2015 are currently expected to be in the area of $15 million.
Praxair assumes an expected return on plan assets for 2015 in the United States of 8.00%, which is consistent with the long-term expected return on its investment portfolio.
Excluding the impact of any settlements, 2015 consolidated pension expense is expected to be approximately $95 million. The increase is due primarily to higher net actuarial losses to be amortized as a result of a decrease in the discount rates and new mortality assumptions. The amortization is recognized based on the amount of net actuarial gains/losses above certain thresholds and over the periods of either the average remaining service lives or the average remaining life expectancies of the retirees.
OPEB
The net periodic benefit cost for OPEB plans was $7 million in 2014, $11 million in 2013 and $9 million in 2012. The funded status deficit decreased $28 million during 2014 primarily due to favorable plan experience.
In 2015, consolidated net periodic benefit costs for the OPEB plans is expected to be approximately $8 million.
See the Critical Accounting Policies section and Note 16 to the consolidated financial statements for a more detailed discussion of the company’s retirement benefits, including a description of the various retirement plans and the assumptions used in the calculation of net periodic benefit cost and funded status.
Insurance
Praxair purchases insurance to limit a variety of property and casualty risks, including those related to property, business interruption, third-party liability and workers’ compensation. Currently, the company self-retains the first $5 million per occurrence for workers’ compensation, general and vehicle liability in the United States and retains $2.5 million to $5 million per occurrence at its various properties worldwide. To mitigate its aggregate loss potential above these retentions, the company purchases insurance coverage from highly rated insurance companies. The company does not currently operate or participate in any captive insurance companies.
At December 31, 2014 and 2013, the company had recorded a total of $33 million representing an estimate of the retained liability for the ultimate cost of claims incurred and unpaid as of the balance sheet dates. The estimated liability is established using statistical analysis and is based upon historical experience, actuarial assumptions and professional judgment. These estimates are subject to the effects of trends in loss severity and frequency and are subject to a significant degree of inherent variability. If actual claims differ from the company’s estimates, they will be adjusted at that time and financial results could be impacted.
Praxair recognizes estimated insurance proceeds relating to damages at the time of loss only to the extent of incurred losses. Any insurance recoveries for business interruption and for property damages in excess of the net book value of the property are recognized only when realized.
SEGMENT DISCUSSION
The following summary of sales and operating profit by segment provides a basis for the discussion that follows (for additional information concerning Praxair’s segments, see Note 18 to the consolidated financial statements). Praxair evaluates the performance of its reportable segments based on operating profit, excluding the items not indicative of ongoing business trends (See Note 2 to the consolidated financial statements).
24
(Dollar amounts in millions) Year Ended December 31, | Variance | ||||||||||||||||
2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | |||||||||||||
Sales | |||||||||||||||||
North America | $ | 6,436 | $ | 6,164 | $ | 5,598 | 4 | % | 10 | % | |||||||
Europe | 1,546 | 1,542 | 1,474 | — | % | 5 | % | ||||||||||
South America | 1,993 | 2,042 | 2,082 | (2 | )% | (2 | )% | ||||||||||
Asia | 1,619 | 1,525 | 1,414 | 6 | % | 8 | % | ||||||||||
Surface Technologies | 679 | 652 | 656 | 4 | % | (1 | )% | ||||||||||
$ | 12,273 | $ | 11,925 | $ | 11,224 | 3 | % | 6 | % | ||||||||
Operating Profit | |||||||||||||||||
North America | $ | 1,580 | $ | 1,538 | $ | 1,465 | 3 | % | 5 | % | |||||||
Europe | 291 | 270 | 256 | 8 | % | 5 | % | ||||||||||
South America | 449 | 467 | 429 | (4 | )% | 9 | % | ||||||||||
Asia | 303 | 271 | 246 | 12 | % | 10 | % | ||||||||||
Surface Technologies | 123 | 111 | 106 | 11 | % | 5 | % | ||||||||||
Segment operating profit | 2,746 | 2,657 | 2,502 | 3 | % | 6 | % | ||||||||||
Venezuela currency devaluation and other charges | (138 | ) | (32 | ) | (65 | ) | |||||||||||
Consolidated operating profit | $ | 2,608 | $ | 2,625 | $ | 2,437 | |||||||||||
North America
(Dollar amounts in millions) Year Ended December 31, | Variance | ||||||||||||||||
2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | |||||||||||||
Sales | $ | 6,436 | $ | 6,164 | $ | 5,598 | 4 | % | 10 | % | |||||||
Cost of sales, exclusive of depreciation and amortization | 3,514 | 3,301 | 2,968 | ||||||||||||||
Gross margin | 2,922 | 2,863 | 2,630 | ||||||||||||||
Operating expenses | 731 | 759 | 667 | ||||||||||||||
Depreciation and amortization | 611 | 566 | 498 | ||||||||||||||
Operating profit | $ | 1,580 | $ | 1,538 | $ | 1,465 | 3 | % | 5 | % | |||||||
Margin % | 24.5 | % | 25.0 | % | 26.2 | % | |||||||||||
25
2014 vs. 2013 | 2013 vs. 2012 | |||||||||||
% Change | % Change | |||||||||||
Sales | Operating Profit | Sales | Operating Profit | |||||||||
Factors Contributing to Changes | ||||||||||||
Volume | 3 | % | 1 | % | 2 | % | 1 | % | ||||
Price | 1 | % | 5 | % | 2 | % | 8 | % | ||||
Cost pass-through | 1 | % | — | % | 1 | % | — | % | ||||
Currency | (2 | )% | (2 | )% | — | % | — | % | ||||
Acquisitions/Divestitures | 1 | % | 1 | % | 5 | % | 5 | % | ||||
Other | — | % | (2 | )% | — | % | (9 | )% | ||||
4 | % | 3 | % | 10 | % | 5 | % | |||||
The following tables provide sales by end-market and distribution method:
% of Sales | % Change* | ||||||||||||||
2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | |||||||||||
Sales by End Markets | |||||||||||||||
Manufacturing | 30 | % | 30 | % | 32 | % | 3 | % | 3 | % | |||||
Metals | 12 | % | 13 | % | 14 | % | 1 | % | 1 | % | |||||
Energy | 20 | % | 19 | % | 17 | % | 9 | % | 13 | % | |||||
Chemicals | 10 | % | 10 | % | 11 | % | 3 | % | 4 | % | |||||
Electronics | 4 | % | 5 | % | 5 | % | 7 | % | (8 | )% | |||||
Healthcare | 7 | % | 7 | % | 7 | % | 2 | % | — | % | |||||
Food & Beverage | 8 | % | 8 | % | 5 | % | 4 | % | (1 | )% | |||||
Aerospace | 1 | % | 1 | % | 1 | % | (1 | )% | 14 | % | |||||
Other | 8 | % | 7 | % | 8 | % | 8 | % | — | % | |||||
100 | % | 100 | % | 100 | % | ||||||||||
* Excludes impact of currency, natural gas/precious metals cost pass-through and acquisitions/divestitures.
% of Sales | |||||||||
2014 | 2013 | 2012 | |||||||
Sales by Distribution Method | |||||||||
On-Site | 30 | % | 28 | % | 27 | % | |||
Merchant | 36 | % | 36 | % | 35 | % | |||
Packaged Gas | 32 | % | 34 | % | 36 | % | |||
Other | 2 | % | 2 | % | 2 | % | |||
100 | % | 100 | % | 100 | % | ||||
The North America segment includes Praxair’s industrial gases operations in the United States, Canada and Mexico.
Sales for 2014 increased $272 million, or 4%, versus 2013. Organic sales growth was 4% driven primarily by higher pricing and higher volumes. Volume growth came from higher on-site volumes from new project start-ups including hydrogen supply to refinery customers in the United States, and higher merchant and packaged gas volumes. Sales growth was strongest in the energy, manufacturing, and food and beverage end-markets. The strong sales growth to the energy end-market was primarily due to hydrogen project start-ups. Acquisitions, primarily NuCO2 and several packaged gas distributors in the U.S., added 1% sales growth. Higher cost pass-through, primarily higher natural gas prices passed through to hydrogen customers, increased sales by 1%. Packaged gases sales were higher for 2014, primarily due to growth in the U.S. business, however are lower as a percentage of total sales for the segment as compared to the prior-year period, due to strong growth in on-site sales.
26
Operating profit for 2014 increased $42 million, or 3% from 2013. Operating profit grew 5% excluding currency translation impacts primarily driven by higher pricing. The increase was due to higher gross margin and lower operating expenses, partially offset by $45 million increase in depreciation and amortization expense due to new project start-ups and acquisitions. Operating profit during 2014 included a $9 million benefit related to a change in accounting principle for LIFO inventories in the United States (see notes 1 and 7 to the consolidated financial statements). Operating profit in 2013 included a $23 million customer contract settlement.
Sales for 2013 increased $566 million, or 10%, versus 2012. Underlying sales growth was 4% driven primarily by higher on-site volumes from new project start-ups for hydrogen supply to refinery customers in the United States, higher merchant volumes and higher pricing. Sales grew to the energy, chemicals, manufacturing, and food and beverage end-markets. Strong sales growth to the energy end-market was primarily due to hydrogen project start-ups. Acquisitions, primarily NuCO2, added 5% sales growth and contributed to the 3% increase of total sales represented by the food and beverage end-market in 2013. Higher cost pass-through, primarily higher natural gas prices passed through to hydrogen customers, increased sales by 1%. North American packaged gas sales were above prior year due to solid growth in the US business. However, with the growth in on-site sales due to the start-up of new hydrogen projects and the growth in merchant sales due to the acquisition of NuCO2, packaged gas sales decreased as a percentage of total sales for the segment.
Operating profit for 2013 increased $73 million, or 5% from 2012. Higher pricing, higher volumes from project start-ups and acquisitions contributed to the growth in operating profit. Operating profit included a contract settlement for $23 million. The growth was partially offset by higher operating costs and the impact of a gain on asset sale in the prior year. Depreciation and amortization increased $68 million in 2013 due to acquisitions and new project start-ups.
Europe
(Dollar amounts in millions) Year Ended December 31, | Variance | ||||||||||||||||
2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | |||||||||||||
Sales | $ | 1,546 | $ | 1,542 | $ | 1,474 | — | % | 5 | % | |||||||
Cost of sales, exclusive of depreciation and amortization | 868 | 881 | 841 | ||||||||||||||
Gross margin | 678 | 661 | 633 | ||||||||||||||
Operating expenses | 219 | 222 | 228 | ||||||||||||||
Depreciation and amortization | 168 | 169 | 149 | ||||||||||||||
Operating profit | $ | 291 | $ | 270 | $ | 256 | 8 | % | 5 | % | |||||||
Margin % | 18.8 | % | 17.5 | % | 17.4 | % | |||||||||||
2014 vs. 2013 | 2013 vs. 2012 | |||||||||||
% Change | % Change | |||||||||||
Sales | Operating Profit | Sales | Operating Profit | |||||||||
Factors Contributing to Changes | ||||||||||||
Volume | — | % | 2 | % | (1 | )% | (12 | )% | ||||
Price | 1 | % | 5 | % | 1 | % | 6 | % | ||||
Cost pass-through | (1 | )% | — | % | (1 | )% | — | % | ||||
Currency | (1 | )% | — | % | 3 | % | 3 | % | ||||
Acquisitions/Divestitures | 1 | % | 3 | % | 3 | % | 3 | % | ||||
Other | — | % | (2 | )% | — | % | 5 | % | ||||
— | % | 8 | % | 5 | % | 5 | % | |||||
27
The following tables provide sales by end-market and distribution method:
% of Sales | % Change* | ||||||||||||||
2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | |||||||||||
Sales by End Markets | |||||||||||||||
Manufacturing | 22 | % | 22 | % | 23 | % | 4 | % | (4 | )% | |||||
Metals | 16 | % | 16 | % | 16 | % | 3 | % | 2 | % | |||||
Energy | 7 | % | 6 | % | 4 | % | (4 | )% | 7 | % | |||||
Chemicals | 15 | % | 16 | % | 17 | % | (9 | )% | — | % | |||||
Electronics | 7 | % | 7 | % | 8 | % | (3 | )% | 5 | % | |||||
Healthcare | 11 | % | 11 | % | 11 | % | (1 | )% | (2 | )% | |||||
Food & Beverage | 9 | % | 9 | % | 9 | % | 5 | % | — | % | |||||
Aerospace | — | % | 1 | % | 1 | % | (11 | )% | — | % | |||||
Other | 13 | % | 12 | % | 11 | % | 2 | % | (6 | )% | |||||
100 | % | 100 | % | 100 | % | ||||||||||
* Excludes impact of currency, natural gas/precious metals cost pass-through and acquisitions/divestitures.
% of Sales | |||||||||
2014 | 2013 | 2012 | |||||||
Sales by Distribution Method | |||||||||
On-Site | 19 | % | 20 | % | 20 | % | |||
Merchant | 35 | % | 34 | % | 34 | % | |||
Packaged Gas | 43 | % | 43 | % | 42 | % | |||
Other | 3 | % | 3 | % | 4 | % | |||
100 | % | 100 | % | 100 | % | ||||
Praxair’s European industrial gases business operates in Spain, Italy, Germany, Russia, the United Kingdom, Scandinavia and the Benelux region.
Sales for 2014 increased $4 million, versus 2013. Excluding unfavorable currency impacts and lower cost pass-through, sales increased 2% year-over-year. The increase came from higher pricing to merchant and packaged gas customers, and acquisitions primarily Dominion Technology Gases Investment Limited acquired in 2013.
Operating profit of $291 million increased 8% from 2013 primarily driven by higher pricing, volumes and acquisitions. The strong operating leverage came from price attainment across the region coupled with strong productivity and cost initiatives. In addition, the acquisition of an industrial gas business in Italy and a divestiture in France contributed to the higher operating profit and margin.
Sales for 2013 increased $68 million, or 5% versus 2012. Sales growth was primarily driven by higher pricing, acquisitions, primarily Dominion Technology Gases Investment Limited, and favorable currency effects. Underlying sales were unchanged from the prior year as volumes were higher year over year in Germany, Russia, and Scandinavia but overall volumes in Spain and Italy were below the prior year.
Operating profit for 2013 of $270 million grew 5% from 2012. Higher pricing, favorable currency effects, acquisitions, and lower costs from prior-year cost reduction actions more than offset the impact of lower volumes, primarily in Spain.
28
South America
(Dollar amounts in millions) Year Ended December 31, | Variance | ||||||||||||||||
2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | |||||||||||||
Sales | $ | 1,993 | $ | 2,042 | $ | 2,082 | (2 | )% | (2 | )% | |||||||
Cost of sales, exclusive of depreciation and amortization | 1,101 | 1,134 | 1,202 | ||||||||||||||
Gross margin | 892 | 908 | 880 | ||||||||||||||
Operating expenses | 266 | 260 | 267 | ||||||||||||||
Depreciation and amortization | 177 | 181 | 184 | ||||||||||||||
Operating profit | $ | 449 | $ | 467 | $ | 429 | (4 | )% | 9 | % | |||||||
Margin % | 22.5 | % | 22.9 | % | 20.6 | % | |||||||||||
2014 vs. 2013 | 2013 vs. 2012 | |||||||||||
% Change | % Change | |||||||||||
Sales | Operating Profit | Sales | Operating Profit | |||||||||
Factors Contributing to Changes | ||||||||||||
Volume | 2 | % | (2 | )% | 4 | % | 7 | % | ||||
Price | 4 | % | 19 | % | 3 | % | 13 | % | ||||
Cost pass-through | 1 | % | — | % | — | % | — | % | ||||
Currency | (9 | )% | (10 | )% | (9 | )% | (9 | )% | ||||
Acquisitions/Divestitures | — | % | — | % | — | % | — | % | ||||
Other | — | % | (11 | )% | — | % | (2 | )% | ||||
(2 | )% | (4 | )% | (2 | )% | 9 | % | |||||
The following tables provide sales by end-market and distribution method:
% of Sales | % Change* | ||||||||||||||
2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | |||||||||||
Sales by End Markets | |||||||||||||||
Manufacturing | 21 | % | 21 | % | 22 | % | 3 | % | 3 | % | |||||
Metals | 27 | % | 29 | % | 28 | % | 2 | % | 10 | % | |||||
Energy | 2 | % | 2 | % | 4 | % | 23 | % | (4 | )% | |||||
Chemicals | 9 | % | 9 | % | 6 | % | 10 | % | 20 | % | |||||
Electronics | — | % | — | % | — | % | — | % | — | % | |||||
Healthcare | 18 | % | 17 | % | 16 | % | 9 | % | 10 | % | |||||
Food & Beverage | 13 | % | 12 | % | 12 | % | 16 | % | 8 | % | |||||
Aerospace | — | % | — | % | — | % | — | % | — | % | |||||
Other | 10 | % | 10 | % | 12 | % | 2 | % | (1 | )% | |||||
100 | % | 100 | % | 100 | % | ||||||||||
* Excludes impact of currency, natural gas/precious metals cost pass-through and acquisitions/divestitures.
29
% of Sales | |||||||||
2014 | 2013 | 2012 | |||||||
Sales by Distribution Method | |||||||||
On-Site | 26 | % | 25 | % | 23 | % | |||
Merchant | 43 | % | 43 | % | 43 | % | |||
Packaged Gas | 29 | % | 30 | % | 31 | % | |||
Other | 2 | % | 2 | % | 3 | % | |||
100 | % | 100 | % | 100 | % | ||||
Praxair’s South American industrial gases operations are conducted by its subsidiary, White Martins Gases Industriais Ltda. ("White Martins"), the largest industrial gases company in Brazil. White Martins also manages Praxair’s operations in Argentina, Bolivia, Chile, Colombia, Paraguay, Peru, Uruguay and Venezuela.
Sales in 2014 decreased $49 million, or 2%, versus 2013. Unfavorable currency translation impacts reduced sales by 9%. Organic sales grew 6% primarily due to higher pricing and modest volume growth. Sales growth came primarily from the food and beverage and healthcare end-markets.
Operating profit decreased $18 million or 4% versus 2013. Excluding negative currency effects, operating profit increased 6% due to higher pricing partially offset by cost inflation primarily in Brazil, Argentina and Venezuela. The 2013 period included the impact of a $10 million positive litigation settlement in Brazil.
In 2015, the adoption of the SICAD II exchange rate in Venezuela (see Note 2 to the consolidated financial statements) will have the impact of reducing reported segment sales by an estimated $125 million.
Sales in 2013 decreased $40 million, or 2%, versus 2012. Excluding unfavorable currency translation impacts, underlying sales grew 7% from broad-based volume growth and higher pricing. Sales growth came from metals, chemicals, food and beverage and healthcare customers.
Operating profit in 2013 increased $38 million or 9% versus 2012 and 18% excluding currency effects. Operating leverage was primarily due to higher volumes and pricing across the region. Operating profit included a $10 million litigation settlement in Brazil. Depreciation and amortization increased in 2013 due to the start up of new on-site production facilities but was more than offset by the impacts of currency translation.
Asia
(Dollar amounts in millions) Year Ended December 31, | Variance | ||||||||||||||||
2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | |||||||||||||
Sales | $ | 1,619 | $ | 1,525 | $ | 1,414 | 6 | % | 8 | % | |||||||
Cost of sales, exclusive of depreciation and amortization | 1,041 | 1,005 | 952 | ||||||||||||||
Gross margin | 578 | 520 | 462 | ||||||||||||||
Operating expenses | 105 | 99 | 89 | ||||||||||||||
Depreciation and amortization | 170 | 150 | 127 | ||||||||||||||
Operating profit | $ | 303 | $ | 271 | $ | 246 | 12 | % | 10 | % | |||||||
Margin % | 18.7 | % | 17.8 | % | 17.4 | % | |||||||||||
30
2014 vs. 2013 | 2013 vs. 2012 | |||||||||||
% Change | % Change | |||||||||||
Sales | Operating Profit | Sales | Operating Profit | |||||||||
Factors Contributing to Changes | ||||||||||||
Volume / Equipment | 7 | % | 6 | % | 10 | % | 14 | % | ||||
Price | 1 | % | 5 | % | (1 | )% | (4 | )% | ||||
Cost pass-through | (1 | )% | — | % | (1 | )% | — | % | ||||
Currency | (1 | )% | (1 | )% | — | % | — | % | ||||
Other | — | % | 2 | % | — | % | — | % | ||||
6 | % | 12 | % | 8 | % | 10 | % | |||||
The following tables provide sales by end-market and distribution method:
% of Sales | % Change* | ||||||||||||||
2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | |||||||||||
Sales by End Markets | |||||||||||||||
Manufacturing | 10 | % | 11 | % | 12 | % | (2 | )% | 1 | % | |||||
Metals | 28 | % | 27 | % | 25 | % | 13 | % | 15 | % | |||||
Energy | 3 | % | 2 | % | 1 | % | 57 | % | 172 | % | |||||
Chemicals | 12 | % | 13 | % | 11 | % | (2 | )% | 19 | % | |||||
Electronics | 31 | % | 34 | % | 37 | % | — | % | — | % | |||||
Healthcare | 1 | % | 1 | % | 1 | % | — | % | — | % | |||||
Food & Beverage | 2 | % | 2 | % | 3 | % | 1 | % | (18 | )% | |||||
Aerospace | — | % | — | % | — | % | — | % | — | % | |||||
Other | 13 | % | 10 | % | 10 | % | 35 | % | 18 | % | |||||
100 | % | 100 | % | 100 | % | ||||||||||
* Excludes impact of currency, natural gas/precious metals cost pass-through and acquisitions/divestitures.
% of Sales | |||||||||
2014 | 2013 | 2012 | |||||||
Sales by Distribution Method | |||||||||
On-Site | 51 | % | 48 | % | 43 | % | |||
Merchant | 29 | % | 29 | % | 29 | % | |||
Packaged Gas | 12 | % | 11 | % | 12 | % | |||
Other | 8 | % | 12 | % | 16 | % | |||
100 | % | 100 | % | 100 | % | ||||
The Asia segment includes Praxair’s industrial gases operations in China, India, Korea and Thailand, with smaller operations in Taiwan and the Middle East.
Asia segment sales for 2014 increased $94 million, or 6%, as compared to the prior year. Volume growth of 7% came from new project start-ups primarily in India and Korea and included the sale of an air separation plant to a joint venture in China. By end-market, the strongest sales growth came from energy and metals customers. Strong growth in on-site volumes due to new plant start-ups accounted for the increase in on-site sales as a percentage of total sales. Merchant volumes in India and China also showed solid growth versus the prior year. Cost pass-through decreased sales 1% and relates to the contractual pass through of precious metals and power costs fluctuations, with minimal impact on operating profit. Higher helium pricing increased sales by 1%.
31
Asia segment operating profit for 2014 increased $32 million, or 12%, as compared to the prior year. Strong on-site volume growth contributed to a 6% increase in operating profit. Pricing increased operating profit by 5% primarily due to higher merchant and packaged gas pricing for helium sales. Depreciation and amortization expense increased $20 million as compared to the prior year primarily due to new plant start-ups. In the fourth quarter 2014, operating profit included a $14 million gain related to the acquisition of an equity investment. In the fourth quarter 2013, operating profit included a $13 million gain related to a land sale in Korea.
Asia segment sales for 2013 increased $111 million, or 8%, versus 2012. Volume growth increased sales by 10% due to new on-site sales plant start-ups in China, India and Korea. By end-market, the strongest sales growth came from metals, energy and chemicals customers. Strong growth in on-site volumes due to new plant start-ups accounted for the increase in on-site sales as a percentage of total sales. Merchant volumes in China, India and Korea also showed solid growth versus the prior year. Cost pass-through decreased sales 1% and relates to the contractual pass through of precious metals and power costs fluctuations, with minimal impact on operating profit. Lower merchant pricing, primarily due to the electronics end-market, reduced sales by 1%.
Asia segment operating profit for 2013 increased $25 million, or 10%, versus 2012. Strong on-site volume growth was partially offset by the effects of lower pricing in the electronics end-market. Operating profit included a gain related to a land sale in Korea in the fourth quarter of $13 million. Pricing reduced operating profit by 4% primarily due to lower pricing for liquid argon sales in China and electronic gas customers. Operating expenses increased $10 million primarily due to new plant start-ups, salary increases and other benefit costs. Depreciation and amortization expense increased $23 million as compared to the prior year primarily due to new plant start-ups.
Surface Technologies
(Dollar amounts in millions) Year Ended December 31, | Variance | ||||||||||||||||
2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | |||||||||||||
Sales | $ | 679 | $ | 652 | $ | 656 | 4 | % | (1 | )% | |||||||
Cost of sales, exclusive of depreciation and amortization | 438 | 423 | 433 | ||||||||||||||
Gross margin | 241 | 229 | 223 | ||||||||||||||
Operating expenses | 75 | 75 | 74 | ||||||||||||||
Depreciation and amortization | 43 | 43 | 43 | ||||||||||||||
Operating profit | $ | 123 | $ | 111 | $ | 106 | 11 | % | 5 | % | |||||||
18.1 | % | 17.0 | % | 16.2 | % | ||||||||||||
2014 vs. 2013 | 2013 vs. 2012 | |||||||||||
% Change | % Change | |||||||||||
Sales | Operating Profit | Sales | Operating Profit | |||||||||
Factors Contributing to Changes | ||||||||||||
Volume/Price | 1 | % | 6 | % | — | % | 2 | % | ||||
Cost pass-through | — | % | — | % | (1 | )% | — | % | ||||
Currency | — | % | — | % | — | % | — | % | ||||
Acquisitions/Divestitures | — | % | — | % | — | % | — | % | ||||
Other* | 3 | % | 5 | % | — | % | 3 | % | ||||
4 | % | 11 | % | (1 | )% | 5 | % | |||||
* Other primarily relates to business transfers for 2014 vs. 2013.
32
The following table provides sales by end-market:
% of Sales | % Change* | ||||||||||||||
2014 | 2013 | 2012 | 2014 vs. 2013 | 2013 vs. 2012 | |||||||||||
Sales by End Markets | |||||||||||||||
Manufacturing | 13 | % | 13 | % | 14 | % | 1 | % | (2 | )% | |||||
Metals | 8 | % | 8 | % | 8 | % | 3 | % | 4 | % | |||||
Energy | 28 | % | 28 | % | 28 | % | 2 | % | — | % | |||||
Chemicals | 2 | % | 2 | % | 3 | % | — | % | (9 | )% | |||||
Electronics | 1 | % | 1 | % | — | % | — | % | — | % | |||||
Healthcare | — | % | — | % | — | % | 1 | % | — | % | |||||
Food & Beverage | 3 | % | 3 | % | 3 | % | 3 | % | (3 | )% | |||||
Aerospace | 34 | % | 34 | % | 34 | % | 3 | % | (1 | )% | |||||
Other | 11 | % | 11 | % | 10 | % | 9 | % | 2 | % | |||||
100 | % | 100 | % | 100 | % | ||||||||||
* Excludes impact of currency, precious metals cost pass-through, acquisitions/divestitures and business transfers.
Surface technologies provides high-performance coatings and thermal-spray powders and equipment in the Americas, Europe, and Asia.
Sales increased $27 million, or 4% versus 2013 due to modest organic sales growth primarily to the metals and aerospace end-markets, and business transfers.
Operating profit increased $12 million, or 11% versus 2013 primarily due to higher pricing and productivity gains which more than offset cost inflation.
Sales decreased $4 million, or 1% versus 2012 due primarily to lower cost pass-through for metals for thermal-spray powders. Lower industrial coating and aviation volumes were offset by higher pricing.
Operating profit increased $5 million, or 5% versus 2012. The impact of higher pricing and lower costs, primarily due to the prior-year cost reduction program in Europe and productivity gains, offset the impact of modestly lower overall volumes.
33
Currency
The results of Praxair’s non-U.S. operations are translated to the company’s reporting currency, the U.S. dollar, from the functional currencies used in the countries in which the company operates. For most foreign operations, Praxair uses the local currency as its functional currency. There is inherent variability and unpredictability in the relationship of these functional currencies to the U.S. dollar and such currency movements may materially impact Praxair’s results of operations in any given period.
To help understand the reported results, the following is a summary of the significant currencies underlying Praxair’s consolidated results and the exchange rates used to translate the financial statements (rates of exchange expressed in units of local currency per U.S. dollar):
Percent of 2014 Consolidated Sales | Statements of Income | Balance Sheets | |||||||||||||||
Average Year Ended December 31, | December 31, | ||||||||||||||||
Currency | 2014 | 2013 | 2012 | 2014 | 2013 | ||||||||||||
Brazilian real | 13 | % | 2.35 | 2.15 | 1.95 | 2.66 | 2.34 | ||||||||||
Euro | 12 | % | 0.75 | 0.75 | 0.78 | 0.83 | 0.73 | ||||||||||
Canadian dollar | 8 | % | 1.10 | 1.03 | 1.00 | 1.16 | 1.06 | ||||||||||
Mexican peso | 6 | % | 13.30 | 12.76 | 13.24 | 14.75 | 13.04 | ||||||||||
Chinese yuan | 5 | % | 6.16 | 6.16 | 6.31 | 6.21 | 6.05 | ||||||||||
Indian rupee | 3 | % | 61.03 | 58.31 | 53.46 | 63.04 | 61.80 | ||||||||||
Korean won | 3 | % | 1,053 | 1,094 | 1,132 | 1,094 | 1,050 | ||||||||||
Norwegian krone | 1 | % | 6.28 | 5.87 | 5.81 | 7.45 | 6.07 | ||||||||||
Colombia peso | 1 | % | 1,994 | 1,868 | 1,797 | 2,392 | 1,927 | ||||||||||
Venezuelan bolivar fuerte ("VEF") (a) | 1 | % | 6.30 | 5.97 | 4.30 | 50.00 | 6.30 | ||||||||||
Argentine peso | <1% | 8.10 | 5.45 | 4.54 | 8.55 | 6.52 | |||||||||||
Russian ruble | <1% | 37.77 | 31.82 | 31.02 | 60.74 | 32.87 | |||||||||||
Thailand bhat | <1% | 32.48 | 30.69 | 31.11 | 32.91 | 32.71 | |||||||||||
________________________
(a) At December 31, 2014 Praxair changed the exchange rate used to translate the monetary assets and liabilities of its Venezuelan subsidiary to the SICAD II rate of 50 VEF per U.S. dollar (see Note 2 to the consolidated financial statements). On February 10, 2015, the Venezuelan government initiated a new foreign exchange platform referred to as SIMADI which replaced the SICAD II exchange control mechanism. The SIMADI exchange rate was initially set at 170 VEF per U.S. dollar. This change will not have a material impact on Praxair.
34
LIQUIDITY, CAPITAL RESOURCES AND OTHER FINANCIAL DATA
(Millions of dollars) Year Ended December 31, | 2014 | 2013 | 2012 | ||||||||
Net Cash Provided by (Used for) | |||||||||||
Operating Activities | |||||||||||
Net Income (including noncontrolling interests) | $ | 1,746 | $ | 1,836 | $ | 1,744 | |||||
Non-cash charges (credits): | |||||||||||
Add: Venezuela devaluations and other charges (a) | 138 | 23 | 43 | ||||||||
Add: Depreciation and amortization | 1,170 | 1,109 | 1,001 | ||||||||
Add: Deferred income taxes | 55 | 101 | 258 | ||||||||
Add: Other non-cash charges | (65 | ) | (18 | ) | (57 | ) | |||||
Net Income adjusted for non-cash charges | 3,044 | 3,051 | 2,989 | ||||||||
Less: Pension payments | (18 | ) | (52 | ) | (184 | ) | |||||
Less: Working capital | (129 | ) | (100 | ) | (105 | ) | |||||
Other | (29 | ) | 18 | 52 | |||||||
Net cash provided from operating activities | $ | 2,868 | $ | 2,917 | $ | 2,752 | |||||
Investing Activities | |||||||||||
Capital expenditures | $ | (1,689 | ) | $ | (2,020 | ) | $ | (2,180 | ) | ||
Acquisitions, net of cash acquired | (206 | ) | (1,323 | ) | (280 | ) | |||||
Divestitures and asset sales | 92 | 106 | 82 | ||||||||
Total used for investing | $ | (1,803 | ) | $ | (3,237 | ) | $ | (2,378 | ) | ||
Financing Activities | |||||||||||
Debt increases – net | $ | 589 | $ | 1,461 | $ | 807 | |||||
Purchases of common stock – net | (759 | ) | (436 | ) | (459 | ) | |||||
Cash dividends – Praxair, Inc. shareholders | (759 | ) | (708 | ) | (655 | ) | |||||
Excess tax benefit on stock based compensation | 31 | 46 | 60 | ||||||||
Noncontrolling interest transactions and other | (110 | ) | (35 | ) | (56 | ) | |||||
Total provided (used) for financing | $ | (1,008 | ) | $ | 328 | $ | (303 | ) | |||
Effect of exchange rate changes on cash | $ | (69 | ) | $ | (27 | ) | $ | (4 | ) | ||
Cash and cash equivalents | $ | 126 | $ | 138 | $ | 157 | |||||
Other Financial Data (b) | |||||||||||
Debt-to-capital ratio | 59.6 | % | 54.3 | % | 51.9 | % | |||||
After-tax return on capital ("ROC") | 12.7 | % | 12.8 | % | 13.9 | % | |||||
Return on Praxair, Inc. shareholder's equity ("ROE") | 28.7 | % | 28.6 | % | 28.9 | % | |||||
Adjusted EBITDA | $ | 3,958 | $ | 3,804 | $ | 3,537 | |||||
Debt-to-Adjusted EBITDA | 2.3 | 2.2 | 1.9 | ||||||||
(a) | See Note 2 to the consolidated financial statements. |
(b) | Non-GAAP measures. See the “Non-GAAP Financial Measures” section for definitions and reconciliations to reported amounts. |
Cash decreased $12 million in 2014 versus 2013. The primary sources of cash in 2014 were cash flows from operations of $2,868 million, and debt increases net of repayments of $589 million. The major uses of cash were capital expenditures of $1,689 million, acquisitions of $206 million, purchases of Praxair common stock net of issuances of $759 million, and cash dividends to shareholders of $759 million. The effect of exchange rate changes on cash and cash
35
equivalents relates primarily to the currency devaluations in Venezuela (see Note 2 to the consolidated financial statements).
Cash Flows From Operations
________________________
* Includes Spanish income tax settlement payment of $481 million.
2014 compared with 2013
Cash flows from operations was $2,868 million, or 23% of sales, a decrease of $49 million from $2,917 million in 2013. Cash flows provided from net income decreased $90 million, but decreased $7 million after adjusting for the year-over-year change in non-cash items included in net income. Pension contributions decreased $34 million versus 2013 while cash used for working capital requirements increased $29 million versus 2013.
2013 compared with 2012
Cash flows from operations increased $165 million to a record $2,917 million in 2013, or 24% of sales, from $2,752 million in 2012. Cash flows provided from net income increased $92 million versus 2012 but decreased $62 million after adjusting for the impact of non-cash items included in net income. Pension contributions decreased $132 million versus 2012 while cash used for working capital requirements remained essentially flat.
36
Investing
2014 compared with 2013
Net cash used for investing activities of $1,803 million decreased $1,434 million versus 2013 primarily due to lower acquisition, net of cash acquired and capital expenditures.
Acquisition expenditures in 2014 were $206 million, a decrease of $1,117 million from 2013. Acquisitions in 2014 consisted primarily of an industrial gases business in Italy, packaged gases businesses in North and South America and the controlling interest of an equity investment in China (see Note 3 to the consolidated financial statements).
Capital expenditures in 2014 were $1,689 million, a decrease of $331 million from 2013. Capital expenditures during 2014 related primarily to growth capital investments. Approximately half of the capital expenditures were in North America, about 20% in South America and the rest evenly between Asia and Europe.
Divestitures and asset sales in 2014 totaled $92 million, which included the sale of Praxair's industrial gas business in France during the first quarter.
2013 compared with 2012
Net cash used for investing activities of $3,237 million increased $859 million versus 2012 primarily due to higher acquisitions, net of cash acquired.
Acquisition expenditures in 2013 were $1,323 million, an increase of $1,043 million from 2012. Acquisitions in 2013 consisted primarily of the acquisition of NuCO2, Inc., Dominion Technology Gases, US packaged gas distributors, and an acquisition in Russia (see Note 3 to the consolidated financial statements).
Capital expenditures in 2013 were $2,020 million, a decrease of $160 million from 2012. Capital expenditures during 2013 related largely to new production plants under contract for customers globally. Approximately half of the capital expenditures were in North American and about 20% were in Asia.
Divestitures and asset sales in 2013 totaled $106 million, which included the sale of a service business and other assets in the United States and proceeds related to a land sale in Korea.
37
Financing
Praxair’s financing strategy is to secure long-term committed funding by issuing public notes and debentures and commercial paper backed by a long-term bank credit agreement. Praxair’s international operations are funded through a combination of local borrowing and inter-company funding to minimize the total cost of funds and to manage and centralize currency exchange exposures. As deemed necessary, Praxair manages its exposure to interest-rate changes through the use of financial derivatives (see Note 12 to the consolidated financial statements and Item 7A. Quantitative and Qualitative Disclosures About Market Risk).
The company believes that it has sufficient operating flexibility, cash reserves, and funding sources to maintain adequate amounts of liquidity to meet its business needs around the world. At December 31, 2014, the company’s credit ratings as reported by Standard & Poor’s and Moody’s were A-1 and P-1 for short-term debt, respectively, and A and A2 for long-term debt, respectively. Additionally, the company plans to maintain its undistributed earnings of foreign subsidiaries to support foreign growth opportunities and reduce local debt.
Note 11 to the consolidated financial statements includes information with respect to the company’s debt refinancing in 2014, current debt position, debt covenants and the available credit facility; and Note 12 includes information relating to derivative financial instruments. Praxair's credit facility is with major financial institutions and is non-cancellable until maturity. Therefore, the company believes the risk of the financial institutions being unable to make required loans under the credit facility, if requested, to be low. Praxair’s major bank credit and long-term debt agreements contain standard covenants. The company was in compliance with these covenants at December 31, 2014 and expects to remain in compliance for the foreseeable future.
Praxair’s total debt outstanding at December 31, 2014 was $9,258 million, $447 million higher than $8,811 million at December 31, 2013. The December 31, 2014 debt balance includes $9,002 million in public securities and $256 million representing primarily worldwide bank borrowings. Praxair’s global effective borrowing rate was approximately 2.4% for 2014.
In March 2014, Praxair issued €600 million ($824 million cash proceeds at issuance) of 1.50% Euro-denominated notes due 2020; and in December 2014, Praxair issued €500 million ($616 million cash proceeds at issuance) of 1.625% Euro-denominated notes due 2025. Praxair has designated these Euro-denominated notes as hedges of the net investment position in its European operations (see Note 12 to the consolidated financial statements).
In March 2014, Praxair repaid $300 million of 4.375% notes that became due. In December 2014, Praxair redeemed $400 million of 5.375% notes due in 2016 (see Note 11 to the consolidated financial statements).
Cash used by financing activities was $1,008 million in 2014 compared to cash provided by financing of $328 million in 2013. Net purchases of common stock of $759 million increased $323 million and cash dividends of $759 million increased $51 million from 2013. The noncontrolling interests and other payments relate primarily to the acquisition of the remaining noncontrolling interests in a U.S. packaged gas business during the first quarter 2014. The
38
cash received from debt issuances-net of $589 million was less than $1,461 million in 2013 primarily due to lower acquisition expenditures. The Euro-denominated notes reflected in the consolidated balance sheet is lower than the cash proceeds reflected in the statement of cash flows primarily due to currency movements of $125 million since the note issuances.
On February 5, 2015, Praxair issued $150 million of floating rate notes that bear interest at the Federal funds effective rate plus 0.33% due 2017, $400 million of 2.65% fixed rate notes due 2025 and $200 million of 3.550% fixed rates notes due in 2042. The proceeds will be used for general corporate purposes, including the repayment of outstanding indebtedness.
Other Financial Data
Praxair’s debt-to-capital ratio was 59.6% at December 31, 2014 versus 54.3% at December 31, 2013. Although net debt increased $459 million during 2014, the increase in debt-to-capital is due primarily to lower capital. The equity component of capital was reduced by a $1,257 million loss in other comprehensive income, primarily from currency impacts and the funded status of benefit plans. The increase in 2013 is attributable to higher debt levels, primarily to fund acquisitions.
After-tax return on capital ("ROC") of 12.7% at December 31, 2014 was slightly below 12.8% at year-end 2013, and ROC was 13.9% in 2012. The decrease in both years is primarily related to capital projects and acquisitions.
Return on equity ("ROE") was strong and consistent for 2014, 2013 and 2012.
Adjusted EBITDA increased $154 million in 2014 and $267 million in 2013 versus the respective prior year amounts. The increases primarily reflect the higher adjusted net income levels and depreciation and amortization from the start-up of new plants and other assets, and from acquisitions; partially offset by negative currency impacts.
Debt-to-Adjusted EBITDA increased slightly in 2014 primarily because debt increased more than adjusted EBITDA. Praxair’s debt is largely denominated in U.S. dollars and, therefore, is not impacted by currency movements. In 2013 the increase was largely due to increased debt incurred to fund acquisitions.
See the “Non-GAAP Financial Measures” section for definitions and reconciliation of these non-GAAP measures to reported amounts.
CONTRACTUAL OBLIGATIONS
The following table sets forth Praxair’s material contract obligations and other commercial commitments as of December 31, 2014:
(Millions of dollars) | Due or expiring by December 31, | ||||||||||||||||||||||||||
2015 | 2016 | 2017 | 2018 | 2019 | Thereafter | Total | |||||||||||||||||||||
Long-term debt obligations: | |||||||||||||||||||||||||||
Debt and capitalized lease maturities (Note 11)* | $ | 2 | $ | 407 | $ | 775 | $ | 1,083 | $ | 2,008 | $ | 4,396 | $ | 8,671 | |||||||||||||
Contractual interest | 209 | 191 | 176 | 159 | 130 | 600 | 1,465 | ||||||||||||||||||||
Operating leases (Note 4)* | 122 | 109 | 91 | 75 | 60 | 60 | 517 | ||||||||||||||||||||
Retirement obligations | 55 | 32 | 34 | 35 | 37 | 163 | 356 | ||||||||||||||||||||
Unconditional purchase obligations (Note 17)* | 543 | 491 | 460 | 445 | 393 | 3,021 | 5,353 | ||||||||||||||||||||
Construction commitments (Note 17)* | 954 | 404 | 27 | — | — | — | 1,385 | ||||||||||||||||||||
Total Contractual Obligations | $ | 1,885 | $ | 1,634 | $ | 1,563 | $ | 1,797 | $ | 2,628 | $ | 8,240 | $ | 17,747 | |||||||||||||
* See Notes to the consolidated financial statements for additional information.
Contractual interest on long-term debt of $1,465 million represents interest the company is contracted to pay on outstanding long-term debt, current portion of long-term debt and capital lease obligations, calculated on a basis consistent with planned debt maturities, excluding the interest impact of interest rate swaps. At December 31, 2014, Praxair had fixed-rate debt of $7,626 million and floating-rate debt of $1,632 million. The rate assumed for floating-rate debt was the rate in effect at December 31, 2014.
39
Retirement obligations of $356 million include estimates of pension plan contributions and expected future benefit payments for unfunded pension and OPEB plans. Pension plan contributions are forecast for 2015 only. For purposes of the table, $15 million of estimated required contributions have been included for 2015. Expected future unfunded pension and OPEB benefit payments are forecast only through 2024. Contribution and unfunded benefit payment estimates are based upon current valuation assumptions. Estimates of pension contributions after 2015 and unfunded benefit payments after 2024 are not included in the table because the timing of their resolution cannot be estimated. Retirement obligations are more fully described in Note 16 to the consolidated financial statements.
Liabilities for uncertain tax positions totaling $71 million, including interest and penalties, are not included in the table because the timing of their resolution cannot be estimated. See Note 5 to the consolidated financial statements for disclosures surrounding uncertain income tax positions.
OFF-BALANCE SHEET ARRANGEMENTS
As discussed in Note 17 to the consolidated financial statements, at December 31, 2014, Praxair had entered into various guarantees and other arrangements, and had undrawn outstanding letters of credit from financial institutions. These arrangements were entered into in connection with normal business operations and they are not reasonably likely to have a material impact on Praxair’s consolidated financial condition, results of operations, or liquidity.
CRITICAL ACCOUNTING POLICIES
The policies discussed below are considered by management to be critical to understanding Praxair’s financial statements and accompanying notes prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). Their application places significant importance on management’s judgment as a result of the need to make estimates of matters that are inherently uncertain. Praxair’s financial position, results of operations and cash flows could be materially affected if actual results differ from estimates made. These policies are determined by management and have been reviewed by Praxair’s Audit Committee.
Depreciable Lives of Property, Plant and Equipment
Praxair’s net property, plant and equipment at December 31, 2014 was $11,997 million, representing 61% of the company’s consolidated total assets. Depreciation expense for the year ended December 31, 2014 was $1,123 million, or 12% of total operating costs. Management judgment is required in the determination of the estimated depreciable lives that are used to calculate the annual depreciation expense and accumulated depreciation.
Property, plant and equipment are recorded at cost and depreciated over the assets’ estimated useful lives on a straight-line basis for financial reporting purposes. The estimated useful life represents the projected period of time that the asset will be productively employed by the company and is determined by management based on many factors, including historical experience with similar assets, technological life cycles, geographic locations and contractual supply relationships with on-site customers. Circumstances and events relating to these assets, such as on-site contract modifications, are monitored to ensure that changes in asset lives or impairments (see “Asset Impairments”) are identified and prospective depreciation expense or impairment expense is adjusted accordingly. Praxair’s largest asset values relate to cryogenic air-separation production plants with depreciable lives of principally 15 years.
Based upon the assets as of December 31, 2014, if depreciable lives of machinery and equipment, on average, were increased or decreased by one year, annual depreciation expense would be decreased by approximately $73 million or increased by approximately $84 million, respectively.
Pension Benefits
Pension benefits represent financial obligations that will be ultimately settled in the future with employees who meet eligibility requirements. Because of the uncertainties involved in estimating the timing and amount of future payments, significant estimates are required to calculate pension expense and liabilities related to the company’s plans. The company utilizes the services of several independent actuaries, whose models are used to facilitate these calculations.
Several key assumptions are used in actuarial models to calculate pension expense and liability amounts recorded in the financial statements. Management believes the three most significant variables in the models are the expected long-term rate of return on plan assets, the discount rate, and the expected rate of compensation increase. The actuarial models also use assumptions for various other factors, including employee turnover, retirement age, and mortality. Praxair management believes the assumptions used in the actuarial calculations are reasonable, reflect the company’s experience and expectations for the future and are within accepted practices in each of the respective geographic locations in which it operates. Actual results in any given year will often differ from actuarial assumptions because of economic and other factors.
40
The weighted-average expected long-term rates of return on pension plan assets were 8.00% for U.S. plans and 8.10% for international plans for the years ended December 31, 2014 (8.00% and 7.50%, respectively at December 31, 2013). These rates are determined annually by management based on a weighted average of current and historical market trends, historical and expected portfolio performance and the current and expected portfolio mix of investments. A 0.50% change in these expected long-term rates of return, with all other variables held constant, would change Praxair’s pension expense by approximately $10 million.
The company has consistently used a market-related value of assets rather than the fair value at the measurement date to determine annual pension expense. The market-related value recognizes investment gains or losses over a five-year period. As a result, changes in the fair value of assets from year to year are not immediately reflected in the company’s annual pension expense. Instead, annual pension expense in future periods will be impacted as deferred investment gains or losses are recognized in the market-related value of assets over the five-year period. The consolidated market-related value of assets was $2,051 million, or $117 million lower than the fair value of assets of $2,168 million at December 31, 2014. These net deferred investment gains of $117 million will be recognized in the calculation of the market-related value of assets ratably over the next four years and will impact future pension expense. Future actual investment gains or losses will impact the market-related value of assets and, therefore, will impact future annual pension expense in a similar manner.
The weighted-average discount rates for pension plan liabilities were 3.95% for U.S. plans and 5.36% for international plans at December 31, 2014 (4.80% and 6.30%, respectively, at December 31, 2013). These rates are used to calculate the present value of plan liabilities and are determined annually by management. The discount rate for the U.S. plans is established utilizing a cash flow matching model provided by the company’s independent actuaries. The model includes a portfolio of corporate bonds graded Aa or better by at least half of the ratings agencies and matches the U.S. plan’s projected cash flows to the calculated spot rates and develops the single equivalent discount rate which produces the same present value. The discount rates for the remaining international plans are based on market yields for high-quality fixed income investments representing the approximate duration of the pension liabilities on the measurement date. A 0.50% change in discount rates, with all other variables held constant, would decrease/increase Praxair’s pension expense by approximately $12 million and would impact the PBO by approximately $185 million.
The weighted-average expected rate of compensation increase was 3.25% for U.S. plans and 3.72% for international plans at December 31, 2014 (3.25% and 4.00%, respectively, at December 31, 2013). The estimated annual compensation increase is determined by management every year and is based on historical trends and market indices. A 0.50% change in the expected rate of compensation increase, with all other variables held constant, would change Praxair’s pension expense by approximately $5 million and would impact the PBO by approximately $34 million.
Asset Impairments
Goodwill
At December 31, 2014, the company had goodwill of $3,121 million, which represents the aggregate of the excess purchase price for acquired businesses over the fair value of the net assets acquired.
The company performs a goodwill impairment test annually in the second quarter or more frequently if events or circumstances indicate that an impairment loss may have been incurred, and no impairments were indicated. The company has continuously re-evaluated the likelihood of goodwill impairments in its reporting units subsequent to the second quarter test, and does not believe there is indication of impairment for any of its reporting units. At December 31, 2014, Praxair’s enterprise value was approximately $47 billion (outstanding shares multiplied by the year-end stock price plus debt, and without any control premium) while its total capital was approximately $15 billion.
The impairment test allows an entity to first assess qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than carrying value. If it is determined that it is more likely than not that the fair value of a reporting unit is less than carrying value then the company will estimate and compare the fair value of its reporting units to their carrying value, including goodwill. Reporting units are determined based on one level below the operating segment level. Fair value is determined through the use of projected future cash flows, multiples of earnings and sales and other factors.
Such analysis requires the use of certain market assumptions and discount factors, which are subjective in nature. As applicable, estimated values can be affected by many factors beyond the company's control such as business and economic trends, government regulation, and technological changes. Management believes that the qualitative factors used to perform its annual goodwill impairment assessment are appropriate and reasonable. Although the 2014 qualitative assessment indicated that it is more likely than not that the fair value of each reporting unit substantially exceeded its
41
carrying value, changes in circumstances or conditions affecting this analysis could have a significant impact on the fair value determination, which could then result in a material impairment charge to the company's results of operations.
See Note 9 to the consolidated financial statements for disclosures concerning the carrying value of goodwill by reportable segment.
Property, Plant and Equipment
Property, plant and equipment is tested for impairment whenever events or changes in circumstances indicate that the carrying amount of an individual asset or asset group may not be recoverable. For purposes of this test, asset groups are determined based upon the lowest level for which there are identifiable cash flows. Based upon Praxair's business model, an asset group may be a single plant and related assets used to support on-site, merchant and packaged gas customers. Alternatively, the asset group may be a pipeline complex which includes multiple interdependent plants and related assets connected by pipelines within a geographic area used to support the same distribution methods.
Income Taxes
At December 31, 2014, Praxair had deferred tax assets of $991 million (net of valuation allowances of $106 million), and deferred tax liabilities of $1,902 million. At December 31, 2014, uncertain tax positions totaled $71 million (see Notes 1 and 5 to the consolidated financial statements). Income tax expense was $691 million for the year ended December 31, 2014, or about 28.9% of pre-tax income.
In the preparation of consolidated financial statements, Praxair estimates income taxes based on diverse legislative and regulatory structures that exist in various jurisdictions where the company conducts business. Deferred income tax assets and liabilities represent tax benefits or obligations that arise from temporary differences due to differing treatment of certain items for accounting and income tax purposes. Praxair evaluates deferred tax assets each period to ensure that estimated future taxable income will be sufficient in character (e.g. capital gain versus ordinary income treatment), amount and timing to result in their recovery. A valuation allowance is established when management determines that it is more likely than not that a deferred tax asset will not be realized to reduce the assets to their realizable value. Considerable judgments are required in establishing deferred tax valuation allowances and in assessing exposures related to tax matters. As events and circumstances change, related reserves and valuation allowances are adjusted to income at that time. Praxair’s tax returns are subject to audit and local taxing authorities could challenge the company’s tax positions. The company’s practice is to review tax filing positions by jurisdiction and to record provisions for uncertain income tax positions, including interest and penalties when applicable. Praxair believes it records and/or discloses such potential tax liabilities as appropriate and has reasonably estimated its income tax liabilities and recoverable tax assets. If new information becomes available, adjustments are charged or credited against income at that time. Management does not anticipate that such adjustments would have a material adverse effect on the company’s consolidated financial position or liquidity; however, it is possible that the final outcomes could have a material impact on the company’s reported results of operations.
Contingencies
The company accrues liabilities for non-income tax contingencies when management believes that a loss is probable and the amounts can be reasonably estimated, while contingent gains are recognized only when realized. If new information becomes available or losses are sustained in excess of recorded amounts, adjustments are charged against income at that time. Management does not anticipate that in the aggregate such losses would have a material adverse effect on the company’s consolidated financial position or liquidity; however, it is possible that the final outcomes could have a material impact on the company’s reported results of operations.
Praxair is subject to various claims, legal proceedings and government investigations that arise from time to time in the ordinary course of business. These actions are based upon alleged environmental, tax, antitrust and personal injury claims, among others (see Note 17 to the consolidated financial statements). Such contingencies are significant and the accounting requires considerable management judgments in analyzing each matter to assess the likely outcome and the need for establishing appropriate liabilities and providing adequate disclosures. Praxair believes it records and/or discloses such potential contingencies as appropriate and has reasonably estimated its liabilities.
NEW ACCOUNTING STANDARDS
See Note 1 to the consolidated financial statements for information concerning new accounting standards and the impact of the implementation of these standards on the company’s financial statements.
42
FAIR VALUE MEASUREMENTS
Praxair does not expect changes in the aggregate fair value of its financial assets and liabilities to have a material impact on the consolidated financial statements. See Note 13 to the consolidated financial statements.
NON-GAAP FINANCIAL MEASURES
The company presents the following non-GAAP financial measures in the discussion of financial condition, results of operations and liquidity throughout the MD&A. These measures are intended to supplement investors’ understanding of the company’s financial information by providing information which investors, financial analysts and management use to help evaluate the company’s financial leverage, return on capital employed and operating performance. Special items which the company does not believe to be indicative of on-going business performance are excluded from these calculations so that investors can better evaluate and analyze historical and future business trends on a consistent basis. Definitions of these non-GAAP measures may not be comparable to similar definitions used by other companies and are not a substitute for similar GAAP measures.
The following are the non-GAAP measures presented in the Selected Financial Data (Item 6) or this MD&A:
(Dollar amounts in millions, except for per share data) Year ended December 31, | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||
Performance Measures: | |||||||||||||||||||
After-tax return on capital ("ROC") | 12.7 | % | 12.8 | % | 13.9 | % | 14.8 | % | 14.5 | % | |||||||||
Return on equity ("ROE") | 28.7 | % | 28.6 | % | 28.9 | % | 28.1 | % | 26.4 | % | |||||||||
Debt-to-capital | 59.6 | % | 54.3 | % | 51.9 | % | 51.8 | % | 47.3 | % | |||||||||
Debt-to-adjusted EBITDA | 2.3 | 2.2 | 1.9 | 1.7 | 1.6 | ||||||||||||||
Adjusted Amounts: | |||||||||||||||||||
Operating profit | $ | 2,746 | $ | 2,657 | $ | 2,502 | $ | 2,469 | $ | 2,167 | |||||||||
As a percent of sales | 22.4 | % | 22.3 | % | 22.3 | % | 21.9 | % | 21.4 | % | |||||||||
EBITDA | $ | 3,958 | $ | 3,804 | $ | 3,537 | $ | 3,512 | $ | 3,130 | |||||||||
EBITDA Margin | 32.2 | % | 31.9 | % | 31.5 | % | 31.2 | % | 30.9 | % | |||||||||
Interest expense - net | $ | 177 | $ | 160 | $ | 141 | $ | 145 | $ | 118 | |||||||||
Effective tax rate | 27.5 | % | 28.0 | % | 28.0 | % | 27.8 | % | 27.9 | % | |||||||||
Noncontrolling interests | $ | (52 | ) | $ | (65 | ) | $ | (54 | ) | $ | (51 | ) | $ | (39 | ) | ||||
Net income – Praxair, Inc. | $ | 1,852 | $ | 1,772 | $ | 1,681 | $ | 1,666 | $ | 1,476 | |||||||||
Diluted earnings per share | $ | 6.27 | $ | 5.93 | $ | 5.57 | $ | 5.43 | $ | 4.74 | |||||||||
43
After-tax Return on Capital ("ROC")
After-tax return on capital is a measure used by investors, financial analysts and management to evaluate the return on capital employed in the business. ROC measures the after-tax operating profit that the company was able to generate with the investments made by all parties in the business (debt, noncontrolling interests and Praxair, Inc. shareholders’ equity).
(Dollar amounts in millions) Year Ended December 31, | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||
Adjusted operating profit (see below) | $ | 2,746 | $ | 2,657 | $ | 2,502 | $ | 2,469 | $ | 2,167 | |||||||||
Less: adjusted income taxes (see below) | (707 | ) | (698 | ) | (660 | ) | (647 | ) | (572 | ) | |||||||||
Less: tax benefit on adjusted interest expense (a) | (50 | ) | (44 | ) | (39 | ) | (41 | ) | (33 | ) | |||||||||
Add: income from equity investments | 42 | 38 | 34 | 40 | 38 | ||||||||||||||
Net operating profit after-tax ("NOPAT") | $ | 2,031 | $ | 1,953 | $ | 1,837 | $ | 1,821 | $ | 1,600 | |||||||||
Beginning capital | $ | 15,983 | $ | 13,878 | $ | 12,489 | $ | 11,663 | $ | 10,658 | |||||||||
First quarter ending capital | $ | 16,319 | $ | 15,344 | $ | 13,248 | $ | 12,289 | $ | 10,758 | |||||||||
Second quarter ending capital | $ | 16,492 | $ | 15,548 | $ | 13,017 | $ | 12,809 | $ | 10,745 | |||||||||
Third quarter ending capital | $ | 16,083 | $ | 15,757 | $ | 13,617 | $ | 12,306 | $ | 11,336 | |||||||||
Year-end ending capital | $ | 15,318 | $ | 15,983 | $ | 13,878 | $ | 12,489 | $ | 11,663 | |||||||||
Five-quarter average capital | $ | 16,039 | $ | 15,302 | $ | 13,250 | $ | 12,311 | $ | 11,032 | |||||||||
After-tax return on capital | 12.7 | % | 12.8 | % | 13.9 | % | 14.8 | % | 14.5 | % | |||||||||
________________________
(a) | Tax benefit on adjusted interest expense is computed using the effective rate adjusted for non-recurring income tax benefits and charges. The effective tax rates used for all periods was 28%. |
Return on Praxair, Inc. Shareholders’ Equity ("ROE")
Return on Praxair, Inc. shareholders’ equity is a measure used by investors, financial analysts and management to evaluate operating performance from a Praxair shareholder perspective. ROE measures the net income attributable to Praxair, Inc. that the company was able to generate with the money shareholders have invested.
(Dollar amounts in millions) Year Ended December 31, | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||
Adjusted net income – Praxair, Inc. (see below) | $ | 1,852 | $ | 1,772 | $ | 1,681 | $ | 1,666 | $ | 1,476 | |||||||||
Beginning Praxair, Inc. shareholders’ equity | $ | 6,609 | $ | 6,064 | $ | 5,488 | $ | 5,792 | $ | 5,315 | |||||||||
First quarter ending Praxair, Inc. shareholders’ equity | $ | 6,600 | $ | 6,169 | $ | 5,940 | $ | 6,165 | $ | 5,398 | |||||||||
Second quarter ending Praxair, Inc. shareholders’ equity | $ | 6,911 | $ | 5,928 | $ | 5,615 | $ | 6,400 | $ | 5,452 | |||||||||
Third quarter ending Praxair, Inc. shareholders’ equity | $ | 6,552 | $ | 6,210 | $ | 6,015 | $ | 5,753 | $ | 5,991 | |||||||||
Year-End ending Praxair, Inc. shareholders’ equity | $ | 5,623 | $ | 6,609 | $ | 6,064 | $ | 5,488 | $ | 5,792 | |||||||||
Five-quarter average Praxair, Inc. shareholders’ equity | $ | 6,459 | $ | 6,196 | $ | 5,824 | $ | 5,920 | $ | 5,590 | |||||||||
Return on Praxair, Inc. Shareholders’ Equity | 28.7 | % | 28.6 | % | 28.9 | % | 28.1 | % | 26.4 | % | |||||||||
44
Debt-to-Capital Ratio
The debt-to-capital ratio is a measure used by investors, financial analysts and management to provide a measure of financial leverage and insights into how the company is financing its operations.
(Dollar amounts in millions) | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||
Year Ended December 31, | |||||||||||||||||||
Total debt | $ | 9,258 | $ | 8,811 | $ | 7,362 | $ | 6,562 | $ | 5,557 | |||||||||
Less: cash and cash equivalents | (126 | ) | (138 | ) | (157 | ) | (90 | ) | (39 | ) | |||||||||
Net debt | 9,132 | 8,673 | 7,205 | 6,472 | 5,518 | ||||||||||||||
Equity and redeemable noncontrolling interests | |||||||||||||||||||
Redeemable noncontrolling interests | 176 | 307 | 252 | 220 | — | ||||||||||||||
Praxair, Inc. shareholders’ equity | 5,623 | 6,609 | 6,064 | 5,488 | 5,792 | ||||||||||||||
Noncontrolling interests | 387 | 394 | 357 | 309 | 353 | ||||||||||||||
Total equity and redeemable noncontrolling interests | 6,186 | 7,310 | 6,673 | 6,017 | 6,145 | ||||||||||||||
Total capital | $ | 15,318 | $ | 15,983 | $ | 13,878 | $ | 12,489 | $ | 11,663 | |||||||||
Debt-to-capital ratio | 59.6 | % | 54.3 | % | 51.9 | % | 51.8 | % | 47.3 | % | |||||||||
45
Adjusted EBITDA, Adjusted EBITDA Margin and Debt-to-Adjusted EBITDA Ratio
(Dollar amounts in millions) | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||
Year Ended December 31, | |||||||||||||||||||
Adjusted net income - Praxair, Inc. (see below) | $ | 1,852 | $ | 1,772 | $ | 1,681 | $ | 1,666 | $ | 1,476 | |||||||||
Add: adjusted noncontrolling interests (see below) | 52 | 65 | 54 | 51 | 39 | ||||||||||||||
Add: adjusted interest expense - net | 177 | 160 | 141 | 145 | 118 | ||||||||||||||
Add: adjusted income taxes (see below) | 707 | 698 | 660 | 647 | 572 | ||||||||||||||
Add: depreciation and amortization | 1,170 | 1,109 | 1,001 | 1,003 | 925 | ||||||||||||||
Adjusted EBITDA | $ | 3,958 | $ | 3,804 | $ | 3,537 | $ | 3,512 | $ | 3,130 | |||||||||
Reported Sales | $ | 12,273 | $ | 11,925 | $ | 11,224 | $ | 11,252 | $ | 10,116 | |||||||||
Adjusted EBITDA Margin | 32.2 | % | 31.9 | % | 31.5 | % | 31.2 | % | 30.9 | % | |||||||||
Beginning Praxair, Inc. net debt | $ | 8,673 | $ | 7,205 | $ | 6,472 | $ | 5,518 | $ | 5,010 | |||||||||
First quarter ending Praxair, Inc. net debt | $ | 9,126 | $ | 8,563 | $ | 6,749 | $ | 5,752 | $ | 5,028 | |||||||||
Second quarter ending Praxair, Inc. net debt | $ | 8,992 | $ | 9,004 | $ | 6,891 | $ | 6,039 | $ | 4,978 | |||||||||
Third quarter ending Praxair, Inc. net debt | $ | 8,953 | $ | 8,892 | $ | 7,028 | $ | 6,185 | $ | 5,006 | |||||||||
Year-End ending Praxair, Inc. net debt | $ | 9,132 | $ | 8,673 | $ | 7,205 | $ | 6,472 | $ | 5,518 | |||||||||
Five-quarter average Praxair, Inc. net debt | $ | 8,975 | $ | 8,467 | $ | 6,869 | $ | 5,993 | $ | 5,108 | |||||||||
Debt-to- adjusted EBITDA ratio | 2.3 | 2.2 | 1.9 | 1.7 | 1.6 | ||||||||||||||
Adjusted Amounts
2014 amounts are adjusted for the impact of the Venezuela currency devaluation, a pension settlement and a bond redemption. 2013 amounts are adjusted for the impact of Venezuela currency devaluation, a pension settlement, an income tax benefit related to the realignment of Praxair's Italian legal structure and a bond redemption. 2012 amounts are adjusted for the impact of the cost reduction program, a pension settlement and an income tax benefit related to US homecare divestiture. 2011 amounts are adjusted for the impact of a net gain on acquisition and the cost reduction program. 2010 amounts are adjusted for the impact of the Spanish income tax settlement, US homecare divestiture, repatriation tax benefit and Venezuela currency devaluation. The company does not believe these items are indicative of on-going business performance and, accordingly, their impacts are excluded from the reported amounts so that investors can better evaluate and analyze historical and future business trends on a consistent basis.
(Dollar amounts in millions, except per share data) | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||
Year Ended December 31, | |||||||||||||||||||
Adjusted Operating Profit and Margin | |||||||||||||||||||
Reported operating profit | $ | 2,608 | $ | 2,625 | $ | 2,437 | $ | 2,468 | $ | 2,082 | |||||||||
Add: Pension settlement charge | 7 | 9 | 9 | — | — | ||||||||||||||
Add: Venezuela currency devaluation | 131 | 23 | — | — | 27 | ||||||||||||||
Add: Cost reduction program | — | — | 56 | 40 | — | ||||||||||||||
Less: Net gain on acquisition | — | — | — | (39 | ) | — | |||||||||||||
Add: US homecare divestiture | — | — | — | — | 58 | ||||||||||||||
Total adjustments | 138 | 32 | 65 | 1 | 85 | ||||||||||||||
Adjusted operating profit | $ | 2,746 | $ | 2,657 | $ | 2,502 | $ | 2,469 | $ | 2,167 | |||||||||
Reported percent change | (1 | )% | 8 | % | (1 | )% | 19 | % | 32 | % | |||||||||
Adjusted percent change | 3 | % | 6 | % | 1 | % | 14 | % | 15 | % | |||||||||
Reported sales | $ | 12,273 | $ | 11,925 | $ | 11,224 | $ | 11,252 | $ | 10,116 | |||||||||
Reported operating profit margin | 21.2 | % | 22.0 | % | 21.7 | % | 21.9 | % | 20.6 | % | |||||||||
Adjusted operating profit margin | 22.4 | % | 22.3 | % | 22.3 | % | 21.9 | % | 21.4 | % | |||||||||
46
(Dollar amounts in millions, except per share data) | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||
Year Ended December 31, | |||||||||||||||||||
Adjusted Interest Expense - Net | |||||||||||||||||||
Reported interest expense | 213 | 178 | 141 | 145 | 118 | ||||||||||||||
Less: Bond redemption | (36 | ) | (18 | ) | — | — | — | ||||||||||||
Adjusted interest expense - net | $ | 177 | $ | 160 | $ | 141 | $ | 145 | $ | 118 | |||||||||
Adjusted Income Taxes and Effective Tax Rate | |||||||||||||||||||
Reported income taxes | $ | 691 | $ | 649 | $ | 586 | $ | 641 | $ | 768 | |||||||||
Add: Bond redemption | 14 | 6 | — | — | — | ||||||||||||||
Add: Income tax benefits | — | 40 | 55 | — | — | ||||||||||||||
Add: Pension settlement charge | 2 | 3 | 3 | — | — | ||||||||||||||
Add: Venezuela currency devaluation | — | — | — | — | 1 | ||||||||||||||
Add: Cost reduction program | — | — | 16 | 9 | — | ||||||||||||||
Less: Spanish income tax settlement | — | — | — | — | (250 | ) | |||||||||||||
Less: Net gain on acquisition | — | — | — | (3 | ) | — | |||||||||||||
Add: US homecare divestiture | — | — | — | — | 18 | ||||||||||||||
Add: Repatriation tax benefit | — | — | — | — | 35 | ||||||||||||||
Total adjustments | 16 | 49 | 74 | 6 | (196 | ) | |||||||||||||
Adjusted income taxes | $ | 707 | $ | 698 | $ | 660 | $ | 647 | $ | 572 | |||||||||
Reported income before income taxes and equity investments | $ | 2,395 | $ | 2,447 | $ | 2,296 | $ | 2,323 | $ | 1,964 | |||||||||
Add: Bond redemption | 36 | 18 | — | — | — | ||||||||||||||
Add: Pension settlement charge | 7 | 9 | 9 | — | — | ||||||||||||||
Add: Venezuela currency devaluation | 131 | 23 | — | — | 27 | ||||||||||||||
Add: Cost reduction program | — | — | 56 | 40 | — | ||||||||||||||
Less: Net gain on acquisition | — | — | — | (39 | ) | — | |||||||||||||
Add: US homecare divestiture | — | — | — | — | 58 | ||||||||||||||
Total adjustments | 174 | 50 | 65 | 1 | 85 | ||||||||||||||
Adjusted income before income taxes and equity investments | $ | 2,569 | $ | 2,497 | $ | 2,361 | $ | 2,324 | $ | 2,049 | |||||||||
Adjusted effective tax rate | 27.5 | % | 28.0 | % | 28.0 | % | 27.8 | % | 27.9 | % | |||||||||
Adjusted Noncontrolling Interests | |||||||||||||||||||
Reported noncontrolling interests | $ | 52 | $ | 81 | $ | 52 | $ | 50 | $ | 39 | |||||||||
Less: Income tax benefits | — | (16 | ) | — | — | — | |||||||||||||
Add: Cost reduction program | — | — | 2 | — | — | ||||||||||||||
Add: Net gain on acquisition | — | — | — | 1 | — | ||||||||||||||
Total adjustments | — | (16 | ) | 2 | 1 | — | |||||||||||||
Adjusted noncontrolling interests | $ | 52 | $ | 65 | $ | 54 | $ | 51 | $ | 39 | |||||||||
Adjusted Net Income – Praxair, Inc. | |||||||||||||||||||
Reported net income – Praxair, Inc. | $ | 1,694 | $ | 1,755 | $ | 1,692 | $ | 1,672 | $ | 1,195 | |||||||||
Add: Bond redemption | 22 | 12 | — | — | — | ||||||||||||||
Less: Income tax benefits | — | (24 | ) | (55 | ) | — | — | ||||||||||||
Add: Pension settlement charge | 5 | 6 | 6 | — | — | ||||||||||||||
Add: Venezuela currency devaluation | 131 | 23 | — | — | 26 | ||||||||||||||
Add: Cost reduction program | — | — | 38 | 31 | — | ||||||||||||||
Less: Net gain on acquisition | — | — | — | (37 | ) | — | |||||||||||||
Add: Spanish tax settlement | — | — | — | — | 250 | ||||||||||||||
Add: US homecare divestiture | — | — | — | — | 40 | ||||||||||||||
47
(Dollar amounts in millions, except per share data) | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||
Year Ended December 31, | |||||||||||||||||||
Less: Repatriation tax benefit | — | — | — | — | (35 | ) | |||||||||||||
Total adjustments | 158 | 17 | (11 | ) | (6 | ) | 281 | ||||||||||||
Adjusted net income – Praxair, Inc. | $ | 1,852 | $ | 1,772 | $ | 1,681 | $ | 1,666 | $ | 1,476 | |||||||||
Reported percent change | (3 | )% | 4 | % | 1 | % | 40 | % | (5 | )% | |||||||||
Adjusted percent change | 5 | % | 5 | % | 1 | % | 13 | % | 18 | % | |||||||||
(Dollar amounts in millions, except per share data) | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||
Year Ended December 31, | |||||||||||||||||||
Adjusted Diluted Earnings Per Share | |||||||||||||||||||
Reported diluted earnings per share | $ | 5.73 | $ | 5.87 | $ | 5.61 | $ | 5.45 | $ | 3.84 | |||||||||
Add: Bond redemption | 0.07 | 0.04 | — | — | — | ||||||||||||||
Less: Income tax benefits | — | (0.08 | ) | (0.18 | ) | — | — | ||||||||||||
Add: Pension settlement charge | 0.02 | 0.02 | 0.02 | — | — | ||||||||||||||
Add: Venezuela currency devaluation | 0.45 | 0.08 | — | — | 0.08 | ||||||||||||||
Add: Cost reduction program | — | — | 0.12 | 0.10 | — | ||||||||||||||
Less: Net gain on acquisition | — | — | — | (0.12 | ) | — | |||||||||||||
Add: Spanish income tax settlement | — | — | — | — | 0.80 | ||||||||||||||
Add: US homecare divestiture | — | — | — | — | 0.13 | ||||||||||||||
Less: Repatriation tax benefit | — | — | — | — | (0.11 | ) | |||||||||||||
Total adjustments | 0.54 | 0.06 | (0.04 | ) | (0.02 | ) | 0.90 | ||||||||||||
Adjusted diluted earnings per share | $ | 6.27 | $ | 5.93 | $ | 5.57 | $ | 5.43 | $ | 4.74 | |||||||||
Reported percent change | (2 | )% | 5 | % | 3 | % | 42 | % | (4 | )% | |||||||||
Adjusted percent change | 6 | % | 6 | % | 3 | % | 15 | % | 19 | % | |||||||||
2015 Diluted Earnings Per Share Outlook | |||||||||||||||||||
Low End | High End | ||||||||||||||||||
2015 diluted EPS outlook | $6.15 | $6.50 | |||||||||||||||||
2014 adjusted diluted EPS (see above) | $6.27 | $6.27 | |||||||||||||||||
Percentage change | (2 | )% | 4 | % | |||||||||||||||
FORWARD-LOOKING STATEMENTS
This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s reasonable expectations and assumptions as of the date the statements are made but involve risks and uncertainties. These risks and uncertainties include, without limitation: the performance of stock markets generally; developments in worldwide and national economies and other international events and circumstances; changes in foreign currencies and in interest rates; the cost and availability of electric power, natural gas and other raw materials; the ability to achieve price increases to offset cost increases; catastrophic events including natural disasters, epidemics and acts of war and terrorism; the ability to attract, hire, and retain qualified personnel; the impact of changes in financial accounting standards; the impact of changes in pension plan liabilities; the impact of tax, environmental, healthcare and other legislation and government regulation in jurisdictions in which the company operates; the cost and outcomes of investigations, litigation and regulatory proceedings; continued timely development and market acceptance of new products and applications; the impact of competitive products and pricing; future financial and operating performance of major customers and industries served; the impact of information technology system failures, network disruptions and breaches in data security; and the effectiveness and speed of integrating new acquisitions into the business. These risks and uncertainties may cause actual future results or circumstances to differ materially from the projections or estimates contained in the forward-looking statements. Additionally, financial projections or estimates exclude the impact of special items which the company believes are not indicative of ongoing business performance.The company assumes no
48
obligation to update or provide revisions to any forward-looking statement in response to changing circumstances. The above listed risks and uncertainties are further described in Item 1A (Risk Factors) in this report which should be reviewed carefully. Please consider the company’s forward-looking statements in light of those risks.
49
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Praxair is exposed to market risks relating to fluctuations in interest rates and currency exchange rates. The objective of financial risk management at Praxair is to minimize the negative impact of interest rate and foreign exchange rate fluctuations on the company’s earnings, cash flows and equity.
To manage these risks, Praxair uses various derivative financial instruments, including interest-rate swaps, treasury rate locks, currency swaps, forward contracts, currency options and commodity contracts. Praxair only uses commonly traded and non-leveraged instruments. These contracts are entered into primarily with major banking institutions thereby minimizing the risk of credit loss. Also, see Notes 1 and 12 to the consolidated financial statements for a more complete description of Praxair’s accounting policies and use of such instruments.
The following discussion presents the sensitivity of the market value, earnings and cash flows of Praxair’s financial instruments to hypothetical changes in interest and exchange rates assuming these changes occurred at December 31, 2014. The range of changes chosen for these discussions reflects Praxair’s view of changes which are reasonably possible over a one-year period. Market values represent the present values of projected future cash flows based on interest rate and exchange rate assumptions.
Interest Rate and Debt Sensitivity Analysis
At December 31, 2014, Praxair had debt totaling $9,258 million ($8,811 million at December 31, 2013). At December 31, 2014 there were two interest-rate swap agreements outstanding with notional amounts totaling $875 million that converts fixed-rate interest to variable-rate interest on the $400 million 3.25% notes that mature in 2015 and the $475 million 1.25% notes that mature in 2018. When considered necessary, interest-rate swaps are entered into as hedges of underlying financial instruments to effectively change the characteristics of the interest rate without actually changing the underlying financial instrument.
For fixed-rate instruments, interest-rate changes affect the fair market value but do not impact earnings or cash flows. Conversely, for floating-rate instruments, interest-rate changes generally do not affect the fair market value but impact future earnings and cash flows, assuming other factors are held constant.
At December 31, 2014, Praxair had fixed-rate debt of $7,626 million and floating-rate debt of $1,632 million, representing 82% and 18%, respectively, of total debt. At December 31, 2013, Praxair had fixed-rate debt of $7,004 million and floating-rate debt of $1,807 million, representing 79% and 21%, respectively, of total debt. Holding other variables constant (such as foreign exchange rates, swaps and debt levels), a one-percentage-point decrease in interest rates would increase the unrealized fair market value of the fixed-rate debt by approximately $440 million ($421 million in 2013). At December 31, 2014 and 2013, the after-tax earnings and cash flows impact for the subsequent year resulting from a one-percentage-point increase in interest rates would be approximately $11 million and $12 million, respectively, holding other variables constant.
Exchange Rate Sensitivity Analysis
Praxair’s exchange-rate exposures result primarily from its investments and ongoing operations in South America (primarily Brazil, Argentina and Colombia), Europe (primarily Germany, Italy, Russia, Scandinavia and Spain), Canada, Mexico, Asia (primarily China, India, Korea and Thailand) and other business transactions such as the procurement of equipment from foreign sources. From time to time, Praxair utilizes foreign exchange forward contracts to hedge these exposures. At December 31, 2014, Praxair had $2,427 million notional amount ($2,197 million at December 31, 2013) of foreign exchange contracts all of which were to hedge recorded balance sheet exposures. See Note 12 to the consolidated financial statements.
Holding other variables constant, if there were a 10% adverse change in foreign-currency exchange rates for the portfolio, the fair market value of foreign-currency contracts outstanding at December 31, 2014 and 2013 would decrease by approximately $86 million and $46 million, respectively, which would be largely offset by an offsetting gain or loss on the foreign-currency fluctuation of the underlying exposure being hedged.
50
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Page | |
Audited Consolidated Financial Statements | |
Notes to Consolidated Financial Statements | |
51
MANAGEMENT’S STATEMENT OF RESPONSIBILITY FOR FINANCIAL STATEMENTS
Praxair’s consolidated financial statements are prepared by management, which is responsible for their fairness, integrity and objectivity. The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America applied on a consistent basis, except for accounting changes as disclosed, and include amounts that are estimates and judgments. All historical financial information in this annual report is consistent with the accompanying financial statements.
Praxair maintains accounting systems, including internal accounting controls, monitored by a staff of internal auditors, that are designed to provide reasonable assurance of the reliability of financial records and the protection of assets. The concept of reasonable assurance is based on recognition that the cost of a system should not exceed the related benefits. The effectiveness of those systems depends primarily upon the careful selection of financial and other managers, clear delegation of authority and assignment of accountability, inculcation of high business ethics and conflict-of-interest standards, policies and procedures for coordinating the management of corporate resources, and the leadership and commitment of top management. In compliance with Section 404 of the Sarbanes-Oxley Act of 2002, Praxair assessed its internal control over financial reporting and issued a report (see below).
PricewaterhouseCoopers LLP, an independent registered public accounting firm, has completed an integrated audit of Praxair’s 2014, 2013 and 2012 consolidated financial statements and of its internal control over financial reporting as of December 31, 2014 in accordance with the standards of the Public Company Accounting Oversight Board (United States) as stated in their report.
The Audit Committee of the Board of Directors, which consists solely of non-employee directors, is responsible for overseeing the functioning of the accounting system and related controls and the preparation of annual financial statements. The Audit Committee periodically meets with management, internal auditors and the independent accountants to review and evaluate their accounting, auditing and financial reporting activities and responsibilities, including management’s assessment of internal control over financial reporting. The independent registered public accounting firm and internal auditors have full and free access to the Audit Committee and meet with the committee, with and without management present.
MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Praxair’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Under the supervision and with the participation of management, including the company’s principal executive officer and principal financial officer, the company conducted an evaluation of the effectiveness of its internal control over financial reporting based on the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (often referred to as COSO). Based on this evaluation, management concluded that the company’s internal control over financial reporting was effective as of December 31, 2014.
PricewaterhouseCoopers LLP, an independent registered public accounting firm, has issued their opinion on the company’s internal control over financial reporting as of December 31, 2014 as stated in their report.
/s/ STEPHEN F. ANGEL | /s/ ELIZABETH T. HIRSCH | |
Stephen F. Angel Chairman, President and Chief Executive Officer | Elizabeth T. Hirsch Vice President and Controller | |
/s/ MATTHEW J. WHITE | ||
Matthew J. White Senior Vice President and Chief Financial Officer | Danbury, Connecticut February 25, 2015 | |
52
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To The Board of Directors and Shareholders of Praxair, Inc.:
In our opinion, the accompanying consolidated balance sheets and the related consolidated statements of income, comprehensive income (loss), equity and cash flows present fairly, in all material respects, the financial position of Praxair and its subsidiaries at December 31, 2014 and 2013, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2014 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company's management is responsible for these financial statements, for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express opinions on these financial statements and on the Company's internal control over financial reporting based on our integrated audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers
Stamford, Connecticut
February 25, 2015
53
CONSOLIDATED STATEMENTS OF INCOME
PRAXAIR, INC. AND SUBSIDIARIES
(Dollar amounts in millions, except per share data)
Year Ended December 31, | 2014 | 2013 | 2012 | ||||||||
Sales | $ | 12,273 | $ | 11,925 | $ | 11,224 | |||||
Cost of sales, exclusive of depreciation and amortization | 6,962 | 6,744 | 6,396 | ||||||||
Selling, general and administrative | 1,308 | 1,349 | 1,270 | ||||||||
Depreciation and amortization | 1,170 | 1,109 | 1,001 | ||||||||
Research and development | 96 | 98 | 98 | ||||||||
Venezuela currency devaluation and other charges – net | 138 | 32 | 65 | ||||||||
Other income (expenses) – net | 9 | 32 | 43 | ||||||||
Operating Profit | 2,608 | 2,625 | 2,437 | ||||||||
Interest expense – net | 213 | 178 | 141 | ||||||||
Income Before Income Taxes and Equity Investments | 2,395 | 2,447 | 2,296 | ||||||||
Income taxes | 691 | 649 | 586 | ||||||||
Income Before Equity Investments | 1,704 | 1,798 | 1,710 | ||||||||
Income from equity investments | 42 | 38 | 34 | ||||||||
Net Income (Including Noncontrolling Interests) | 1,746 | 1,836 | 1,744 | ||||||||
Less: noncontrolling interests | (52 | ) | (81 | ) | (52 | ) | |||||
Net Income – Praxair, Inc. | $ | 1,694 | $ | 1,755 | $ | 1,692 | |||||
Per Share Data – Praxair, Inc. Shareholders | |||||||||||
Basic earnings per share | $ | 5.79 | $ | 5.94 | $ | 5.67 | |||||
Diluted earnings per share | $ | 5.73 | $ | 5.87 | $ | 5.61 | |||||
Weighted Average Shares Outstanding (000’s): | |||||||||||
Basic shares outstanding | 292,494 | 295,523 | 298,316 | ||||||||
Diluted shares outstanding | 295,608 | 298,965 | 301,845 | ||||||||
The accompanying Notes on pages 60 to 100 are an integral part of these financial statements.
54
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
PRAXAIR, INC. AND SUBSIDIARIES
(Dollar amounts in millions)
Year Ended December 31, | 2014 | 2013 | 2012 | ||||||||
NET INCOME (INCLUDING NONCONTROLLING INTERESTS) | $ | 1,746 | $ | 1,836 | $ | 1,744 | |||||
OTHER COMPREHENSIVE INCOME (LOSS) | |||||||||||
Translation adjustments: | |||||||||||
Foreign currency translation adjustments | (1,087 | ) | (474 | ) | (13 | ) | |||||
Reclassifications to net income | (5 | ) | — | — | |||||||
Income Taxes | (4 | ) | 27 | 17 | |||||||
Translation adjustments | (1,096 | ) | (447 | ) | 4 | ||||||
Funded status - retirement obligations (Note 16): | |||||||||||
Retirement program remeasurements | (318 | ) | 408 | (228 | ) | ||||||
Reclassifications to net income | 59 | 95 | 71 | ||||||||
Income taxes | 95 | (180 | ) | 49 | |||||||
Funded status - retirement obligations | (164 | ) | 323 | (108 | ) | ||||||
Derivative instruments (Note 12): | |||||||||||
Current year unrealized gain (loss) | 4 | 1 | (1 | ) | |||||||
Reclassifications to net income | — | — | — | ||||||||
Income taxes | (1 | ) | — | 1 | |||||||
Derivative instruments | 3 | 1 | — | ||||||||
TOTAL OTHER COMPREHENSIVE LOSS | (1,257 | ) | (123 | ) | (104 | ) | |||||
COMPREHENSIVE INCOME (INCLUDING NONCONTROLLING INTERESTS) | 489 | 1,713 | 1,640 | ||||||||
Less: noncontrolling interests | 1 | (76 | ) | (54 | ) | ||||||
COMPREHENSIVE INCOME - PRAXAIR, INC. | $ | 490 | $ | 1,637 | $ | 1,586 | |||||
The accompanying Notes on pages 60 to 100 are an integral part of these financial statements.
55
CONSOLIDATED BALANCE SHEETS
PRAXAIR, INC. AND SUBSIDIARIES
(Dollar amounts in millions)
December 31, | 2014 | 2013 | |||||
Assets | |||||||
Cash and cash equivalents | $ | 126 | $ | 138 | |||
Accounts receivable – net | 1,796 | 1,892 | |||||
Inventories | 551 | 506 | |||||
Prepaid and other current assets | 366 | 380 | |||||
Total Current Assets | 2,839 | 2,916 | |||||
Property, plant and equipment – net | 11,997 | 12,278 | |||||
Equity investments | 693 | 702 | |||||
Goodwill | 3,121 | 3,194 | |||||
Other intangible assets – net | 603 | 596 | |||||
Other long-term assets | 549 | 569 | |||||
Total Assets | $ | 19,802 | $ | 20,255 | |||
Liabilities and Equity | |||||||
Accounts payable | $ | 864 | $ | 921 | |||
Short-term debt | 587 | 782 | |||||
Current portion of long-term debt | 2 | 3 | |||||
Accrued taxes | 119 | 168 | |||||
Other current liabilities | 918 | 790 | |||||
Total Current Liabilities | 2,490 | 2,664 | |||||
Long-term debt | 8,669 | 8,026 | |||||
Other long-term liabilities | 1,176 | 859 | |||||
Deferred credits | 1,281 | 1,396 | |||||
Total Liabilities | 13,616 | 12,945 | |||||
Commitments and contingencies (Note 17) | |||||||
Redeemable noncontrolling interests | 176 | 307 | |||||
Praxair, Inc. Shareholders’ Equity: | |||||||
Common stock $0.01 par value, authorized – 800,000,000 shares, issued 2014 and 2013 – 383,230,625 shares | 4 | 4 | |||||
Additional paid-in capital | 3,994 | 3,970 | |||||
Retained earnings | 11,461 | 10,528 | |||||
Accumulated other comprehensive income (loss) | (3,185 | ) | (1,981 | ) | |||
Less: Treasury stock, at cost (2014 – 93,969,017 shares and 2013 – 89,096,761 shares) | (6,651 | ) | (5,912 | ) | |||
Total Praxair, Inc. Shareholders’ Equity | 5,623 | 6,609 | |||||
Noncontrolling interests | 387 | 394 | |||||
Total Equity | 6,010 | 7,003 | |||||
Total Liabilities and Equity | $ | 19,802 | $ | 20,255 | |||
The accompanying Notes on pages 60 to 100 are an integral part of these financial statements.
56
CONSOLIDATED STATEMENTS OF CASH FLOWS
PRAXAIR, INC. AND SUBSIDIARIES
(Millions of dollars)
Year Ended December 31, | 2014 | 2013 | 2012 | ||||||||
Increase (Decrease) in Cash and Cash Equivalents | |||||||||||
Operations | |||||||||||
Net income – Praxair, Inc. | $ | 1,694 | $ | 1,755 | $ | 1,692 | |||||
Noncontrolling interests | 52 | 81 | 52 | ||||||||
Net income (including noncontrolling interests) | $ | 1,746 | $ | 1,836 | $ | 1,744 | |||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Venezuela currency devaluation and other charges-net, net of payments | 138 | 23 | 43 | ||||||||
Depreciation and amortization | 1,170 | 1,109 | 1,001 | ||||||||
Deferred income taxes | 55 | 101 | 258 | ||||||||
Share-based compensation | 51 | 70 | 70 | ||||||||
Non-cash charges and other | (116 | ) | (88 | ) | (127 | ) | |||||
Working capital | |||||||||||
Accounts receivable | (80 | ) | (84 | ) | (36 | ) | |||||
Inventory | (42 | ) | (54 | ) | (18 | ) | |||||
Prepaid and other current assets | (20 | ) | (69 | ) | (17 | ) | |||||
Payables and accruals | 13 | 107 | (34 | ) | |||||||
Pension contributions | (18 | ) | (52 | ) | (184 | ) | |||||
Long-term assets, liabilities and other | (29 | ) | 18 | 52 | |||||||
Net cash provided by operating activities | 2,868 | 2,917 | 2,752 | ||||||||
Investing | |||||||||||
Capital expenditures | (1,689 | ) | (2,020 | ) | (2,180 | ) | |||||
Acquisitions, net of cash acquired | (206 | ) | (1,323 | ) | (280 | ) | |||||
Divestitures and asset sales | 92 | 106 | 82 | ||||||||
Net cash used for investing activities | (1,803 | ) | (3,237 | ) | (2,378 | ) | |||||
Financing | |||||||||||
Short-term debt borrowings (repayments) – net | (193 | ) | 149 | 293 | |||||||
Long-term debt borrowings | 1,546 | 2,659 | 2,036 | ||||||||
Long-term debt repayments | (764 | ) | (1,347 | ) | (1,522 | ) | |||||
Issuances of common stock | 103 | 154 | 164 | ||||||||
Purchases of common stock | (862 | ) | (590 | ) | (623 | ) | |||||
Cash dividends – Praxair, Inc. shareholders | (759 | ) | (708 | ) | (655 | ) | |||||
Excess tax benefit on stock based compensation | 31 | 46 | 60 | ||||||||
Noncontrolling interest transactions and other | (110 | ) | (35 | ) | (56 | ) | |||||
Net cash used for financing activities | (1,008 | ) | 328 | (303 | ) | ||||||
Effect of exchange rate changes on cash and cash equivalents | (69 | ) | (27 | ) | (4 | ) | |||||
Change in cash and cash equivalents | (12 | ) | (19 | ) | 67 | ||||||
Cash and cash equivalents, beginning-of-period | 138 | 157 | 90 | ||||||||
Cash and cash equivalents, end-of-period | $ | 126 | $ | 138 | $ | 157 | |||||
Supplemental Data | |||||||||||
Income taxes paid | $ | 606 | $ | 532 | $ | 277 | |||||
Interest paid, net of capitalized interest (Note 7) | $ | 210 | $ | 184 | $ | 153 | |||||
The accompanying Notes on pages 60 to 100 are an integral part of these financial statements.
57
CONSOLIDATED STATEMENTS OF EQUITY
PRAXAIR, INC. AND SUBSIDIARIES
(Dollar amounts in millions, except per share data, shares in thousands)
Praxair, Inc. Shareholders’ Equity | |||||||||||||||||||||||||||||||||||||
Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) (Note 7) | Treasury Stock | Praxair, Inc. Shareholders’ Equity | Noncontrolling Interests | Total Equity | ||||||||||||||||||||||||||||||
Activity | Shares | Amounts | Shares | Amounts | |||||||||||||||||||||||||||||||||
Balance, December 31, 2011 | 382,854 | $ | 4 | $ | 3,809 | $ | 8,510 | $ | (1,746 | ) | 84,324 | $ | (5,089 | ) | $ | 5,488 | $ | 309 | $ | 5,797 | |||||||||||||||||
Net Income | 1,692 | 1,692 | 34 | 1,726 | |||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | (106 | ) | (106 | ) | 2 | (104 | ) | ||||||||||||||||||||||||||||||
Noncontrolling interests: | |||||||||||||||||||||||||||||||||||||
Dividends and other capital reductions | — | (48 | ) | (48 | ) | ||||||||||||||||||||||||||||||||
Additions (Reductions) | — | 44 | 44 | ||||||||||||||||||||||||||||||||||
Reclassification to redeemable noncontrolling interests (Note 14) | — | 16 | 16 | ||||||||||||||||||||||||||||||||||
Redemption value adjustments (Note 14) | (13 | ) | (13 | ) | (13 | ) | |||||||||||||||||||||||||||||||
Dividends to Praxair, Inc. common stock ($2.20 per share) | (655 | ) | (655 | ) | (655 | ) | |||||||||||||||||||||||||||||||
Issuances of common stock: | |||||||||||||||||||||||||||||||||||||
For the dividend reinvestment and stock purchase plan | 66 | 7 | 7 | 7 | |||||||||||||||||||||||||||||||||
For employee savings and incentive plans | 153 | (60 | ) | (3,298 | ) | 208 | 148 | 148 | |||||||||||||||||||||||||||||
Purchases of common stock | 5,818 | (630 | ) | (630 | ) | (630 | ) | ||||||||||||||||||||||||||||||
Tax benefit from stock options | 63 | 63 | 63 | ||||||||||||||||||||||||||||||||||
Share-based compensation | 70 | 70 | 70 | ||||||||||||||||||||||||||||||||||
Balance, December 31, 2012 | 383,073 | $ | 4 | $ | 3,889 | $ | 9,534 | $ | (1,852 | ) | 86,844 | $ | (5,511 | ) | $ | 6,064 | $ | 357 | $ | 6,421 | |||||||||||||||||
Net Income | 1,755 | 1,755 | 57 | 1,812 | |||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | (129 | ) | (129 | ) | 6 | (123 | ) | ||||||||||||||||||||||||||||||
Noncontrolling interests: | |||||||||||||||||||||||||||||||||||||
Dividends and other capital reductions | — | (41 | ) | (41 | ) | ||||||||||||||||||||||||||||||||
Additions (Reductions) | — | 15 | 15 | ||||||||||||||||||||||||||||||||||
Redemption value adjustments (Note 14) | (53 | ) | (53 | ) | (53 | ) | |||||||||||||||||||||||||||||||
Dividends to Praxair, Inc. common stock ($2.40 per share) | (708 | ) | (708 | ) | (708 | ) | |||||||||||||||||||||||||||||||
58
Praxair, Inc. Shareholders’ Equity | |||||||||||||||||||||||||||||||||||||
Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) (Note 7) | Treasury Stock | Praxair, Inc. Shareholders’ Equity | Noncontrolling Interests | Total Equity | ||||||||||||||||||||||||||||||
Activity | Shares | Amounts | Shares | Amounts | |||||||||||||||||||||||||||||||||
Issuances of common stock: | |||||||||||||||||||||||||||||||||||||
For the dividend reinvestment and stock purchase plan | 47 | 5 | (14 | ) | 2 | 7 | 7 | ||||||||||||||||||||||||||||||
For employee savings and incentive plans | 111 | (41 | ) | (2,767 | ) | 180 | 139 | 139 | |||||||||||||||||||||||||||||
Purchases of common stock | 5,034 | (583 | ) | (583 | ) | (583 | ) | ||||||||||||||||||||||||||||||
Tax benefit from stock options | 47 | 47 | 47 | ||||||||||||||||||||||||||||||||||
Share-based compensation | 70 | 70 | 70 | ||||||||||||||||||||||||||||||||||
Balance, December 31, 2013 | 383,231 | $ | 4 | $ | 3,970 | $ | 10,528 | $ | (1,981 | ) | 89,097 | $ | (5,912 | ) | $ | 6,609 | $ | 394 | $ | 7,003 | |||||||||||||||||
Net Income | 1,694 | 1,694 | 40 | 1,734 | |||||||||||||||||||||||||||||||||
Other comprehensive loss | (1,204 | ) | (1,204 | ) | (29 | ) | (1,233 | ) | |||||||||||||||||||||||||||||
Noncontrolling interests: | |||||||||||||||||||||||||||||||||||||
Dividends and other capital reductions | — | (28 | ) | (28 | ) | ||||||||||||||||||||||||||||||||
Purchases of noncontrolling interests | (24 | ) | (24 | ) | 2 | (22 | ) | ||||||||||||||||||||||||||||||
Additions (Reductions) | — | 8 | 8 | ||||||||||||||||||||||||||||||||||
Redemption value adjustments (Note 14) | (2 | ) | (2 | ) | (2 | ) | |||||||||||||||||||||||||||||||
Dividends to Praxair, Inc. common stock ($2.60 per share) | (759 | ) | (759 | ) | (759 | ) | |||||||||||||||||||||||||||||||
Issuances of common stock: | |||||||||||||||||||||||||||||||||||||
For the dividend reinvestment and stock purchase plan | (56 | ) | 7 | 7 | 7 | ||||||||||||||||||||||||||||||||
For employee savings and incentive plans | (36 | ) | (1,830 | ) | 122 | 86 | 86 | ||||||||||||||||||||||||||||||
Purchases of common stock | 6,758 | (868 | ) | (868 | ) | (868 | ) | ||||||||||||||||||||||||||||||
Tax benefit from stock options | 33 | 33 | 33 | ||||||||||||||||||||||||||||||||||
Share-based compensation | 51 | 51 | 51 | ||||||||||||||||||||||||||||||||||
Balance, December 31, 2014 | 383,231 | $ | 4 | $ | 3,994 | $ | 11,461 | $ | (3,185 | ) | 93,969 | $ | (6,651 | ) | $ | 5,623 | $ | 387 | $ | 6,010 | |||||||||||||||||
The accompanying Notes on pages 60 to 100 are an integral part of these financial statements
59
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
PRAXAIR, INC. AND SUBSIDIARIES
NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Operations – Praxair, Inc. and its subsidiaries ("Praxair" or "the company") comprise one of the largest industrial gases companies worldwide, and the largest in North and South America. Praxair produces, sells and distributes atmospheric, process and specialty gases, and high-performance surface coatings to a diverse group of industries including aerospace, chemicals, food and beverage, electronics, energy, healthcare, manufacturing, and metals.
Principles of Consolidation – The consolidated financial statements were prepared in conformity with accounting principles generally accepted in the United States of America (" U.S. GAAP") and include the accounts of all significant subsidiaries where control exists and, in limited situations, variable-interest entities where the company is the primary beneficiary. Intercompany transactions and balances are eliminated in consolidation and any significant related-party transactions have been disclosed.
Equity investments generally consist of 20% to 50% owned operations where the company exercises significant influence, but does not have control. Equity income from equity investments in corporations is reported on an after-tax basis. Pre-tax income from equity investments that are partnerships or limited-liability corporations ("LLC") is included in other income (expenses) – net with related taxes included in Income taxes. Equity investments are reviewed for impairment whenever events or circumstances reflect that an impairment loss may have incurred. Operations less than 20% owned, where the company does not exercise significant influence, are generally carried at cost.
Changes in ownership interest that result either in consolidation or deconsolidation of an investment are recorded at fair value through earnings, including the retained ownership interest, while changes that do not result in either consolidation or deconsolidation of a subsidiary are treated as equity transactions.
Use of Estimates – The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. While actual results could differ, management believes such estimates to be reasonable.
Revenue Recognition – Product sales represent approximately 89% of consolidated sales while all other sources of revenue are approximately 11% in the aggregate. Revenue is recognized when a firm sales agreement exists, collectability of a fixed or determinable sales price is reasonably assured, and when title and risks of ownership transfer to the customer for product sales or, in the case of other revenues when obligations are satisfied or services are performed. Sales returns and allowances are not a normal practice in the industry and are not significant.
A small portion of the company’s revenues relate to long-term construction contracts and are generally recognized using the percentage-of-completion method. Under this method, revenues from sales of major equipment, such as large air-separation facilities, are recognized based primarily on cost incurred to date compared with total estimated cost. Changes to total estimated cost and anticipated losses, if any, are recognized in the period determined.
For contracts that contain multiple products and/or services, amounts assigned to each component are based on its objectively determined fair value, such as the sales price for the component when it is sold separately or competitor prices for similar components.
Certain of the company’s facilities that are built to provide product to a specific customer are required to be accounted for as leases. The associated revenue streams are classified as rental revenue and are not significant.
Amounts billed for shipping and handling fees are recorded as sales, generally on FOB destination terms, and costs incurred for shipping and handling are recorded as cost of sales.
Amounts billed for sales and use taxes, value-added taxes, and certain excise and other specific transactional taxes imposed on revenue producing transactions are presented on a net basis and are not included in sales in the consolidated statement of income.
Cash Equivalents – Cash equivalents are considered to be highly liquid securities with original maturities of three months or less.
Inventories – Inventories are stated at the lower of cost or market. Cost is determined using the average-cost method. Effective July 1, 2014, the Company changed its method of accounting for all remaining U.S. operations that were using the last-in, first-out (“LIFO”) method to the average-cost method. See Note 7.
60
Property, Plant and Equipment – Net – Property, plant and equipment are carried at cost, net of accumulated depreciation. The company capitalizes interest as part of the cost of constructing major facilities (see Note 7). Depreciation is calculated on the straight-line method based on the estimated useful lives of the assets, which range from 3 years to 40 years (see Note 8). Praxair uses accelerated depreciation methods for tax purposes where appropriate. Maintenance of property, plant and equipment is generally expensed as incurred.
The company performs a test for impairment whenever events or changes in circumstances indicate that the carrying amount of an individual asset or asset group may not be recoverable. Should projected undiscounted future cash flows be less than the carrying amount of the asset or asset group, an impairment charge reducing the carrying amount to fair value is required. Fair value is determined based on the most appropriate valuation technique, including discounted cash flows.
Asset-Retirement Obligations – An asset-retirement obligation is recognized in the period in which sufficient information exists to determine the fair value of the liability with a corresponding increase to the carrying amount of the related property, plant and equipment which is then depreciated over its useful life. The liability is initially measured at discounted fair value and then accretion expense is recorded in each subsequent period. The company’s asset-retirement obligations are primarily associated with its on-site long-term supply arrangements where the company has built a facility on land leased from the customer and is obligated to remove the facility at the end of the contract term. The company’s asset-retirement obligations are not material to its consolidated financial statements.
Foreign Currency Translation – For most foreign operations, the local currency is the functional currency and translation gains and losses are reported as part of the accumulated other comprehensive income (loss) component of equity as a cumulative translation adjustment (see Note 7). For Venezuelan operations, the U.S. dollar is the functional currency and translation gains and losses are included in other income (expenses) – net.
Financial Instruments – Praxair enters into various derivative financial instruments to manage its exposure to fluctuating interest and currency exchange rates and energy costs. Such instruments primarily include interest-rate swap and treasury rate lock agreements; currency-swap agreements; forward contracts; currency options; and commodity-swap agreements. These instruments are not entered into for trading purposes. Praxair only uses commonly traded and non-leveraged instruments.
There are three types of derivatives the company enters into: (i) those relating to fair-value exposures, (ii) those relating to cash-flow exposures, and (iii) those relating to foreign currency net investment exposures. Fair-value exposures relate to recognized assets or liabilities, and firm commitments; cash-flow exposures relate to the variability of future cash flows associated with recognized assets or liabilities, or forecasted transactions; and net investment exposures relate to the impact of foreign currency exchange rate changes on the carrying value of net assets denominated in foreign currencies.
When a derivative is executed and hedge accounting is appropriate, it is designated as either a fair-value hedge, cash-flow hedge, or a net investment hedge. Currently, Praxair designates all interest-rate and treasury rate locks as hedges for accounting purposes; however, currency contracts are generally not designated as hedges for accounting purposes unless they are related to forecasted transactions. Whether designated as hedges for accounting purposes or not, all derivatives are linked to an appropriate underlying exposure. On an ongoing basis, the company assesses the hedge effectiveness of all derivatives designated as hedges for accounting purposes to determine if they continue to be highly effective in offsetting changes in fair values or cash flows of the underlying hedged items. If it is determined that the hedge is not highly effective, then hedge accounting will be discontinued prospectively.
Changes in the fair value of derivatives designated as fair-value hedges are recognized in earnings as an offset to the change in the fair values of the underlying exposures being hedged. The changes in fair value of derivatives that are designated as cash-flow hedges are deferred in accumulated other comprehensive income (loss) and are reclassified to earnings as the underlying hedged transaction affects earnings. Any ineffectiveness is recognized in earnings immediately. Hedges of net investments in foreign subsidiaries are recognized in the cumulative translation adjustment component of accumulated other comprehensive income (loss) on the consolidated balance sheets to offset translation gains and losses associated with the hedged net investment. Derivatives that are entered into for risk-management purposes and are not designated as hedges (primarily related to anticipated net income and currency derivatives other than for firm commitments) are recorded at their fair market values and recognized in current earnings.
See Note 12 for additional information relating to financial instruments.
Goodwill – Acquisitions are accounted for using the acquisition method which requires allocation of the purchase price to assets acquired and liabilities assumed based on estimated fair values. Any excess of the purchase price over the fair value of the assets and liabilities acquired is recorded as goodwill. Allocations of the purchase price are based on preliminary estimates and assumptions at the date of acquisition and are subject to revision based on final information received, including appraisals and other analyses which support underlying estimates.
61
The company performs a goodwill impairment test annually in the second quarter or more frequently if events or circumstances indicate that an impairment loss may have been incurred. The applicable guidance allows an entity to first assess qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than carrying value. If it is determined that it is more likely than not that the fair value of a reporting unit is less than carrying value then the company will estimate and compare the fair value of its reporting units to their carrying value, including goodwill. Reporting units are determined based on one level below the operating segment level. As applicable, fair value is determined through the use of projected future cash flows, multiples of earnings and sales and other factors. Such analysis requires the use of certain market assumptions and discount factors, which are subjective in nature.
See Note 9 for additional information relating to goodwill.
Other Intangible Assets – Customer and license/use agreements, non-compete agreements and patents and other intangibles are amortized over the estimated period of benefit. The determination of the estimated period of benefit will be dependent upon the use and underlying characteristics of the intangible asset. Praxair evaluates the recoverability of its intangible assets subject to amortization when facts and circumstances indicate that the carrying value of the asset may not be recoverable. If the carrying value is not recoverable, impairment is measured as the amount by which the carrying value exceeds its estimated fair value. Fair value is generally estimated based on either appraised value or other valuation techniques.
See Note 10 for additional information relating to other intangible assets.
Income Taxes – Deferred income taxes are recorded for the temporary differences between the financial statement and tax bases of assets and liabilities using currently enacted tax rates. Valuation allowances are established against deferred tax assets whenever circumstances indicate that it is more likely than not that such assets will not be realized in future periods.
Under the guidance for accounting for uncertainty in income taxes, the company can recognize the benefit of an income tax position only if it is more likely than not (greater than 50%) that the tax position will be sustained upon tax examination, based solely on the technical merits of the tax position. Otherwise, no benefit can be recognized. The tax benefits recognized are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Additionally, the company accrues interest and related penalties, if applicable, on all tax exposures for which reserves have been established consistent with jurisdictional tax laws. Interest and penalties are classified as income tax expense in the financial statements.
See Note 5 for additional information relating to income taxes.
Retirement Benefits – Most Praxair employees participate in a form of defined benefit or contribution retirement plan, and additionally certain employees are eligible to participate in various post-employment health care and life insurance benefit plans. The cost of contribution plans is recognized in the year earned while the cost of other plans is recognized over the employees’ expected service period to the company, all in accordance with the applicable accounting standards. The funded status of the plans is recorded as an asset or liability in the consolidated balance sheets. Funding of retirement benefits varies and is in accordance with local laws and practices.
See Note 16 for additional information relating to retirement programs.
Share-based Compensation– The company has granted share-based awards which consist of stock options, restricted stock and performance-based stock. Share-based compensation expense is generally recognized on a straight-line basis over the stated vesting period. For stock awards granted to full-retirement-eligible employees, compensation expense is recognized over the period from the grant date to the date retirement eligibility is achieved. For performance-based awards, compensation expense is recognized only if it is probable that the performance condition will be achieved.
See Note 15 for additional disclosures relating to share-based compensation.
Recently Issued Accounting Standards
Accounting Standards Implemented in 2014
The following standards were effective for Praxair in 2014 and their adoption did not have a significant impact on the condensed consolidated financial statements:
• | Accounting for Cumulative Translation Adjustment - In March 2013, the Financial Accounting Standards Board ("FASB") issued updated guidance on the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity, or as a result of acquisitions achieved in stages. The adoption of this guidance did not have a significant impact on the condensed consolidated financial statements. |
62
• | Presentation of Unrecognized Tax Benefits - In July 2013, the FASB issued updated guidance on the presentation of unrecognized tax benefits. The new guidance requires an entity to present certain unrecognized tax benefits, or a portion thereof, as a reduction to the related deferred tax asset, primarily for loss and tax credit carryforwards. The adoption of this guidance did not have a significant impact on the condensed consolidated financial statements. |
Accounting Standards to Be Implemented
• | Reporting Discontinued Operations – In April 2014, the FASB issued updated guidance on the reporting and disclosures of discontinued operations. The new guidance requires that the disposal of a component of an entity be reported as discontinued operations only if the action represents a strategic shift that will have a major effect on an entity’s operations and financial results, and would require expanded disclosures. Praxair does not expect this requirement to have a significant impact on the consolidated financial statements. This guidance will be effective for Praxair beginning in the first quarter of 2015. |
• | Revenue Recognition – In May 2014, the FASB issued updated guidance on the reporting and disclosure of revenue. The new guidance requires the evaluation of contracts with customers to determine the recognition of revenue when or as the entity satisfies a performance obligation, and would require expanded disclosures. This guidance will be effective for Praxair beginning in the first quarter 2017 and can be adopted either retrospectively or as a cumulative-effect adjustment as of the date of adoption. Early adoption is not permitted. Praxair is currently evaluating the new guidance and the transition options and will provide updates on the expected impact to Praxair in future filings, as determined. |
• | Accounting for Share-based Compensation - In June 2014, the FASB issued updated guidance on the accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. Praxair does not expect this requirement to have a significant impact on the consolidated financial statements. This guidance will be effective for Praxair beginning in the first quarter 2016, with early adoption optional. |
Reclassifications – Certain prior years’ amounts have been reclassified to conform to the current year’s presentation.
NOTE 2. VENEZUELA CURRENCY DEVALUATION AND OTHER CHARGES – NET
2014 Charges
Venezuela Currency Devaluation
In recent years, exchange control and other regulations in Venezuela have restricted the Company's operations in Venezuela. During 2014, the Venezuelan government introduced a new exchange control market-based mechanism (referred to as "SICAD II") which allows companies to apply for the conversion of VEF to the U.S. dollar. At December 31, 2014 the SICAD II rate was 50 VEF per U.S. Dollar versus the official rate of 6.3 (a devaluation of about 88%). After considerable analysis, Praxair concluded that the SICAD II rate more accurately reflects the economic reality of its business in Venezuela versus the official exchange rate. Currently, there is a lack of exchangeability between the Venezuelan bolivar fuerte ("VEF") and the U.S. dollar.
As a result, effective December 31, 2014 Praxair changed the exchange rate used to translate the monetary assets and liabilities of its Venezuelan subsidiary to the SICAD II rate of 50 VEF per U.S. Dollar. Also, the Company evaluated the carrying value of its non-monetary assets for impairment and lower of cost or market adjustments considering the new SICAD II rate. As a result, Praxair recorded a pre-tax charge of $131 million ($131 million after-tax, or $0.45 per diluted share) in the Company's consolidated statement of income for the year ended December 31, 2014. This charge includes $68 million related to translation of monetary assets and liabilities to the SICAD II rate and $63 million related primarily to long-lived asset impairments. As a result, Praxair's net asset position in Venezuela at December 31, 2014 was immaterial.
Pension Settlement Charge
During the fourth quarter of 2014, Praxair offered certain former employees who participate in either of the two U.S. qualified defined benefit pension plans, the option to receive a one-time lump sum benefit payment of their vested pension benefits under the plans rather than receiving lifetime annuity payments of these benefits. As a result, a pension settlement of the related pension obligation was triggered for one of the U.S. qualified defined benefit pension plans due to the
63
acceptance rate of the lump sum payment option. Accordingly, Praxair recorded a pension settlement charge of $7 million ($5 million after-tax, or $0.02 per diluted share) in the fourth quarter of 2014 (refer to Note 16).
2013 Charges
Venezuela Currency Devaluation
On February 8, 2013, Venezuela announced a devaluation of the Venezuelan Bolivar from 4.30 to 6.30 (a 32% devaluation), effective on February 13, 2013. In the first quarter 2013 Praxair recorded a $23 million pre-tax charge ($23 million after-tax or $0.08 per diluted share) due primarily to the remeasurement of the local Venezuelan balance sheet to reflect the new official 6.30 exchange rate.
Pension Settlement Charge
In 2012, a number of senior managers retired. These retirees are covered by the U.S. supplemental pension plan which provides for a lump sum benefit payment option. Under certain circumstances, such lump sum payments must be accounted for as a settlement of the related pension obligation, but only when paid. Accordingly, Praxair recorded a settlement charge related to net unrecognized actuarial losses of $9 million ($6 million after-tax or $0.02 per diluted share) in the third quarter of 2013, when the cash payments were made to the retirees (refer to Note 16).
2012 Charges
Cost Reduction Program
In the third quarter of 2012, Praxair recorded pre-tax charges totaling $56 million ($38 million after taxes of $16 million and noncontrolling interests of $2 million or $0.12 per diluted share), relating to severance and business restructuring actions primarily in Europe within the industrial gases and surface technologies businesses. The cost reduction program was initiated primarily in response to the continuing economic downturn in Europe.
The following is a summary of the charges by reportable segment:
(Millions of dollars) | Severance Costs | Costs Associated with Exit or Disposal Activities | Total Cost Reduction Program | |||||||||
North America | $ | 1 | $ | — | $ | 1 | ||||||
Europe | 28 | 8 | 36 | |||||||||
South America | 1 | — | 1 | |||||||||
Asia | 2 | — | 2 | |||||||||
Surface Technologies | 11 | 5 | 16 | |||||||||
Total | $ | 43 | $ | 13 | $ | 56 | ||||||
The severance costs of $43 million are for the termination of approximately 410 employees, primarily in Europe (industrial gases and surface technologies). These actions reflected the continued business slow-down in Europe and resulted from a decision to eliminate and/or restructure operations and product lines. The actions are completed as of December 31, 2014 and the remaining liability associated with those actions is expected to be paid during the next twelve months.
The costs associated with exit or disposal activities of $13 million include asset write-downs and other costs associated with a decision to eliminate and/or restructure operations and product lines. In Europe the costs primarily relate to the elimination and consolidation of operations in Spain. In Surface Technologies, the costs relate to the consolidation/rationalization of operations and product lines, primarily in Germany and Italy.
64
The following table summarizes the activities related to the company's cost reduction program through December 31, 2014:
(Millions of dollars) | Severance Costs | Costs Associated with Exit or Disposal Activities | Total Cost Reduction Program | |||||||||
Cost reduction program charges in the third quarter of 2012 | $ | 43 | $ | 13 | $ | 56 | ||||||
Less: Cash payments | (13 | ) | — | (13 | ) | |||||||
Less: Non-cash asset write-offs | — | (9 | ) | (9 | ) | |||||||
Balance December 31, 2012 | $ | 30 | $ | 4 | $ | 34 | ||||||
Less: Cash payments | (16 | ) | (4 | ) | (20 | ) | ||||||
Foreign currency translation | 1 | — | 1 | |||||||||
Balance, December 31, 2013 | $ | 15 | $ | — | $ | 15 | ||||||
Less: Cash payments | (4 | ) | — | (4 | ) | |||||||
Foreign currency translation and other | (4 | ) | — | (4 | ) | |||||||
Balance, December 31, 2014 | $ | 7 | $ | — | $ | 7 | ||||||
Pension Settlement Charge
During 2011, a number of senior managers retired. These retirees are covered by the U.S. supplemental pension plan which provides for a lump sum benefit payment option. Under certain circumstances, such lump sum payments must be accounted for as a settlement of the related pension obligation, but only when paid. Accordingly, Praxair recorded a settlement charge related to net unrecognized actuarial losses of $9 million ($6 million after-tax or $0.02 per diluted share) in the third quarter of 2012 when the cash payments were made (refer to Note 16).
Classification in the consolidated financial statements
The pre-tax net charges or benefits for each year are shown in operating profit in a separate line item on the consolidated statement of income. In the balance sheets, asset write-offs are recorded as a reduction to the carrying value of the related assets and unpaid amounts are recorded as short-term liabilities (See Note 7). On the consolidated statement of cash flows, the pre-tax impact of the net charges or benefits, net of cash payments, is shown as an adjustment to reconcile net income to net cash provided by operating activities. In Note 18 - Segment Information, Praxair excluded these items in its management definition of segment operating profit; a reconciliation of segment operating profit to consolidated operating profit is shown within the operating profit table.
NOTE 3. ACQUISITIONS
The results of operations of these businesses have been included in Praxair’s consolidated statements of income since their respective dates of acquisition. Proforma financial statements for the following acquisitions have not been provided as the acquisitions are not material individually or in the aggregate.
2014 Acquisitions
During the year-ended December 31, 2014 Praxair had acquisitions totaling $206 million. These acquisitions consisted primarily of an industrial gases business in Italy, packaged gas businesses in North and South America and an acquisition of a controlling interest of an equity investment in Asia. These transactions resulted in goodwill and other intangible assets of $86 million and $66 million, respectively (see Note 9 and Note 10). In each case, the allocation of the purchase price is based on preliminary estimates and assumptions, and are subject to revision based on final information received, including appraisals and other analyses that support the underlying estimates. Adjustments, if any, are not expected to be material.
2013 Acquisitions
NuCO2
On March 1, 2013 Praxair acquired 100% of NuCO2 Inc. ("NuCO2") for $1,095 million. NuCO2 is the leading national provider of beverage carbonation solutions in the United States to the restaurant and hospitality industries with 162,000 customer locations and 900 employees, and with 2012 sales of approximately $230 million. The NuCO2 micro-
65
bulk beverage carbonation solution is the service model of choice for quick service restaurants and convenience stores offering fountain beverages and represents an extension of Praxair's core industrial gas business.
The acquisition of NuCO2 was accounted for as a business combination. Following the acquisition date, 100% of NuCO2's results were consolidated in the North America business segment. Praxair's 2013 consolidated income statement includes sales of $208 million related to NuCO2. Pro forma results for 2013 and 2012 have not been included as the impact of the acquisition is not material to the consolidated statements of income.
The following table summarizes the fair value of identifiable assets acquired and liabilities assumed in the acquisition of NuCO2 as of the acquisition date. Purchase accounting has been finalized and adjustments made subsequent to the acquisition date were not material.
(Millions of dollars) | March 1, 2013 | |||
Trade receivables, net | $ | 17 | ||
Property, plant and equipment | 199 | |||
Intangible assets | 374 | |||
Deferred income taxes | (85 | ) | ||
Other assets and (liabilities) | (28 | ) | ||
Goodwill | 618 | |||
Purchase price | $ | 1,095 | ||
The identifiable intangible assets primarily consist of customer relationships that will be amortized over their estimated useful life of 25 years. The deferred income taxes relate primarily to property, plant and equipment, intangibles and operating loss carryforwards. The goodwill resulting from the acquisition is attributable to (i) expected growth from market penetration into the quick service restaurants, convenience stores and themed restaurant chains in the United States and select international markets as we leverage Praxair's customer and distribution networks worldwide, and (ii) cost synergies related to the procurement of raw materials, distribution-related expenses and administrative costs as Praxair integrates and rationalizes administration tasks and leverages its purchasing scale. The goodwill is not expected to be deductible for income tax purposes.
Other Acquisitions
On May 29, 2013 Praxair acquired Dominion Technology Gases Investment Limited (“Dominion”), a leading global supplier of diving, welding, industrial, laboratory and calibration gases and associated equipment to the offshore oil and gas industry based in Aberdeen, Scotland. Dominion provides products and services to the expanding global offshore oil and gas market.
On June 3, 2013 Praxair acquired Volgograd Oxygen Factory (“VOF”), the largest independent industrial gas business in southern Russia, expanding Praxair's production and distribution capabilities in the Volgograd region. Additionally, during 2013, Praxair acquired several smaller independent packaged gas distributors in the United States, an industrial gas business in Italy and a customer contract with operating assets in China.
The aggregate purchase price for these acquisitions was $228 million and resulted in the recognition of $194 million of intangible assets, including $101 million of goodwill and $93 million of other intangible assets, which will be amortized over their estimated useful life.
2012 Acquisitions
In November 2012, Praxair acquired Acetylene Oxygen Company ("AOC"), one of the top ten independent gas and welding products distributors in the U.S, which operates throughout central and southern Texas. The acquisition of AOC allows Praxair to further expand its packaged gases presence in this region. Also, during the twelve months ended December 31, 2012, Praxair completed a number of other smaller acquisitions, primarily North American packaged gas distributors, including PortaGas, located in Houston, Texas. The aggregate purchase price for all seventeen acquisitions was $280 million, and resulted in recognition of $122 million of goodwill.
66
NOTE 4. LEASES
In the normal course of its business, Praxair enters into various leases as the lessee, primarily involving manufacturing and distribution equipment and office space. Total lease and rental expenses under operating leases were $148 million in 2014, $140 million in 2013 and $120 million in 2012. Capital leases are not significant and are included in property, plant and equipment – net. Related obligations are included in debt.
At December 31, 2014, minimum payments due under operating leases are as follows:
(Millions of dollars) | |||
2015 | $ | 122 | |
2016 | 109 | ||
2017 | 91 | ||
2018 | 75 | ||
2019 | 60 | ||
Thereafter | 60 | ||
$ | 517 | ||
The present value of these future lease payments under operating leases is approximately $439 million.
Praxair’s leases where it is the lessor are not material.
NOTE 5. INCOME TAXES
Pre-tax income applicable to U.S. and foreign operations is as follows:
(Millions of dollars) Year Ended December 31, | 2014 | 2013 | 2012 | ||||||||
United States | $ | 1,004 | $ | 890 | $ | 880 | |||||
Foreign | 1,391 | 1,557 | 1,416 | ||||||||
Total income before income taxes | $ | 2,395 | $ | 2,447 | $ | 2,296 | |||||
67
The following is an analysis of the provision for income taxes:
(Millions of dollars) Year Ended December 31, | 2014 | 2013 | 2012 | ||||||||
Current tax expense | |||||||||||
U.S. federal | $ | 291 | $ | 94 | $ | 14 | |||||
State and local | 35 | 27 | 20 | ||||||||
Foreign | 310 | 427 | 294 | ||||||||
636 | 548 | 328 | |||||||||
Deferred tax expense | |||||||||||
U.S. federal | 14 | 164 | 198 | ||||||||
State and local | 12 | 8 | 17 | ||||||||
Foreign | 29 | (71 | ) | 43 | |||||||
55 | 101 | 258 | |||||||||
Total income taxes | $ | 691 | $ | 649 | $ | 586 | |||||
An analysis of the difference between the provision for income taxes and the amount computed by applying the U.S. statutory income tax rate to pre-tax income follows:
(Dollar amounts in millions) Year Ended December 31, | 2014 | 2013 | 2012 | |||||||||||||||||
U.S. statutory income tax rate | $ | 838 | 35.0 | % | $ | 856 | 35.0 | % | $ | 804 | 35.0 | % | ||||||||
State and local taxes – net of federal benefit | 31 | 1.3 | % | 23 | 1.0 | % | 24 | 1.0 | % | |||||||||||
U.S. tax credits and deductions (a) | (37 | ) | (1.5 | )% | (23 | ) | (1.0 | )% | (22 | ) | (1.0 | )% | ||||||||
Foreign tax differentials (b) | (186 | ) | (7.8 | )% | (158 | ) | (6.4 | )% | (159 | ) | (6.9 | )% | ||||||||
Venezuela currency devaluation (c) | 46 | 1.9 | % | 8 | 0.3 | % | — | — | % | |||||||||||
Income tax benefit from realignment of Italian legal structure (d) | — | — | % | (40 | ) | (1.6 | )% | — | — | % | ||||||||||
Income tax benefit from liquidation of subsidiary (e) | — | — | % | — | — | % | (55 | ) | (2.4 | )% | ||||||||||
Other – net | (1 | ) | — | % | (17 | ) | (0.8 | )% | (6 | ) | (0.2 | )% | ||||||||
Provision for income taxes | $ | 691 | 28.9 | % | $ | 649 | 26.5 | % | $ | 586 | 25.5 | % | ||||||||
________________________
(a) | U.S. tax credits and deductions relate to manufacturing deductions and to the research and experimentation tax credit. |
(b) | Primarily related to differences between the U.S. tax rate of 35% and the statutory tax rate in the countries where Praxair operates. 2014 includes $56 million of tax benefits related to a reduction of uncertain tax positions as a result of a lapse of statute of limitations. Other permanent items and tax rate changes were not significant. |
(c) | Impact related to non-deductible Venezuela currency devaluations in 2014 and 2013 (see Note 2). |
(d) | In December of 2013, Praxair's Italian legal structure was realigned. As a result of the new structure, an income tax benefit of $40 million ($24 million net of noncontrolling interests) was recorded. The benefit is recorded as $56 million in foreign current tax expense and $(96) million included in federal deferred tax expense. |
(e) | In 2011 Praxair requested a pre-filing agreement (“PFA”) with the U.S. Internal Revenue Service (“IRS”) related to a loss on a liquidated subsidiary resulting from the divestiture of the U.S. Homecare Business. During the third quarter of 2012, the IRS approved the PFA resulting in a net income tax benefit of $(55) million. The benefit is recorded in U.S. current federal tax expense. |
68
Net deferred tax liabilities included in the consolidated balance sheet are comprised of the following:
(Millions of dollars) December 31, | 2014 | 2013 | |||||
Deferred tax liabilities | |||||||
Fixed assets | $ | 1,402 | $ | 1,374 | |||
Exchange gains | 85 | 61 | |||||
Goodwill | 144 | 127 | |||||
Other intangible assets | 125 | 112 | |||||
Other | 146 | 133 | |||||
$ | 1,902 | $ | 1,807 | ||||
Deferred tax assets | |||||||
Carryforwards | $ | 333 | $ | 323 | |||
Benefit plans and related (a) | 389 | 285 | |||||
Inventory | 18 | 20 | |||||
Accruals and other (b) | 357 | 312 | |||||
$ | 1,097 | $ | 940 | ||||
Less: Valuation allowances (c) | (106 | ) | (85 | ) | |||
$ | 991 | $ | 855 | ||||
Net deferred tax liabilities | $ | 911 | $ | 952 | |||
Recorded in the consolidated balance sheets as (See Note 7): | |||||||
Prepaid and other current assets | $ | 189 | $ | 181 | |||
Other long-term assets | 98 | 72 | |||||
Deferred credits | 1,198 | 1,205 | |||||
$ | 911 | $ | 952 | ||||
________________________
(a) | Includes deferred taxes of $342 million and $247 million in 2014 and 2013, respectively, related to pension / OPEB funded status (see Notes 7 and 16). |
(b) | Includes $179 million and $112 million in 2014 and 2013, respectively, related to research and development costs and $67 million and $70 million in 2014 and 2013, respectively, related to goodwill. |
(c) | Summary of valuation allowances relating to deferred tax assets follows (millions of dollars): |
2014 | 2013 | 2012 | ||||||||||
Balance, January 1, | $ | (85 | ) | $ | (86 | ) | $ | (107 | ) | |||
Income tax (charge) benefit | (20 | ) | 1 | 9 | ||||||||
Translation adjustments | 6 | — | — | |||||||||
Other, including write-offs | (7 | ) | — | 12 | ||||||||
Balance, December 31, | $ | (106 | ) | $ | (85 | ) | $ | (86 | ) | |||
Praxair evaluates deferred tax assets quarterly to ensure that estimated future taxable income will be sufficient in character (e.g., capital gain versus ordinary income treatment), amount and timing to result in their recovery. After considering the positive and negative evidence, a valuation allowance is established to reduce the assets to their realizable value when management determines that it is more likely than not (i.e., greater than 50% likelihood) that a deferred tax asset will not be realized. Considerable judgment is required in establishing deferred tax valuation allowances. At December 31, 2014, Praxair had $333 million of deferred tax assets relating to net operating losses (“NOLs”) and tax credits and $106 million of valuation allowances. These deferred tax assets include $157 million relating to NOLs of which $56 million are in the United States primarily related to Praxair's NuCo2 acquisition in 2013, and $101 million are in Brazil. The U.S. NOLs expire through 2032 and the Brazil NOLs have no expiration. These NOLs have no valuation allowances. The deferred tax assets as of December 31, 2014 also include $73 million relating to U.S. foreign tax credits
69
which expire in 2021 and have a $56 million valuation allowance. The utilization of the U.S. foreign tax credits is dependent on many factors including U.S. interest expense, future U.S. investment, foreign sales and earnings growth, foreign currency exchange rates, and acquisitions and dispositions. Management’s assessment and judgment are highly dependent on these variables and any significant changes to any one of them can substantially impact the amount of foreign tax credit utilization over the ten-year carryforward period.
The remaining deferred tax assets of $103 million relate to U.S. state ($67 million) and other foreign ($36 million) NOLs and credit carryforwards, which expire through 2033, have valuation allowances totaling $50 million. These valuation allowances relate to certain foreign and U.S. state NOLs and are required because management has determined, based on financial projections and available tax strategies, that it is unlikely that the NOLs will be utilized before they expire. If events or circumstances change, valuation allowances are adjusted at that time resulting in an income tax benefit or charge.
A provision has not been made for additional U.S. federal or foreign taxes at December 31, 2014 on $10.4 billion of undistributed earnings of foreign subsidiaries because Praxair intends to reinvest these funds indefinitely to support foreign growth opportunities. It is not practicable to estimate the unrecognized deferred tax liability on these undistributed earnings. These earnings could become subject to additional tax if they are remitted as dividends, loaned to Praxair in the U.S., or upon sale of the subsidiary’s stock.
Uncertain Tax Positions
Unrecognized income tax benefits represent income tax positions taken on income tax returns but not yet recognized in the consolidated financial statements. The company has unrecognized income tax benefits totaling $71 million, $121 million and $142 million as of December 31, 2014, 2013 and 2012, respectively. If recognized, essentially all of the unrecognized tax benefits and related interest and penalties would be recorded as a benefit to income tax expense on the consolidated statement of income.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
(Millions of dollars) | 2014 | 2013 | 2012 | ||||||||
Unrecognized income tax benefits, January 1 | $ | 121 | $ | 142 | $ | 163 | |||||
Additions for tax positions of prior years | 13 | 8 | 12 | ||||||||
Reductions for tax positions of prior years | (2 | ) | (24 | ) | (17 | ) | |||||
Additions for current year tax positions | 3 | 10 | — | ||||||||
Reductions for settlements with taxing authorities (a) | (3 | ) | (2 | ) | (1 | ) | |||||
Reductions as a result of a lapse of an applicable statute of limitations (b) | (56 | ) | (1 | ) | (9 | ) | |||||
Foreign currency translation and other | (5 | ) | (12 | ) | (6 | ) | |||||
Unrecognized income tax benefits, December 31 | $ | 71 | $ | 121 | $ | 142 | |||||
________________________
(a) | Settlements are uncertain tax positions that were effectively settled with the taxing authorities, including positions where the company has agreed to amend its tax returns to eliminate the uncertainty. |
(b) | See note (b) to the effective tax rate reconciliation. |
Praxair classifies interest income and expense related to income taxes as tax expense in the consolidated statement of income. Praxair recognized net interest income of $3 million in 2014 related to the reversal of uncertain tax positions; net interest income of $11 million in 2013 primarily related to refunds received from taxing authorities; and net interest expense of $1 million in 2012. Praxair had $8 million and $12 million of accrued interest and penalties as of December 31, 2014 and December 31, 2013, respectively which were recorded in other long-term liabilities in the consolidated balance sheets (see Note 7).
70
As of December 31, 2014, the company remained subject to examination in the following major tax jurisdictions for the tax years as indicated below:
Major tax jurisdictions | Open Years |
North America | |
United States | 2011 through 2014 |
Canada | 2007 through 2014 |
Mexico | 2009 through 2014 |
Europe | |
Germany | 2008 through 2014 |
Italy | 2010 through 2014 |
Spain | 2004 through 2014 |
South America | |
Brazil | 2003 through 2014 |
Asia | |
China | 2009 through 2014 |
India | 2006 through 2014 |
Korea | 2008 through 2014 |
Thailand | 2008 through 2014 |
The company is currently under audit in a number of tax jurisdictions. As a result, it is reasonably possible that some of these audits will conclude or reach the stage where a change in unrecognized income tax benefits may occur within the next twelve months. At that time, the company will record any adjustment to income tax expense as required. In 2014, settlements were not material to the consolidated financial statements. The company is also subject to income taxes in many hundreds of state and local taxing jurisdictions that are open to tax examinations.
NOTE 6. EARNINGS PER SHARE – PRAXAIR, INC. SHAREHOLDERS
Basic earnings per share is computed by dividing Net income – Praxair, Inc. for the period by the weighted average number of Praxair common shares outstanding. Diluted earnings per share is computed by dividing Net income – Praxair, Inc. for the period by the weighted average number of Praxair common shares outstanding and dilutive common stock equivalents, as follows:
2014 | 2013 | 2012 | |||||||||
Numerator (Millions of dollars) | |||||||||||
Net income – Praxair, Inc. | $ | 1,694 | $ | 1,755 | $ | 1,692 | |||||
Denominator (Thousands of shares) | |||||||||||
Weighted average shares outstanding | 291,987 | 294,994 | 297,746 | ||||||||
Shares earned and issuable under compensation plans | 507 | 529 | 570 | ||||||||
Weighted average shares used in basic earnings per share | 292,494 | 295,523 | 298,316 | ||||||||
Effect of dilutive securities | |||||||||||
Stock options and awards | 3,114 | 3,442 | 3,529 | ||||||||
Weighted average shares used in diluted earnings per share | 295,608 | 298,965 | 301,845 | ||||||||
Basic Earnings Per Common Share | $ | 5.79 | $ | 5.94 | $ | 5.67 | |||||
Diluted Earnings Per Common Share | $ | 5.73 | $ | 5.87 | $ | 5.61 | |||||
There were no antidilutive shares for the years ended December 31, 2014 and 2013. There were 1,589,235 antidilutive shares for the year ended December 31, 2012.
71
NOTE 7. SUPPLEMENTAL INFORMATION
Income Statement
(Millions of dollars) Year Ended December 31, | 2014 | 2013 | 2012 | ||||||||
Selling, General and Administrative | |||||||||||
Selling | $ | 572 | $ | 567 | $ | 547 | |||||
General and administrative | 736 | 782 | 723 | ||||||||
$ | 1,308 | $ | 1,349 | $ | 1,270 | ||||||
Year Ended December 31, | 2014 | 2013 | 2012 | ||||||||
Depreciation and Amortization | |||||||||||
Depreciation | $ | 1,123 | $ | 1,068 | $ | 980 | |||||
Amortization of other intangibles (Note 10) | 47 | 41 | 21 | ||||||||
$ | 1,170 | $ | 1,109 | $ | 1,001 | ||||||
Year Ended December 31, | 2014 | 2013 | 2012 | ||||||||
Other Income (Expenses) – Net | |||||||||||
Currency related net gains (losses) | $ | 1 | $ | 3 | $ | (9 | ) | ||||
Partnership income | 16 | 7 | 10 | ||||||||
Net legal settlements | — | 10 | 24 | ||||||||
Severance expense | (22 | ) | (14 | ) | (17 | ) | |||||
Business divestitures and asset gains (losses) – net | 36 | 43 | 49 | ||||||||
Other – net | (22 | ) | (17 | ) | (14 | ) | |||||
$ | 9 | $ | 32 | $ | 43 | ||||||
Year Ended December 31, | 2014 | 2013 | 2012 | ||||||||
Interest Expense – Net | |||||||||||
Interest incurred on debt | $ | 215 | $ | 233 | $ | 226 | |||||
Interest capitalized | (38 | ) | (69 | ) | (70 | ) | |||||
Amortization of swap termination costs (Note 12) | — | (4 | ) | (15 | ) | ||||||
Bond redemption (a) | 36 | 18 | — | ||||||||
$ | 213 | $ | 178 | $ | 141 | ||||||
Year Ended December 31, | 2014 | 2013 | 2012 | ||||||||
Income Attributable to Noncontrolling Interests | |||||||||||
Noncontrolling interests' operations | $ | 40 | $ | 41 | $ | 34 | |||||
Income tax benefit in Italy (Note 5) | — | 16 | — | ||||||||
Redeemable noncontrolling interests' operations (Note 14) | 12 | 24 | 18 | ||||||||
$ | 52 | $ | 81 | $ | 52 | ||||||
72
Balance Sheet
(Millions of dollars) December 31, | 2014 | 2013 | |||||
Accounts Receivable | |||||||
Trade | $ | 1,746 | $ | 1,815 | |||
Other | 152 | 175 | |||||
1,898 | 1,990 | ||||||
Less: allowance for doubtful accounts (b) | (102 | ) | (98 | ) | |||
$ | 1,796 | $ | 1,892 | ||||
December 31, | 2014 | 2013 | |||||
Inventories (c) | |||||||
Raw materials and supplies | $ | 200 | $ | 167 | |||
Work in process | 52 | 58 | |||||
Finished goods | 299 | 281 | |||||
$ | 551 | $ | 506 | ||||
December 31, | 2014 | 2013 | |||||
Prepaid and Other Current Assets | |||||||
Deferred income taxes (Note 5) | $ | 189 | $ | 181 | |||
Prepaid (d) | 116 | 145 | |||||
Other | 61 | 54 | |||||
$ | 366 | $ | 380 | ||||
December 31, | 2014 | 2013 | |||||
Other Long-term Assets | |||||||
Pension assets (Note 16) | $ | 35 | $ | 42 | |||
Insurance contracts (e) | 73 | 73 | |||||
Long-term receivables, net (f) | 43 | 36 | |||||
Deposits | 64 | 62 | |||||
Investments carried at cost | 8 | 7 | |||||
Deferred charges | 114 | 133 | |||||
Deferred income taxes (Note 5) | 98 | 72 | |||||
Other | 114 | 144 | |||||
$ | 549 | $ | 569 | ||||
73
December 31, | 2014 | 2013 | |||||
Other Current Liabilities | |||||||
Accrued expenses | $ | 296 | $ | 291 | |||
Payroll | 177 | 184 | |||||
Cost reduction program (Note 2) | 7 | 15 | |||||
Pension and postretirement (Note 16) | 39 | 33 | |||||
Interest payable | 69 | 62 | |||||
Employee benefit accrual | 22 | 20 | |||||
Severance | 14 | 13 | |||||
Insurance reserves | 9 | 11 | |||||
Other | 285 | 161 | |||||
$ | 918 | $ | 790 | ||||
December 31, | 2014 | 2013 | |||||
Other Long-term Liabilities | |||||||
Pension and postretirement (Note 16) | $ | 777 | $ | 498 | |||
Tax liabilities for uncertain tax positions | 57 | 55 | |||||
Interest and penalties for uncertain tax positions (Note 5) | 8 | 12 | |||||
Insurance reserves | 23 | 22 | |||||
Other | 311 | 272 | |||||
$ | 1,176 | $ | 859 | ||||
December 31, | 2014 | 2013 | |||||
Deferred Credits | |||||||
Deferred income taxes (Note 5) | $ | 1,198 | $ | 1,205 | |||
Other | 83 | 191 | |||||
$ | 1,281 | $ | 1,396 | ||||
December 31, | 2014 | 2013 | |||||
Accumulated Other Comprehensive Income (Loss) | |||||||
Cumulative translation adjustment (includes $64 million and $60 million tax charges in 2014 and 2013, respectively) | |||||||
North America (g) | $ | (553 | ) | $ | (315 | ) | |
South America (g) | (1,510 | ) | (1,179 | ) | |||
Europe (g) | (432 | ) | (63 | ) | |||
Asia | (49 | ) | 21 | ||||
Surface Technologies | (7 | ) | 28 | ||||
(2,551 | ) | (1,508 | ) | ||||
Derivatives – net of taxes | (1 | ) | (4 | ) | |||
Pension/OPEB funded status obligation (net of $342 million and $247 million tax benefits in 2014 and 2013, respectively) (Note 16) | (633 | ) | (469 | ) | |||
$ | (3,185 | ) | $ | (1,981 | ) | ||
________________________
(a) | In December 2014, Praxair redeemed $400 million of 5.375% notes due November 2016 for $434 million resulting in a $36 million charge ($22 million after-tax, or $0.07 per diluted share). In December 2013, Praxair |
74
redeemed $400 million of 5.25% notes due November 2014 for $418 million resulting in an $18 million charge ($12 million after-tax, or $0.04 per diluted share).
(b) | Provisions to the allowance for doubtful accounts were $39 million, $38 million, and $29 million in 2014, 2013, and 2012, respectively. The allowance activity in each period related primarily to write-offs of uncollectible amounts, net of recoveries and currency movements. |
(c) | Effective July 1, 2014, Praxair changed its method of accounting for all remaining U.S. operations that were using the last-in, first-out ("LIFO") method to the average-cost method, primarily raw materials. Prior to this change, approximately 6% of consolidated inventories were accounted for under the LIFO method. Praxair applied this change as a cumulative effect adjustment in the third quarter 2014 and did not restate prior periods because the impact was not material. The accounting change increased inventories by $9 million at July 1, 2014. The Company believes the change is preferable because it will better reflect the impact of current costs in both the consolidated balance sheets and consolidated statements of income. Had the Company not changed its accounting method, reported inventory amounts at December 31, 2014 would not have been significantly different than the amount disclosed above at July 1, 2014. |
At December 31, 2013, approximately 6% of total inventories were valued using the LIFO method, all in the United States. If inventories had been valued at current costs, they would have been approximately $9 million higher than reported at December 31, 2013.
(d) | Includes estimated income tax payments of $36 million in 2014 and $75 million in 2013. |
(e) | Consists primarily of insurance contracts and other investments to be utilized for non-qualified pension and OPEB obligations. |
(f) | Financing receivables is not normal practice for the company. The balances at December 31, 2014 and 2013 are net of reserves of $48 million and $51 million, respectively. The amounts in both periods relate primarily to government receivables in Brazil and other long-term notes receivable from customers, the majority of which are fully reserved. Collectibility is reviewed regularly and uncollectible amounts are written-off as appropriate. The account balance change during 2014 was primarily the result of additional receivables, net of reserves. |
(g) | North America consists primarily of currency translation adjustments in Canada and Mexico, South America relates primarily to Brazil and Argentina, and Europe relates primarily to Spain and Germany. |
NOTE 8. PROPERTY, PLANT AND EQUIPMENT – NET
Significant classes of property, plant and equipment are as follows:
(Millions of dollars) December 31, | Depreciable Lives (Yrs) | 2014 | 2013 | |||||||
Production plants (primarily 15-year life) (a) | 10-20 | $ | 14,400 | $ | 14,378 | |||||
Storage tanks | 15-20 | 2,267 | 2,330 | |||||||
Transportation equipment and other | 3-15 | 1,895 | 1,866 | |||||||
Cylinders (primarily 30-year life) | 10-30 | 1,724 | 1,740 | |||||||
Buildings | 25-40 | 1,089 | 1,108 | |||||||
Land and improvements (b) | 0-20 | 499 | 493 | |||||||
Construction in progress | 1,980 | 2,116 | ||||||||
23,854 | 24,031 | |||||||||
Less: accumulated depreciation | (11,857 | ) | (11,753 | ) | ||||||
$ | 11,997 | $ | 12,278 | |||||||
(a) - Depreciable lives of production plants related to long-term customer supply contracts are consistent with the contract lives.
(b) - Land is not depreciated.
75
NOTE 9. GOODWILL
Changes in the carrying amount of goodwill for the years ended December 31, 2014 and 2013 were as follows:
(Millions of dollars) | North America | South America | Europe | Asia | Surface Technologies | Total | |||||||||||||||||
Balance, December 31, 2012 | $ | 1,499 | $ | 195 | $ | 645 | $ | 25 | $ | 143 | $ | 2,507 | |||||||||||
Acquisitions (Note 3) | 625 | — | 94 | — | — | 719 | |||||||||||||||||
Purchase adjustments & other | 3 | — | — | — | — | 3 | |||||||||||||||||
Foreign currency translation | (10 | ) | (29 | ) | 4 | (1 | ) | 1 | (35 | ) | |||||||||||||
Balance, December 31, 2013 | $ | 2,117 | $ | 166 | $ | 743 | $ | 24 | $ | 144 | $ | 3,194 | |||||||||||
Acquisitions (Note 3) | 47 | 4 | 17 | 14 | 4 | 86 | |||||||||||||||||
Purchase adjustments & other | 1 | — | (6 | ) | — | 5 | — | ||||||||||||||||
Foreign currency translation | (26 | ) | (23 | ) | (100 | ) | — | (10 | ) | (159 | ) | ||||||||||||
Balance, December 31, 2014 | $ | 2,139 | $ | 147 | $ | 654 | $ | 38 | $ | 143 | $ | 3,121 | |||||||||||
Praxair has performed its goodwill impairment tests annually during the second quarter of each year, and historically has determined that the fair value of each of its reporting units was substantially in excess of its carrying value. For the 2014 test Praxair applied the FASB's updated accounting guidance which allows the company to first assess qualitative factors to determine the extent of additional quantitative analysis, if any, that may be required to test goodwill for impairment. Based on the qualitative assessments performed, Praxair concluded that it was more likely than not that the fair value of each reporting unit substantially exceeded its carrying value and therefore, further quantitative analysis was not required. As a result, no impairment was recorded. There were no indicators of impairment through December 31, 2014.
76
NOTE 10. OTHER INTANGIBLE ASSETS
The following is a summary of Praxair’s other intangible assets at December 31, 2014 and 2013:
(Millions of dollars) For the year ended December 31, 2014 | Customer & License/Use Agreements | Non-compete Agreements | Patents & Other | Total | |||||||||||
Cost: | |||||||||||||||
Balance, December 31, 2013 | $ | 661 | $ | 31 | $ | 43 | $ | 735 | |||||||
Additions (primarily acquisitions) | 54 | 12 | — | 66 | |||||||||||
Foreign currency translation | (22 | ) | (1 | ) | (1 | ) | (24 | ) | |||||||
Other * | — | (5 | ) | 5 | — | ||||||||||
Balance, December 31, 2014 | 693 | 37 | 47 | 777 | |||||||||||
Less: accumulated amortization: | |||||||||||||||
Balance, December 31, 2013 | (118 | ) | (16 | ) | (5 | ) | (139 | ) | |||||||
Amortization expense | (36 | ) | (7 | ) | (4 | ) | (47 | ) | |||||||
Foreign currency translation | 7 | — | — | 7 | |||||||||||
Other * | — | 5 | — | 5 | |||||||||||
Balance, December 31, 2014 | (147 | ) | (18 | ) | (9 | ) | (174 | ) | |||||||
Net balance at December 31, 2014 | $ | 546 | $ | 19 | $ | 38 | $ | 603 | |||||||
(Millions of dollars) For the year ended December 31, 2013 | Customer & License/Use Agreements | Non-compete Agreements | Patents & Other | Total | |||||||||||
Cost: | |||||||||||||||
Balance, December 31, 2012 | $ | 232 | $ | 37 | $ | 20 | $ | 289 | |||||||
Additions (primarily acquisitions) | 433 | 4 | 30 | 467 | |||||||||||
Foreign currency translation | 3 | — | — | 3 | |||||||||||
Other * | (7 | ) | (10 | ) | (7 | ) | (24 | ) | |||||||
Balance, December 31, 2013 | 661 | 31 | 43 | 735 | |||||||||||
Less: accumulated amortization: | |||||||||||||||
Balance, December 31, 2012 | (89 | ) | (20 | ) | (7 | ) | (116 | ) | |||||||
Amortization expense | (32 | ) | (6 | ) | (3 | ) | (41 | ) | |||||||
Foreign currency translation | (1 | ) | — | — | (1 | ) | |||||||||
Other * | 4 | 10 | 5 | 19 | |||||||||||
Balance, December 31, 2013 | (118 | ) | (16 | ) | (5 | ) | (139 | ) | |||||||
Net balance at December 31, 2013 | $ | 543 | $ | 15 | $ | 38 | $ | 596 | |||||||
________________________
* | Other primarily relates to the write-off of fully amortized assets, purchase accounting adjustments and reclassifications. |
There are no expected residual values related to these intangible assets. Amortization expense for the years ended December 31, 2014, 2013 and 2012 was $47 million, $41 million and $21 million, respectively. The remaining weighted-average amortization period for intangible assets is approximately 18 years.
77
Total estimated annual amortization expense is as follows:
(Millions of dollars) | |||
2015 | $ | 49 | |
2016 | 48 | ||
2017 | 42 | ||
2018 | 37 | ||
2019 | 37 | ||
Thereafter | 390 | ||
$ | 603 | ||
78
NOTE 11. DEBT
The following is a summary of Praxair’s outstanding debt at December 31, 2014 and 2013:
(Millions of dollars) | 2014 | 2013 | |||||
Short-term | |||||||
Commercial paper and U.S. bank borrowings | $ | 514 | $ | 712 | |||
Other bank borrowings (primarily international) | 73 | 70 | |||||
Total short-term debt | 587 | 782 | |||||
Long-term | |||||||
U.S. borrowings | |||||||
4.375% Notes due 2014 (a) | — | 300 | |||||
4.625% Notes due 2015 (b) | 500 | 500 | |||||
3.25% Notes due 2015 (b, d) | 408 | 418 | |||||
0.75% Notes due 2016 | 400 | 400 | |||||
5.375% Notes due 2016 (a) | — | 400 | |||||
5.20% Notes due 2017 | 325 | 325 | |||||
1.05% Notes due 2017 | 400 | 400 | |||||
1.20% Notes due 2018 | 500 | 500 | |||||
1.25% Notes due 2018 (c, d) | 481 | 478 | |||||
4.50% Notes due 2019 (c) | 599 | 598 | |||||
1.90% Notes due 2019 | 500 | 500 | |||||
1.50% Euro denominated notes due 2020 (c, e) | 722 | — | |||||
4.05% Notes due 2021 (c) | 499 | 498 | |||||
3.00% Notes due 2021 (c) | 497 | 497 | |||||
2.45% Notes due 2022 (c) | 598 | 598 | |||||
2.20% Notes due 2022 (c) | 499 | 499 | |||||
2.70% Notes due 2023 (c) | 499 | 498 | |||||
1.625% Euro denominated notes due 2025 (c, e) | 599 | — | |||||
3.55% Notes due 2042 (c) | 466 | 466 | |||||
Other | 4 | 5 | |||||
International bank borrowings | 167 | 140 | |||||
Obligations under capital lease | 8 | 9 | |||||
8,671 | 8,029 | ||||||
Less: current portion of long-term debt | (2 | ) | (3 | ) | |||
Total long-term debt | 8,669 | 8,026 | |||||
Total debt | $ | 9,258 | $ | 8,811 | |||
________________________
(a) | In March 2014, Praxair repaid $300 million of 4.375% notes that became due. In December of 2014, Praxair redeemed $400 million of 5.375% notes due November 2016 for $434 million resulting in an $36 million bond redemption charge (see Note 7). |
(b) | Classified as long-term because of the Company’s intent to refinance this debt on a long-term basis and the availability of such financing under the terms of an existing $2.5 billion long-term credit facility. |
(c) | Amounts are net of unamortized discounts. |
(d) | December 31, 2014 and 2013 include a $14 million and $22 million fair value increase, respectively, related to hedge accounting. See Note 12 for additional information. |
79
(e) | During 2014, Praxair issued the following Euro-denominated notes totaling €1.1 billion: €600 million of 1.50% Euro-denominated notes due 2020 and €500 million of 1.625% Euro-denominated notes due 2025. These debt issuances have been designated as a hedges of the net investment position in European operations where the Euro is the functional currency (see Note 12). The proceeds of this debt issuance were used for general corporate purposes, including acquisitions, repayment of debt and share repurchases under the company's share repurchase program. Since the time the Euro-denominated notes were first issued in March 2014 through December 31, 2014, exchange rate movements have reduced long-term debt by $125 million. |
On February 5, 2015, Praxair issued $150 million of floating rate notes that bear interest at the Federal funds effective rate plus 0.33% due 2017, $400 million of 2.65% fixed rate notes due 2025 and $200 million of 3.550% fixed rates notes due in 2042. The proceeds will be used for general corporate purposes, including the repayment of outstanding indebtedness.
Credit Facilities
At December 31, 2014, the company has the following major credit facility available for future borrowing:
Millions of dollars | Total Facility | Borrowings Outstanding | Available for Borrowing | Expires | |||||||||
Senior Unsecured | $ | 2,500 | $ | — | $ | 2,500 | December 2019 | ||||||
In December 2014, the company entered into a $2.5 billion senior unsecured credit facility with a syndicate of major financial institutions. This facility replaced the company's $2.0 billion senior unsecured credit facility which was set to expire in 2016. The credit facility is non-cancellable by the issuing financial institutions until its maturity in December 2019. No borrowings were outstanding under the credit agreement at December 31, 2014.
Covenants
Praxair’s $2.5 billion senior unsecured credit facility and long-term debt agreements contain various covenants which may, among other things, restrict the ability of Praxair to merge with another entity, incur or guarantee debt, sell or transfer certain assets, create liens against assets, enter into sale and leaseback agreements, or pay dividends and make other distributions beyond certain limits. These agreements also require Praxair to not exceed a maximum 70% leverage ratio defined in the agreements as the ratio of consolidated total debt to the sum of consolidated total debt plus consolidated shareholders’ equity of the company. For purposes of the leverage ratio calculation, consolidated shareholders’ equity excludes changes in the cumulative foreign currency translation adjustments after June 30, 2011. At December 31, 2014, the actual leverage ratio, as calculated according to the agreement, was 54% and the company is in compliance with all financial covenants. Also, there are no material adverse change clauses or other subjective conditions that would restrict the company’s ability to borrow under the agreement.
Other Debt Information
As of December 31, 2014 and 2013, the weighted-average interest rate of short-term borrowings outstanding was 0.6% and 0.4%, respectively.
Expected maturities on long-term debt are as follows:
(Millions of dollars) | ||||
2015 | $ | 2 | * | |
2016 | 407 | |||
2017 | 775 | |||
2018 | 1,083 | |||
2019 | 2,008 | * | ||
Thereafter | 4,396 | |||
$ | 8,671 | |||
________________________
* $908 million of debt due in 2015 has been reflected in 2019 maturities due to the company’s intent to refinance this debt on a long-term basis and the ability to do so under the $2.5 billion senior unsecured credit facility with a syndicate of banks which expires in 2019.
80
As of December 31, 2014, $9 million of Praxair’s assets (principally international fixed assets) were pledged as collateral for $8 million of long-term debt, including the current portion of long-term debt.
See Note 13 for the fair value information related to debt.
NOTE 12. FINANCIAL INSTRUMENTS
In its normal operations, Praxair is exposed to market risks relating to fluctuations in interest rates, foreign currency exchange rates, energy costs and to a lesser extent precious metal prices. The objective of financial risk management at Praxair is to minimize the negative impact of such fluctuations on the company’s earnings and cash flows. To manage these risks, among other strategies, Praxair routinely enters into various derivative financial instruments (“derivatives”) including interest-rate swap and treasury rate lock agreements, currency-swap agreements, forward contracts, currency options, and commodity-swap agreements. These instruments are not entered into for trading purposes and Praxair only uses commonly traded and non-leveraged instruments.
There are three types of derivatives that the company enters into: (i) those relating to fair-value exposures, (ii) those relating to cash-flow exposures, and (iii) those relating to foreign currency net investment exposures. Fair-value exposures relate to recognized assets or liabilities, and firm commitments; cash-flow exposures relate to the variability of future cash flows associated with recognized assets or liabilities, or forecasted transactions; and net investment exposures relate to the impact of foreign currency exchange rate changes on the carrying value of net assets denominated in foreign currencies.
When a derivative is executed and hedge accounting is appropriate, it is designated as either a fair-value hedge, cash-flow hedge, or a net investment hedge. Currently, Praxair designates all interest-rate and treasury-rate locks as hedges for accounting purposes; however, currency contracts are generally not designated as hedges for accounting purposes unless they are related to forecasted transactions. Whether designated as hedges for accounting purposes or not, all derivatives are linked to an appropriate underlying exposure. On an ongoing basis, the company assesses the hedge effectiveness of all derivatives designated as hedges for accounting purposes to determine if they continue to be highly effective in offsetting changes in fair values or cash flows of the underlying hedged items. If it is determined that the hedge is not highly effective, then hedge accounting will be discontinued prospectively.
Counterparties to Praxair’s derivatives are major banking institutions with credit ratings of investment grade or better and no collateral is required, and there are no significant risk concentrations. Management believes the risk of incurring losses on derivative contracts related to credit risk is remote and any losses would be immaterial.
The following table is a summary of the notional amount and fair value of derivatives outstanding at December 31, 2014 and 2013 for consolidated subsidiaries:
Fair Value | |||||||||||||||||||||||
(Millions of dollars) | Notional Amounts | Assets | Liabilities | ||||||||||||||||||||
December 31, | 2014 | 2013 | 2014 | 2013 | 2014 | 2013 | |||||||||||||||||
Derivatives Not Designated as Hedging Instruments: | |||||||||||||||||||||||
Currency contracts: | |||||||||||||||||||||||
Balance sheet items (a) | $ | 2,427 | $ | 2,197 | $ | 5 | $ | 4 | $ | 13 | $ | 14 | |||||||||||
Derivatives Designated as Hedging Instruments: | |||||||||||||||||||||||
Currency contracts: | |||||||||||||||||||||||
Forecasted purchases (a) | $ | — | $ | 5 | $ | — | $ | — | $ | — | $ | — | |||||||||||
Interest rate contracts: | |||||||||||||||||||||||
Interest rate swaps (b) | 875 | 875 | 14 | 22 | — | — | |||||||||||||||||
Total Hedges | $ | 875 | $ | 880 | $ | 14 | $ | 22 | $ | — | $ | — | |||||||||||
Total Derivatives | $ | 3,302 | $ | 3,077 | $ | 19 | $ | 26 | $ | 13 | $ | 14 | |||||||||||
________________________
(a) | Assets are recorded in prepaid and other current assets, and liabilities are recorded in other current liabilities. |
(b) | Assets are recorded in other current and other long term assets. |
81
Currency Contracts
Balance Sheet Items
Foreign currency contracts related to balance sheet items consist of forward contracts entered into to manage the exposure to fluctuations in foreign-currency exchange rates on recorded balance sheet assets and liabilities denominated in currencies other than the functional currency of the related operating unit. The fair value adjustments on these contracts are offset by the fair value adjustments recorded on the hedged assets and liabilities.
Forecasted Purchases
Foreign currency contracts related to forecasted purchases consist of forward contracts entered into to manage the exposure to fluctuations in foreign-currency exchange rates on forecasted purchases of capital-related equipment and services denominated in currencies other than the functional currency of the related operating units. These forward contracts were designated and accounted for as cash flow hedges.
Net Investment Hedges
Praxair has designated the €600 million ($722 million million as of December 31, 2014)1.50% Euro-denominated notes due 2020 and the €500 million ($599 million as of December 31, 2014) 1.625% Euro-denominated notes due 2025 as hedges of the net investment position in its European operations. These Euro-denominated debt instruments reduce the company's exposure to changes in the currency exchange rate on investments in foreign subsidiaries with Euro functional currencies. Since the time the Euro-denominated notes were first issued in March 2014 through December 31, 2014, exchange rate movements have reduced long-term debt by $125 million, with the offsetting gain shown within the cumulative translation component of AOCI in the consolidated balance sheets and the consolidated statements of comprehensive income (loss).
Interest Rate Contracts
Outstanding Interest Rate Swaps
At December 31, 2014, Praxair had $875 million notional amount of interest-rate swap agreements outstanding related to the $400 million 3.25% fixed-rate notes that mature in 2015 and the $475 million 1.25% notes that mature 2018, which effectively convert fixed-rate interest to variable-rate interest. These swap agreements were designated as fair value hedges with the resulting fair value adjustments recognized in earnings along with an equally offsetting charge / benefit to earnings for the changes in the fair value of the underlying debt instruments. At December 31, 2014, $14 million was recognized as an increase in the fair value of this note ($22 million at December 31, 2013).
Terminated Interest Rate Swaps
During 2010, 2011 and 2012 Praxair terminated three interest rate swap agreements which were previously designated as fair value hedges related to fixed-rate notes due in 2012 and 2013. The unrecognized gain existing upon termination of the swaps was received in cash and shown as an increase to the respective long-term notes. This deferred gain was then recognized on a straight-line basis to interest expense – net over the term of the underlying debt agreements. During 2013 and 2012, $4 million and $15 million, respectively, was recognized as a reduction to interest expense – net.
Terminated Treasury Rate Locks
The following table summarizes the unrecognized gains (losses) related to terminated treasury rate lock contracts:
Unrecognized Gain / (Loss) (a) | |||||||||||||
(Millions of dollars) | Year Terminated | Original Gain / (Loss) | December 31, 2014 | December 31, 2013 | |||||||||
Treasury Rate Locks | |||||||||||||
Underlying debt instrument: | |||||||||||||
$500 million 2.20% fixed-rate notes that mature in 2022 (b) | 2012 | $ | (2 | ) | $ | (1 | ) | $ | (2 | ) | |||
$500 million 3.00% fixed-rate notes that mature in 2021 (b) | 2011 | (11 | ) | (8 | ) | (9 | ) | ||||||
$600 million 4.50% fixed-rate notes that mature in 2019 (b) | 2009 | 16 | 8 | 10 | |||||||||
$500 million 4.625% fixed-rate notes that mature in 2015 (b) | 2008 | (7 | ) | — | (1 | ) | |||||||
Total – pre-tax | $ | (1 | ) | $ | (2 | ) | |||||||
Less: income taxes | — | 1 | |||||||||||
After- tax amounts | $ | (1 | ) | $ | (1 | ) | |||||||
________________________
82
(a) | The unrecognized gains / (losses) for the treasury rate locks are shown in accumulated other comprehensive income ("AOCI") and are being recognized on a straight line basis to interest expense – net over the term of the underlying debt agreements. Refer to the table below summarizing the impact of the company’s consolidated statements of income and AOCI for current period gain (loss) recognition. |
(b) | The notional amount of the treasury rate lock contracts are equal to the underlying debt instrument with the exception of the treasury rate lock contract entered into to hedge the $600 million 4.50% fixed-rate notes that mature in 2019. The notional amount of this contract was $500 million. |
The following table summarizes the impact of the company's derivatives not designated as hedging instruments on the consolidated statements of income:
(Millions of dollars) | Amount of Pre-Tax Gain (Loss) Recognized in Earnings * | ||||||||||
December 31, | 2014 | 2013 | 2012 | ||||||||
Derivatives Not Designated as Hedging Instruments | |||||||||||
Currency contracts: | |||||||||||
Balance sheet items: | |||||||||||
Debt-related | $ | (69 | ) | $ | (46 | ) | $ | 33 | |||
Other balance sheet items | (2 | ) | (9 | ) | (1 | ) | |||||
Anticipated net income | — | — | (4 | ) | |||||||
Total | $ | (71 | ) | $ | (55 | ) | $ | 28 | |||
The following table summarizes the impact of the company's derivatives designated as hedging instruments that impact AOCI:
(Millions of dollars) | Amount of Gain (Loss) Recognized in AOCI | |||||||||||
December 31, | 2014 | 2013 | 2012 | |||||||||
Derivatives Designated as Hedging Instruments** | ||||||||||||
Currency contracts: | ||||||||||||
Net Investment hedge | $ | (6 | ) | $ | — | $ | — | |||||
Forecasted purchases | $ | 1 | $ | 1 | $ | 1 | ||||||
Interest rate contracts: | ||||||||||||
Treasury rate locks | — | — | (2 | ) | ||||||||
Total – Pre tax | $ | (5 | ) | $ | 1 | $ | (1 | ) | ||||
Less: income taxes | 2 | — | 1 | |||||||||
Total - Net of Taxes | $ | (3 | ) | $ | 1 | $ | — | |||||
** The gains (losses) on net investment hedges are recorded as a component of AOCI within foreign currency translation adjustments in the condensed consolidated balance sheets and condensed consolidated statements of comprehensive income. The gains (losses) on forecasted purchases and treasury rate locks are recorded as a component of AOCI within derivative instruments in the condensed consolidated balance sheets and the condensed consolidated statements of comprehensive income. There was no ineffectiveness for these instruments during 2014 or 2013. The gains (losses) on net investment hedges are reclassified to earnings only when the related currency translation adjustments are required to be reclassified, usually upon sale or liquidation of the investment. The gains (losses) for interest rate contracts are reclassified to earnings as interest expense –net on a straight-line basis over the remaining maturity of the underlying debt. Net losses of less than $1 million are expected to be reclassified to earnings during 2015.
NOTE 13. FAIR VALUE DISCLOSURES
The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three broad levels as follows:
83
Level 1 – quoted prices in active markets for identical assets or liabilities
Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable
Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes assets and liabilities measured at fair value on a recurring basis at December 31, 2014 and 2013:
Fair Value Measurements Using | |||||||||||||||||||||||
(Millions of dollars) | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | 2014 | 2013 | ||||||||||||||||||
Assets | |||||||||||||||||||||||
Derivative assets | $ | — | $ | — | $ | 19 | $ | 26 | $ | — | $ | — | |||||||||||
Liabilities | |||||||||||||||||||||||
Derivative liabilities | $ | — | $ | — | $ | 13 | $ | 14 | $ | — | $ | — | |||||||||||
The fair values of the derivative assets and liabilities are based on market prices obtained from independent brokers or determined using quantitative models that use as their basis readily observable market parameters that are actively quoted and can be validated through external sources, including third-party pricing services, brokers and market transactions. Investments are marketable securities traded on an exchange.
The fair value of cash and cash equivalents, short-term debt, accounts receivables-net, and accounts payable approximate carrying value because of the short-term maturities of these instruments. The fair value of long-term debt is estimated based on the quoted market prices for the same or similar issues, which is deemed a Level 2 measurement. At December 31, 2014, the estimated fair value of Praxair’s long-term debt portfolio was $8,753 million versus a carrying value of $8,671 million. At December 31, 2013, the estimated fair value of Praxair’s long-term debt portfolio was $7,976 million versus a carrying value of $8,029 million. These differences are attributable to interest-rate changes subsequent to when the debt was issued.
Assets Measured at Fair Value on a Non-Recurring Basis
At December 31, 2014 in connection with the adoption of the SICAD II currency exchange system in Venezuela, Praxair reduced the value of certain assets in Venezuela, primarily long-lived assets, to estimated fair value which resulted in a $63 million pre-tax charge to income (see Note 2).
During the first quarter 2012, the company reduced the value of certain assets in Brazil, Colombia and Chile to estimated fair value which resulted in a $21 million pre-tax charge to other income (expense) – net.
The above fair value measurements were based on internal assessments of the best information available about the local business conditions and political environment, including the impact of foreign currency exchange restrictions that would be indicative of what the assets could be sold for and are considered to be Level 3 measurements.
NOTE 14. EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS
Praxair, Inc. Shareholders’ Equity
At December 31, 2014 and 2013, there were 800,000,000 shares of common stock authorized (par value $0.01 per share) of which 383,230,625 shares were issued and 289,261,608 were outstanding at December 31, 2014 (294,133,864 were outstanding at December 31, 2013).
At December 31, 2014 and 2013, there were 25,000,000 shares of preferred stock (par value $0.01 per share) authorized, of which no shares were issued and outstanding. Praxair’s board of directors may from time to time authorize the issuance of one or more series of preferred stock and, in connection with the creation of such series, determine the characteristics of each such series including, without limitation, the preference and relative, participating, optional or other special rights, and the qualifications, limitations or restrictions of the series.
Redeemable Noncontrolling Interests
Noncontrolling interests with redemption features, such as put/sell options, that are not solely within the company’s control (“redeemable noncontrolling interests”) are reported separately in the consolidated balance sheets at the greater of carrying value or redemption value. For redeemable noncontrolling interests that are not yet exercisable, Praxair calculates the redemption value by accreting the carrying value to the redemption value over the period until exercisable. If the
84
redemption value is greater than the carrying value, any increase is adjusted directly to retained earnings and does not impact net income.
During 2011, Praxair acquired a controlling interest in Yara Praxair, a joint venture in Scandinavia that was previously accounted for as an equity investment (see Note 3). As part of the transaction, the noncontrolling shareholder obtained the right to sell its shares to Praxair starting in the first quarter 2015 for a period of 4 years at a formula price. Praxair also obtained the right to purchase the shares held by the noncontrolling shareholder starting in 2017 for a period of 2 years, also at a formula price. Accordingly, the noncontrolling interests related to Yara Praxair have been recorded in the consolidated balance sheets as redeemable noncontrolling interests. Other redeemable noncontrolling interests relate to three packaged gas distributors in the United States where the noncontrolling shareholders have put options.
The following is a summary of redeemable noncontrolling interests for the years ended December 31, 2014, 2013 and 2012:
(Millions of dollars) | 2014 | 2013 | 2012 | ||||||||
Beginning Balance | $ | 307 | $ | 252 | $ | 220 | |||||
Net income | 12 | 24 | 18 | ||||||||
Distributions to noncontrolling interest | (9 | ) | (11 | ) | (9 | ) | |||||
Redemption value adjustment/accretion | 2 | 53 | 13 | ||||||||
Foreign currency translation and other | (24 | ) | (11 | ) | 10 | ||||||
Purchase of noncontrolling interest * | (112 | ) | — | — | |||||||
Ending Balance | $ | 176 | $ | 307 | $ | 252 | |||||
* In January 2014, Praxair acquired the noncontrolling interests related to Praxair Distribution Mid-Atlantic, LLC. The cash payment is shown in the financing section of the condensed consolidated statements of cash flows under the caption "Noncontrolling interest transactions and other".
85
NOTE 15. SHARE-BASED COMPENSATION
Share-based compensation expense was $51 million in 2014, and $70 million in each of 2013 and 2012. The related income tax benefit recognized was $14 million in 2014, and $21 million in each of 2013 and 2012. The share-based compensation expense was primarily recorded in selling, general and administrative expenses and no share-based compensation expense was capitalized.
Summary of Plans
The 2009 Praxair, Inc. Long-Term Incentive Plan was initially adopted by the board of directors and shareholders of the company on April 28, 2009 and was amended and restated in its entirety by the board and shareholders on April 22, 2014 ("the 2009 Plan"). Prior to April 28, 2009, equity awards were granted under the 2002 Praxair, Inc. Long-Term Incentive Plan and the company’s ability to make further equity awards under that plan ended with its adoption of the 2009 Plan. The 2009 Plan permits awards of stock options, stock appreciation rights, restricted stock and restricted stock units, performance-based stock units and other equity awards to eligible officer and non-officer employees and non-employee directors of the company and its affiliates. Under the 2009 Plan, as amended and restated in 2014, the aggregate number of shares available for option and other equity grants is 8,000,000 shares, of which up to 2,600,000 shares may be granted as awards other than options or stock appreciation rights. The 2009 Plan also provides calendar year per-participant limits on grants of stock options and stock appreciation rights and on other types of awards intended to qualify as Performance-Based Compensation under Section 162(m) of the Internal Revenue Code. As of December 31, 2014, 7,982,085 shares remained available for equity grants under the 2009 Plan.
In 2005, the board of directors and shareholders of the company adopted the 2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc. ("the 2005 Plan"). Under the 2005 Plan, the aggregate number of shares available for option and other equity grants was limited to a total of 500,000 shares. The 2005 Plan expired on April 30, 2010, by its own terms, and no shares were available for grant thereafter.
Exercise prices for options granted under the 2009 Plan may not be less than the closing market price of the company’s common stock on the date of grant and granted options may not be re-priced or exchanged without shareholder approval. Options granted under the 2009 Plan subject only to time vesting requirements may become partially exercisable after a minimum of one year after the date of grant but may not become fully exercisable until at least three years have elapsed from the date of grant, and all options have a maximum duration of ten years. Options granted under predecessor plans had similar terms.
The company has the ability to repurchase shares on the open market to satisfy share option exercises and issues shares from treasury stock upon the exercise of certain stock options.
Stock Option Fair Value
The company utilizes the Black-Scholes Options-Pricing Model to determine the fair value of stock options consistent with that used for pro forma disclosures in prior years. Management is required to make certain assumptions with respect to selected model inputs, including anticipated changes in the underlying stock price (i.e., expected volatility) and option exercise activity (i.e., expected life). Expected volatility is based on the historical volatility of the company’s stock over the most recent period commensurate with the estimated expected life of the company’s stock options and other factors. The expected life of options granted, which represents the period of time that the options are expected to be outstanding, is based primarily on historical exercise experience. The expected dividend yield is based on the company’s most recent history and expectation of dividend payouts. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for a period commensurate with the estimated expected life. If factors change and result in different assumptions in future periods, the stock option expense that the company records for future grants may differ significantly from what the company has recorded in the current period.
The weighted-average fair value of options granted during 2014 was $14.62 per option ($16.31 in 2013 and $17.43 in 2012) based on the Black-Scholes Options-Pricing model. The following weighted-average assumptions were used for grants in 2014, 2013 and 2012:
Year Ended December 31, | 2014 | 2013 | 2012 | |||||
Dividend yield | 2.0 | % | 2.2 | % | 2.0 | % | ||
Volatility | 15.2 | % | 21.7 | % | 22.5 | % | ||
Risk-free interest rate | 1.57 | % | 0.76 | % | 0.86 | % | ||
Expected term years | 5 | 5 | 5 | |||||
86
The following table summarizes option activity under the plans for 2014 (averages are calculated on a weighted basis; life in years; intrinsic value expressed in millions):
Activity | Number of Options (000’s) | Average Exercise Price | Average Remaining Life | Aggregate Intrinsic Value | ||||||||
Outstanding at January 1, 2014 | 11,161 | $ | 81.42 | |||||||||
Granted | 1,293 | 128.80 | ||||||||||
Exercised | (1,380 | ) | 63.39 | |||||||||
Cancelled or expired | (93 | ) | 110.68 | |||||||||
Outstanding at December 31, 2014 | 10,981 | $ | 89.02 | 5.3 | $ | 445 | ||||||
Exercisable at December 31, 2014 | 8,400 | $ | 79.74 | 4.3 | $ | 418 | ||||||
The aggregate intrinsic value represents the difference between the company’s closing stock price of $129.56 as of December 31, 2014 and the exercise price multiplied by the number of options outstanding as of that date. The total intrinsic value of stock options exercised during 2014 was $93 million ($143 million and $165 million for 2013 and 2012, respectively).
Cash received from option exercises under all share-based payment arrangements for 2014 was $88 million . The cash tax benefit realized from all share-based compensation totaled $48 million for 2014, of which $31 million in excess tax benefits was classified as financing cash flows.
As of December 31, 2014, $18 million of unrecognized compensation cost related to non-vested stock options is expected to be recognized over a weighted-average period of approximately 1 year.
Performance-Based and Restricted Stock Awards
In 2014, the company granted performance-based stock awards under the 2009 Plans to senior level executives of 328,082 shares that vest, subject to the attainment of pre-established minimum performance criteria, principally on the third anniversary of their date of grant. The actual number of shares issued in settlement of a vested award can range from zero to 200 percent of the target number of shares granted based upon the company’s attainment of specified performance targets at the end of a three-year period. Compensation expense related to these awards is recognized over the three-year performance period based on the fair value of the closing market price of the company’s common stock on the date of the grant and the estimated performance that will be achieved. Compensation expense will be adjusted during the three-year performance period based upon the estimated performance levels that will be achieved.
There were 94,988 restricted stock units granted to employees during 2014. In addition, the company had previously granted restricted stock to certain key employees that vest after a designated service period ranging from 2 to 10 years. Generally, restricted stock does not earn quarterly dividends while vesting. Compensation expense related to the restricted stock units and restricted stock is recognized on a straight-line basis over the vesting period.
The weighted-average fair value of performance-based stock units granted during 2014 was $121.16 per unit ($103.46 in 2013 and $103.13 in 2012). The weighted-average fair value of restricted stock units granted during 2014 was $122.55 per unit ($105.79 in 2013 and $104.71 in 2012). This is based on the closing market price of the company’s common stock on the grant date adjusted for dividends that will not be paid during the vesting period.
87
The following table summarizes non-vested performance-based and restricted stock award activity as of December 31, 2014 and changes during the period then ended (shares based on target amounts, averages are calculated on a weighted basis):
Performance-Based | Restricted Stock | ||||||||||||
Performance-Based and Restricted Stock Activity | Number of Shares (000’s) | Average Grant Date Fair Value | Number of Shares (000’s) | Average Grant Date Fair Value | |||||||||
Non-vested at January 1, 2014 | 867 | $ | 99.55 | 337 | $ | 100.41 | |||||||
Granted (a) | 328 | 121.16 | 95 | 122.55 | |||||||||
Vested | (338 | ) | 92.06 | (109 | ) | 96.02 | |||||||
Cancelled | (24 | ) | 110.27 | (16 | ) | 104.61 | |||||||
Non-vested at December 31, 2014 | 833 | $ | 109.09 | 307 | $ | 106.63 | |||||||
(a) | Performance-based stock unit ("PSU") grants during 2014 include 49 thousand shares relating to the actual payout of the 2011 PSU grants in 2014. |
As of December 31, 2014, based on current estimates of future performance, $32 million of unrecognized compensation cost related to performance-based awards and $14 million of unrecognized compensation cost related to the restricted stock awards is expected to be recognized on a straight-line basis primarily through the first quarter of 2017.
NOTE 16. RETIREMENT PROGRAMS
Defined Benefit Pension Plans
Praxair has two main U.S. retirement programs which are non-contributory defined benefit plans: the Praxair Pension Plan and the CBI Pension Plan. The latter program benefits primarily former employees of CBI Industries, Inc. which Praxair acquired in 1996. Effective July 1, 2002, the Praxair Pension Plan was amended to give participating employees a one-time choice to remain covered by the old formula or to elect coverage under a new formula. The old formula is based predominantly on years of service, age and compensation levels prior to retirement, while the new formula provides for an annual contribution to an individual account which grows with interest each year at a predetermined rate. Also, this new formula applies to all new employees hired after April 30, 2002 into businesses adopting this plan. The U.S. and international pension plan assets are comprised of a diversified mix of investments, including domestic and international corporate equities, government securities and corporate debt securities. Praxair has several plans that provide supplementary retirement benefits primarily to higher level employees that are unfunded and are nonqualified for federal tax purposes. Pension coverage for employees of certain of Praxair’s international subsidiaries generally is provided by those companies through separate plans. Obligations under such plans are primarily provided for through diversified investment portfolios, with some smaller plans provided for under insurance policies or by book reserves.
Multi-employer Pension Plans
In the United States Praxair participates in seven multi-employer defined benefit pension plans ("MEP") pursuant to the terms of collective bargaining agreements covering approximately 200 union-represented employees. The collective bargaining agreements expire on different dates through 2019. In connection with such agreements, the Company is required to make periodic contributions to the MEPs in accordance with the terms of the respective collective bargaining agreements. Praxair’s participation in these plans is not material either at the plan level or in the aggregate. Praxair’s contributions to these plans were $2 million in 2014 and 2013, and $1 million in 2012 (the cost is not included in the tables that follow). For all MEPs Praxair’s contributions were significantly less than 1% of the total contributions to each plan for 2013 and 2012. Total 2014 contributions were not yet available from the MEPs.
Praxair has obtained the most recently available Pension Protection Act ("PPA") zone status letters from the Trustees of the MEPs. The PPA classifies MEPs as either Red, Yellow or Green zone plans. Among other factors, plans in the Red zone are generally less than 65 percent funded; plans in the Yellow zone are generally 65 to 80 percent funded; and plans in the Green zone are generally at least 80 percent funded. According to the most current data available, four of the MEPs that the Company participates are in a Red zone status; one is in a Yellow zone status; and two are in a Green zone status. As of December 31, 2014, the five Red and Yellow Zone plans have pending or have implemented financial improvement or rehabilitation plans. Praxair does not currently anticipate significant future obligations due to the funding status of these plans. If Praxair determined it was probable that it would withdraw from an MEP, the Company would record a liability for its portion of the MEP’s unfunded pension obligations, as calculated at that time. Historically, such withdrawal payments have not been significant.
88
Defined Contribution Plans
Praxair’s U.S. business employees are eligible to participate in the Praxair defined contribution savings plan. Employees may contribute up to 40% of their compensation, subject to the maximum allowable by IRS regulations. For the US packaged gases business, company contributions to this plan are calculated as a percentage of salary based on age plus service. U.S. employees other than those in the packaged gases business have company contributions to this plan calculated on a graduated scale based on employee contributions to the plan. The cost for these defined contribution plans was $26 million in 2014, $25 million in 2013 and $24 million in 2012 (the cost is not included in the tables that follow).
The defined contribution plans includes a non-leveraged employee stock ownership plan ("ESOP") which covers all employees participating in this plan. The collective number of shares of Praxair common stock in the two ESOPs totaled 3,053,710 at December 31, 2014.
Certain international subsidiaries of the company also sponsor defined contribution plans where contributions are determined under various formulas. The expense for these plans was $17 million in 2014 and 2013, and $12 million in 2012 (the expense is not included in the tables that follow).
Postretirement Benefits Other Than Pensions (OPEB)
Praxair provides health care and life insurance benefits to certain eligible retired employees. These benefits are provided through various insurance companies and healthcare providers. Praxair is also obligated to make payments for a portion of postretirement benefits related to retirees of Praxair’s former parent. Additionally, as part of the CBI acquisition in 1996, Praxair assumed responsibility for healthcare and life insurance benefit obligations for CBI’s retired employees. All postretirement healthcare programs have cost caps that limit the company’s exposure to future cost increases. In addition, as part of the retirement elections made for July 1, 2002, eligible employees were given the choice of maintaining coverage in the current retiree medical design (as may be amended from time to time), or to move to a design whereby coverage would be provided, but with no Praxair subsidy whatsoever. Also, all new employees hired after April 30, 2002 into a business adopting these plans will not receive a company subsidy. Praxair does not currently fund its postretirement benefits obligations. Praxair’s retiree plans may be changed or terminated by Praxair at any time for any reason with no liability to current or future retirees.
Praxair uses a measurement date of December 31 for its pension and other post-retirement benefit plans.
Pension and Postretirement Benefit Costs
The components of net pension and OPEB costs for 2014, 2013 and 2012 are shown below:
(Millions of dollars) Year Ended December 31, | Pensions | OPEB | |||||||||||||||||||||
2014 | 2013 | 2012 | 2014 | 2013 | 2012 | ||||||||||||||||||
Service cost | $ | 49 | $ | 56 | $ | 49 | $ | 4 | $ | 5 | $ | 4 | |||||||||||
Interest cost | 121 | 112 | 119 | 11 | 11 | 12 | |||||||||||||||||
Expected return on plan assets | (155 | ) | (149 | ) | (153 | ) | — | — | — | ||||||||||||||
Net amortization and deferral | 60 | 91 | 68 | (8 | ) | (5 | ) | (7 | ) | ||||||||||||||
Net periodic benefit cost before pension settlement charges | $ | 75 | $ | 110 | $ | 83 | $ | 7 | $ | 11 | $ | 9 | |||||||||||
Pension settlement charges * | 7 | 9 | 10 | — | — | — | |||||||||||||||||
Net periodic benefit cost | $ | 82 | $ | 119 | $ | 93 | $ | 7 | $ | 11 | $ | 9 | |||||||||||
* 2014 includes a $7 millions charge in the fourth quarter related to one-time lump sum benefit payment of vested pension benefits to certain former employees. 2012 and 2013 includes a $9 million charge in the third quarter primarily related to the retirement of senior managers in the United States (see Note 2).
89
Funded Status
The changes in benefit obligation and plan assets for Praxair’s pension and OPEB programs, including reconciliation of the funded status of the plans to amounts recorded in the consolidated balance sheet, as of December 31, 2014 and 2013 are shown below:
(Millions of dollars) Year Ended December 31, | Pensions | ||||||||||||||||||||||
2014 | 2013 | OPEB | |||||||||||||||||||||
U.S. | International | U.S. | International | 2014 | 2013 | ||||||||||||||||||
Change in Benefit Obligation ("PBO") | |||||||||||||||||||||||
Benefit obligation January 1 | $ | 1,791 | $ | 661 | $ | 1,926 | $ | 727 | $ | 208 | $ | 251 | |||||||||||
Service cost | 34 | 15 | 38 | 18 | 4 | 5 | |||||||||||||||||
Interest cost | 85 | 36 | 74 | 38 | 11 | 11 | |||||||||||||||||
Participant contributions | — | — | — | — | 10 | 11 | |||||||||||||||||
Actuarial loss (gain) | 276 | 109 | (148 | ) | (43 | ) | (21 | ) | (39 | ) | |||||||||||||
Benefits paid | (136 | ) | (35 | ) | (99 | ) | (38 | ) | (25 | ) | (23 | ) | |||||||||||
Divestiture | — | (1 | ) | — | — | — | — | ||||||||||||||||
Foreign currency translation | — | (66 | ) | — | (41 | ) | (7 | ) | (8 | ) | |||||||||||||
Benefit obligation, December 31 | $ | 2,050 | $ | 719 | $ | 1,791 | $ | 661 | $ | 180 | $ | 208 | |||||||||||
Accumulated benefit obligation ("ABO") | $ | 1,944 | $ | 681 | $ | 1,712 | $ | 629 | |||||||||||||||
Change in Plan Assets | |||||||||||||||||||||||
Fair value of plan assets, January 1 | $ | 1,620 | $ | 551 | $ | 1,391 | $ | 558 | $ | — | $ | — | |||||||||||
Actual return on plan assets | 108 | 76 | 271 | 43 | — | — | |||||||||||||||||
Company contributions | 2 | 16 | 35 | 17 | — | — | |||||||||||||||||
Benefits paid from plan assets | (123 | ) | (30 | ) | (77 | ) | (33 | ) | — | — | |||||||||||||
Foreign currency translation | — | (52 | ) | — | (34 | ) | — | — | |||||||||||||||
Fair value of plan assets, December 31 | $ | 1,607 | $ | 561 | $ | 1,620 | $ | 551 | $ | — | $ | — | |||||||||||
Funded Status, End of Year | $ | (443 | ) | $ | (158 | ) | $ | (171 | ) | $ | (110 | ) | $ | (180 | ) | $ | (208 | ) | |||||
Recorded in the Balance Sheet | |||||||||||||||||||||||
Other long-term assets | $ | — | $ | 35 | $ | — | $ | 42 | $ | — | $ | — | |||||||||||
Other current liabilities | (18 | ) | (5 | ) | (10 | ) | (6 | ) | (16 | ) | (17 | ) | |||||||||||
Other long-term liabilities | (425 | ) | (188 | ) | (161 | ) | (146 | ) | (164 | ) | (191 | ) | |||||||||||
Net amount recognized, December 31 | $ | (443 | ) | $ | (158 | ) | $ | (171 | ) | $ | (110 | ) | $ | (180 | ) | $ | (208 | ) | |||||
Amounts recognized in accumulated other comprehensive income (loss) consist of: | |||||||||||||||||||||||
Net actuarial loss (gain) | $ | 792 | $ | 193 | $ | 563 | $ | 145 | $ | (24 | ) | $ | (7 | ) | |||||||||
Prior service cost (credit) | — | 15 | 1 | 18 | (1 | ) | (4 | ) | |||||||||||||||
Deferred tax benefit (Note 5) | (303 | ) | (50 | ) | (215 | ) | (38 | ) | 11 | 6 | |||||||||||||
Amount recognized in accumulated other comprehensive income (loss) (Note 7) | $ | 489 | $ | 158 | $ | 349 | $ | 125 | $ | (14 | ) | $ | (5 | ) | |||||||||
90
The changes in plan assets and benefit obligations recognized in other comprehensive income in 2014 and 2013 are as follows:
Pensions | OPEB | ||||||||||||||
(Millions of dollars) | 2014 | 2013 | 2014 | 2013 | |||||||||||
Current year net actuarial losses (gains)* | $ | 356 | $ | (356 | ) | $ | (21 | ) | $ | (39 | ) | ||||
Amortization of net actuarial gains (losses) | (59 | ) | (90 | ) | 2 | (1 | ) | ||||||||
Amortization of prior service credits (costs) | (1 | ) | (1 | ) | 6 | 6 | |||||||||
Pension settlements (Note 2) | (7 | ) | (9 | ) | — | — | |||||||||
Foreign currency translation and other | (16 | ) | (12 | ) | (1 | ) | (1 | ) | |||||||
Total recognized in other comprehensive income | $ | 273 | $ | (468 | ) | $ | (14 | ) | $ | (35 | ) | ||||
________________________
* | The pension net actuarial losses in 2014 relates primarily to the decrease in discount rates, when compared to 2013 and updated mortality assumptions. The pension net actuarial gain in 2013 relates primarily to the increase in discount rates, when compared to 2012. The OPEB net actuarial gains in 2014 relates primarily to favorable plan experience, and the 2013 net actuarial gain relates primarily to higher discount rates. |
The amounts in accumulated other comprehensive income (loss) that are expected to be recognized as components of net periodic benefit cost during 2015 are as follows:
(Millions of dollars) | Pension | OPEB | |||||
Net actuarial loss (gain) | $ | 82 | $ | (3 | ) | ||
Prior service cost (credit) | 1 | — | |||||
$ | 83 | $ | (3 | ) | |||
The following table provides information for pension plans where the accumulated benefit obligation exceeds the fair value of the plan assets:
(Millions of dollars) Year Ended December 31, | Pensions | ||||||||||||||
2014 | 2013 | ||||||||||||||
U.S. | International | U.S.* | International | ||||||||||||
Projected benefit obligation ("PBO") | $ | 2,050 | $ | 428 | $ | 244 | $ | 360 | |||||||
Accumulated benefit obligation ("ABO") | $ | 1,944 | $ | 412 | $ | 241 | $ | 352 | |||||||
Fair value of plan assets | $ | 1,607 | $ | 234 | $ | 127 | $ | 207 | |||||||
* In 2013, plan assets related to the main U.S. retirement program exceeded the ABO by $23 million and was therefore excluded from the table above.
91
Assumptions
The assumptions used to determine the benefit obligations are as of the respective balance sheet date and the assumptions used to determine the net benefit cost are at the previous year-end, as shown below:
Pensions | |||||||||||||||||
U.S. | International | OPEB | |||||||||||||||
2014 | 2013 | 2014 | 2013 | 2014 | 2013 | ||||||||||||
Weighted average assumptions used to determine benefit obligations at December 31, | |||||||||||||||||
Discount rate | 3.95 | % | 4.80 | % | 5.36 | % | 6.30 | % | 4.48 | % | 5.87 | % | |||||
Rate of increase in compensation levels | 3.25 | % | 3.25 | % | 3.72 | % | 4.00 | % | N/A | N/A | |||||||
Weighted average assumptions used to determine net periodic benefit cost for years ended December 31, | |||||||||||||||||
Discount rate | 4.80 | % | 3.90 | % | 6.30 | % | 5.80 | % | 5.87 | % | 5.00 | % | |||||
Rate of increase in compensation levels | 3.25 | % | 3.25 | % | 4.00 | % | 4.00 | % | N/A | N/A | |||||||
Expected long-term rate of return on plan assets * | 8.00 | % | 8.00 | % | 8.10 | % | 7.50 | % | N/A | N/A | |||||||
________________________
* | The expected long term rate of return on the U.S. and international plan assets is estimated based on the plans' investment strategy and asset allocation, historical capital market performance and, to a lesser extent, historical plan performance. For the U.S. plans, the expected rate of return of 8.00% was derived based on the target asset allocation of 50%-70% equity securities (approximately 9.5% expected return), 20%-40% fixed income securities (approximately 5.5% expected return) and 2% - 10% real estate funds (approximately 7% expected return). For the international plans, the expected rate of return was derived based on the weighted average target asset allocation of 30%-50% equity securities (approximately 10% expected return), 40%-60% fixed income securities (approximately 7.5% expected return), and 0%-10% alternative investments (approximately 7.5% expected return). For the U.S. plan assets, the actual annualized total returns for the most recent 10-year and 20-year periods ended December 31, 2014 were approximately 6.2% and 8.2%, respectively. For the international plan assets, the actual annualized total returns for the same two periods were approximately 8.3% and 9.7%, respectively. Changes to plan asset allocations and investment strategy over this time period limit the value of historical plan performance as factor in estimating the expected long term rate of return. For 2015, the expected long-term rate of return on plan assets will be 8.00% for the U.S. plans. Expected weighted average returns for international plans will vary. |
OPEB | |||||
Assumed healthcare cost trend rates | 2014 | 2013 | |||
Healthcare cost trend assumed | 7.50 | % | 8.00 | % | |
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) | 5.00 | % | 5.00 | % | |
Year that the rate reaches the ultimate trend rate | 2020 | 2020 | |||
These healthcare-cost trend rate assumptions have an impact on the amounts reported. However, cost caps limit the impact on the net OPEB benefit cost in the U.S. To illustrate the effect, a one-percentage point change in assumed healthcare cost trend rates would have the following effects:
One-Percentage Point | |||||||
(Millions of dollars) | Increase | Decrease | |||||
Effect on the total of service and interest cost components of net OPEB benefit cost | $ | — | $ | — | |||
Effect on OPEB benefit obligation | $ | 3 | $ | (2 | ) | ||
Pension Plan Assets
The investments of the U.S. pension plan are managed to meet the future expected benefit liabilities of the plan over the long term by investing in diversified portfolios consistent with prudent diversification and historical and expected
92
capital market returns. When Praxair became an independent, publicly traded company in 1992, its former parent retained all liabilities for its term-vested and retired employees. Praxair’s plan received assets and retained pension liabilities for its own active employee base. Therefore, the liabilities under the Praxair U.S. pension plan mature at a later date compared to pension funds of other similar companies. Investment strategies are reviewed by the Finance and Pension Committee of the company’s Board of Directors and investment performance is tracked against appropriate benchmarks. There are no concentrations of risk as it relates to the assets within the plans.
The international pension plans are managed individually based on diversified investment portfolios, with different target asset allocations that vary for each plan. Praxair’s U.S. and international pension plans’ weighted-average asset allocations at December 31, 2014 and 2013, and the target asset allocation range for 2014, by major asset category are as follows:
U.S. | International | ||||||||||||||
Asset Category | Target | 2014 | 2013 | Target | 2014 | 2013 | |||||||||
Equity securities | 50%-70% | 65 | % | 70 | % | 30%-50% | 49 | % | 48 | % | |||||
Fixed income securities | 20%-40% | 28 | % | 30 | % | 40%-60% | 42 | % | 43 | % | |||||
Other | 2% - 10% | 7 | % | — | 0%-10% | 9 | % | 9 | % | ||||||
The following table summarizes pension assets measured at fair value by asset category at December 31, 2014 and 2013. During the years presented, there has been no transfer of assets between Levels 1, 2 & 3 (see Note 13 for definition of the levels):
Fair Value Measurements Using | |||||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 * | Total | ||||||||||||||||||||||||||||
(Millions of dollars) | 2014 | 2013 | 2014 | 2013 | 2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||
Cash and cash equivalents | $ | 1 | $ | 2 | $ | — | $ | — | $ | — | $ | — | $ | 1 | $ | 2 | |||||||||||||||
Equity securities: | |||||||||||||||||||||||||||||||
U.S. equities | 340 | 285 | — | — | — | — | 340 | 285 | |||||||||||||||||||||||
International equities | 82 | 82 | — | — | — | — | 82 | 82 | |||||||||||||||||||||||
Mutual funds | 330 | 393 | — | — | — | — | 330 | 393 | |||||||||||||||||||||||
Pooled funds | — | — | 565 | 630 | — | — | 565 | 630 | |||||||||||||||||||||||
Fixed income securities: | |||||||||||||||||||||||||||||||
U.S. government bonds | — | — | 44 | 39 | — | — | 44 | 39 | |||||||||||||||||||||||
International government bonds | — | — | 125 | 128 | — | — | 125 | 128 | |||||||||||||||||||||||
Mutual funds | 253 | 308 | — | — | — | — | 253 | 308 | |||||||||||||||||||||||
Corporate bonds | — | — | 175 | 176 | — | — | 175 | 176 | |||||||||||||||||||||||
Pooled funds | — | — | 90 | 80 | — | — | 90 | 80 | |||||||||||||||||||||||
Other: | |||||||||||||||||||||||||||||||
Insurance contracts | — | — | — | — | 53 | 48 | 53 | 48 | |||||||||||||||||||||||
Real Estate Funds | — | — | — | — | 110 | — | 110 | — | |||||||||||||||||||||||
Fair value of plan assets, December 31, | $ | 1,006 | $ | 1,070 | $ | 999 | $ | 1,053 | $ | 163 | $ | 48 | $ | 2,168 | $ | 2,171 | |||||||||||||||
________________________
93
* | The following table summarizes changes in fair value of the pension plan assets classified as level 3 for the periods ended December 31, 2014 and 2013: |
(Millions of dollars) | Insurance Contracts | Real Estate Funds | Total | ||||||||
Balance, December 31, 2012 | $ | 48 | $ | — | $ | 48 | |||||
Gain or losses for the period | — | — | — | ||||||||
Balance, December 31, 2013 | 48 | — | 48 | ||||||||
Gain for the period | 12 | 10 | 22 | ||||||||
Acquisitions | — | 100 | 100 | ||||||||
Foreign currency translation | (7 | ) | — | (7 | ) | ||||||
Balance, December 31, 2014 | $ | 53 | $ | 110 | $ | 163 | |||||
The descriptions and fair value methodologies for the U.S. and international pension plan assets are as follows:
Cash and Cash Equivalents – This category includes cash and short-term interest bearing investments with maturities of three months or less. Investments are valued at cost plus accrued interest. Cash and cash equivalents are classified within level 1 of the valuation hierarchy.
Equity Securities – This category is comprised of shares of common stock in U.S. and international companies from a diverse set of industries and size. Common stock is valued at the closing market price reported on a U.S. or international exchange where the security is actively traded. Equity securities are classified within level 1 of the valuation hierarchy.
Mutual Funds and Pooled Funds – This category consists of publicly and privately managed funds that invest primarily in marketable equity and fixed income securities. The fair value of these investments is determined by reference to the net asset value of the underlying securities of the fund. Shares of publicly traded mutual funds are valued at the net asset value quoted on the exchange where the fund is traded and are classified as level 1 within the valuation hierarchy. Units of pooled funds are valued at the per unit net asset value determined by the fund manager and are classified as level 2 within the valuation hierarchy.
U.S. and International Government Bonds – This category includes U.S. treasuries, U.S. federal agency obligations and international government debt. The majority of these investments do not have quoted market prices available for a specific government security and so the fair value is determined using quoted prices of similar securities in active markets and is classified as level 2 within the valuation hierarchy.
Corporate Bonds – This category is comprised of corporate bonds of U.S. and international companies from a diverse set of industries and size. The fair values for U.S. and international corporate bonds are determined using quoted prices of similar securities in active markets and observable data or broker or dealer quotations. The fair values for these investments are classified as level 2 within the valuation hierarchy.
Insurance Contracts – The fair value of insurance contracts is determined based on the cash surrender value of the insurance contract, which is determined based on such factors as the fair value of the underlying assets and discounted cash flow. These contracts are with highly rated insurance companies. Insurance contracts are classified within level 3 of the valuation hierarchy.
Real Estate Funds – This category includes real estate properties, partnership equities and investments in operating companies. The fair value of the assets is determined using discounted cash flows by estimating an income stream for the property plus a reversion into a present value at a risk adjusted rate. Yield rates and growth assumptions utilized are derived from market transactions as well as other financial and industry data. The fair value for these investments are classified within level 3 of the valuation hierarchy.
Contributions
At a minimum, Praxair contributes to its pension plans to comply with local regulatory requirements (e.g., ERISA in the United States). Discretionary contributions in excess of the local minimum requirements are made based on many factors, including long-term projections of the plans' funded status, the economic environment, potential risk of overfunding, pension insurance costs and alternative uses of the cash. Changes to these factors can impact the timing of discretionary contributions from year to year. Pension contributions were $18 million in 2014, $52 million in 2013 and $184 million in 2012. Estimated required contributions for 2015 are currently expected to be in the area of $15 million.
94
Estimated Future Benefit Payments
The following table presents estimated future benefit payments, net of participants contributions:
(Millions of dollars) | Pensions | ||||||||||
Year Ended December 31, | U.S. | International | OPEB | ||||||||
2015 | $ | 105 | $ | 36 | $ | 17 | |||||
2016 | 101 | 36 | 16 | ||||||||
2017 | 106 | 37 | 16 | ||||||||
2018 | 111 | 38 | 15 | ||||||||
2019 | 117 | 39 | 15 | ||||||||
2020-2024 | 625 | 211 | 68 | ||||||||
NOTE 17. COMMITMENTS AND CONTINGENCIES
The company accrues non income-tax liabilities for contingencies when management believes that a loss is probable and the amounts can be reasonably estimated, while contingent gains are recognized only when realized. In the event any losses are sustained in excess of accruals, they will be charged against income at that time. Attorney fees are recorded as incurred. Commitments represent obligations, such as those for future purchases of goods or services, that are not yet recorded on the company’s balance sheet as liabilities. The company records liabilities for commitments when incurred (i.e., when the goods or services are received).
Contingent Liabilities
Praxair is subject to various lawsuits and government investigations that arise from time to time in the ordinary course of business. These actions are based upon alleged environmental, tax, antitrust and personal injury claims, among others. Praxair has strong defenses in these cases and intends to defend itself vigorously. However, it is possible that the company may incur losses in connection with some of these actions in excess of accrued liabilities. Management does not anticipate that in the aggregate such losses would have a material adverse effect on the company’s consolidated financial position or liquidity; however, it is possible that the final outcomes could have a significant impact on the company’s reported results of operations in any given period.
Significant matters are:
• | During May 2009, the Brazilian government published Law 11941/2009 instituting a new voluntary amnesty program (“Refis Program”) which allowed Brazilian companies to settle certain federal tax disputes at reduced amounts. During the 2009 third quarter, Praxair decided that it was economically beneficial to settle many of its outstanding federal tax disputes and such disputes were enrolled in the Refis Program, subject to final calculation and review by the Brazilian federal government. The Company recorded estimated liabilities based on the terms of the Refis Program. Since 2009, Praxair has been unable to reach final agreement on the calculations and recently initiated litigation against the government in an attempt to resolve certain items. Open issues relate to the following matters: (i) application of cash deposits and net operating loss carryforwards to satisfy obligations and (ii) the amount of tax reductions available under the Refis Program. Although it is difficult to estimate the timing of resolution of legal matters in Brazil, it is possible that individual disputed matters may be resolved during the next year. |
• | At December 31, 2014 the most significant non-income and income tax claims in Brazil, after enrollment in the Refis Program, relate to state VAT tax matters associated with procedural issues and a federal income tax matter where the taxing authorities are challenging the tax rate that should be applied to income generated by a subsidiary company. The total estimated exposure relating to such claims, including interest and penalties, as appropriate, is approximately $180 million. Praxair has not recorded any liabilities related to such claims based on management judgments, after considering judgments and opinions of outside counsel. Because litigation in Brazil historically takes many years to resolve, it is very difficult to estimate the timing of resolution of these matters; however, it is possible that certain of these matters may be resolved within the near term. The company is vigorously defending against the proceedings. |
• | On September 1, 2010, CADE ("Brazilian Administrative Council for Economic Defense") announced alleged anticompetitive activity on the part of five industrial gas companies in Brazil and imposed fines on all five companies. Originally, CADE imposed a civil fine of R$2.2 billion Brazilian reais (US$828 million) against White Martins, the Brazil-based subsidiary of Praxair, Inc. In response to a motion for clarification, |
95
the fine was reduced to R$1.7 billion Brazilian reais (US$640 million) due to a calculation error made by CADE. The amount of the fine is subject to indexation using SELIC. On September 2, 2010, Praxair issued a press release and filed a report on Form 8-K rejecting all claims and stating that the fine represents a gross and arbitrary disregard of Brazilian law.
On October 19, 2010, White Martins filed an annulment petition (“appeal”) with the Federal Court in Brasilia seeking to have the fine against White Martins entirely overturned. In order to suspend payment of the fine pending the completion of the appeal process, Brazilian law required that the company tender a form of guarantee in the amount of the fine as security. Currently, 50% of the guarantee is satisfied by letters of credit with a financial institution and 50% of the guarantee is satisfied by equity of a Brazilian subsidiary.
Praxair strongly believes that the allegations are without merit and that the fine will be entirely overturned during the appeal process. The company further believes that it has strong defenses and will vigorously defend against the allegations and related fine up to such levels of the Federal Courts in Brazil as may be necessary. Because appeals in Brazil historically take many years to resolve, it is very difficult to estimate when the appeal will be finally decided. Based on management judgments, after considering judgments and opinions of outside counsel, no reserve has been recorded for this proceeding as management does not believe that a loss is probable.
Contingent Asset - Resolution
Praxair's Brazilian-based subsidiary, White Martins, had a long-standing claim against a Brazilian power company, Bandeirante Energia SA, which had been successfully litigated, and in 2011 the courts released a cash deposit to White Martins, subject to completion of an appeal process. During the first quarter of 2012, White Martins was notified that the appeal process was favorably concluded, and accordingly, recognized a $24 million gain to other income (expense), net of legal fees and another litigation matter.
Commitments and Contractual Obligations
The following table sets forth Praxair’s material commitments and contractual obligations as of December 31, 2014, excluding leases, tax liabilities for uncertain tax positions, long-term debt, other post retirement and pension obligations which are summarized elsewhere in the financial statements (see Notes 4, 7, 11, and 16):
(Millions of dollars) Expiring through December 31, | Unconditional Purchase Obligations | Construction Commitments | Guarantees and Other | ||||||||
2015 | $ | 543 | $ | 954 | $ | 12 | |||||
2016 | 491 | 404 | 59 | ||||||||
2017 | 460 | 27 | — | ||||||||
2018 | 445 | — | — | ||||||||
2019 | 393 | — | — | ||||||||
Thereafter | 3,021 | — | — | ||||||||
$ | 5,353 | $ | 1,385 | $ | 71 | ||||||
Unconditional purchase obligations of $5,353 million represent contractual commitments under various long and short-term take-or-pay arrangements with suppliers and are not included on Praxair's balance sheet. These obligations are primarily minimum-purchase commitments for helium, electricity, natural gas and feedstock used to produce atmospheric and process gases. A significant portion of these obligations is passed on to customers through similar take-or-pay or other contractual arrangements. Purchase obligations that are not passed along to customers through such contractual arrangements are subject to market conditions, but do not represent a material risk to Praxair. During 2014, payments related to Praxair's unconditional purchase obligations totaled $1,021 million, including $481 million for electricity and $225 million for natural gas. Approximately $3,550 million of the purchase obligations relates to power and is intended to secure the uninterrupted supply of electricity and feedstock to Praxair's plants to reliably satisfy customer product supply obligations, and extend through 2030. Certain of the power contracts contain various cancellation provisions requiring supplier agreement which the company believes could reduce the reported obligation significantly, if desired, and many are subject to annual escalations based on local inflation factors. The purchase obligations also include a multi-year contract for silane, with a total purchase obligation of $142 million as of December 31, 2014. Since this contract was signed, the market for silane has not developed as expected and prices have decreased due to lower demand from the photovoltaics markets, primarily in Asia. At December 31, 2014, Praxair's current selling prices and estimated future demand for silane
96
are in excess of its contractual purchase obligations under the contract. The company is continually monitoring market developments.
Construction commitments of $1,385 million represent outstanding commitments to complete authorized construction projects as of December 31, 2014. A significant portion of Praxair’s capital spending is related to the construction of new production facilities to satisfy customer commitments which may take a year or more to complete.
Guarantees and other of $71 million include $70 million related to Praxair’s contingent obligations under guarantees of certain debt of unconsolidated affiliates and $1 million of various guarantees relating to outstanding receivables and repurchase agreements. Unconsolidated equity investees had total debt of approximately $245 million at December 31, 2014, which was non-recourse to Praxair with the exception of the guaranteed portions described above. Praxair has no significant financing arrangements with closely-held related parties.
At December 31, 2014, Praxair had undrawn outstanding letters of credit, bank guarantees and surety bonds valued at approximately $1,240 million from financial institutions, including $524 million relating to the CADE anti-trust litigation in Brazil. These relate primarily to customer contract performance guarantees (including plant construction in connection with certain on-site contracts), self-insurance claims and other commercial and governmental requirements, including foreign litigation matters.
NOTE 18. SEGMENT INFORMATION
The company’s operations are organized into five reportable segments, four of which have been determined on a geographic basis of segmentation: North America, Europe, South America and Asia. In addition, Praxair operates its worldwide surface technologies business through its wholly-owned subsidiary, Praxair Surface Technologies, Inc., which represents the fifth reportable segment.
Praxair’s operations consist of two major product lines: industrial gases and surface technologies. The industrial gases product line centers on the manufacturing and distribution of atmospheric gases (oxygen, nitrogen, argon, rare gases) and process gases (carbon dioxide, helium, hydrogen, electronic gases, specialty gases, acetylene). Many of these products are co-products of the same manufacturing process. Praxair manufactures and distributes nearly all of its products and manages its customer relationships on a regional basis. Praxair’s industrial gases are distributed to various end markets within a regional segment through one of three basic distribution methods: on-site or tonnage; merchant or bulk; and packaged or cylinder gases. The distribution methods are generally integrated in order to best meet the customer’s needs and very few of its products can be economically transported outside of a region. Therefore, the distribution economics are specific to the various geographies in which the company operates and are consistent with how management assesses performance.
Praxair evaluates the performance of its reportable segments based primarily on operating profit, excluding inter-company royalties and items not indicative of ongoing business trends. Corporate and globally managed expenses, and research and development costs relating to Praxair’s global industrial gases business, are allocated to operating segments based on sales.
The table below presents information about reportable segments for the years ended December 31, 2014, 2013 and 2012.
(Millions of dollars) | 2014 | 2013 | 2012 | ||||||||
Sales (a) | |||||||||||
North America | $ | 6,436 | $ | 6,164 | $ | 5,598 | |||||
Europe | 1,546 | 1,542 | 1,474 | ||||||||
South America | 1,993 | 2,042 | 2,082 | ||||||||
Asia | 1,619 | 1,525 | 1,414 | ||||||||
Surface Technologies | 679 | 652 | 656 | ||||||||
$ | 12,273 | $ | 11,925 | $ | 11,224 | ||||||
97
2014 | 2013 | 2012 | |||||||||
Operating Profit | |||||||||||
North America | $ | 1,580 | $ | 1,538 | $ | 1,465 | |||||
Europe | 291 | 270 | 256 | ||||||||
South America | 449 | 467 | 429 | ||||||||
Asia | 303 | 271 | 246 | ||||||||
Surface Technologies | 123 | 111 | 106 | ||||||||
Segment operating profit | 2,746 | 2,657 | 2,502 | ||||||||
Venezuela currency devaluation and other charges (Note 2) | (138 | ) | (32 | ) | (65 | ) | |||||
Total operating profit | $ | 2,608 | $ | 2,625 | $ | 2,437 | |||||
2014 | 2013 | 2012 | |||||||||
Total Assets (b) | |||||||||||
North America | $ | 10,205 | $ | 10,133 | $ | 8,491 | |||||
Europe | 3,000 | 3,408 | 2,957 | ||||||||
South America | 2,723 | 2,934 | 3,205 | ||||||||
Asia | 3,198 | 3,098 | 2,757 | ||||||||
Surface Technologies | 676 | 682 | 680 | ||||||||
$ | 19,802 | $ | 20,255 | $ | 18,090 | ||||||
(Millions of dollars) | 2014 | 2013 | 2012 | ||||||||
Depreciation and Amortization | |||||||||||
North America | $ | 611 | $ | 567 | $ | 498 | |||||
Europe | 168 | 169 | 149 | ||||||||
South America | 177 | 181 | 184 | ||||||||
Asia | 170 | 150 | 127 | ||||||||
Surface Technologies | 44 | 42 | 43 | ||||||||
$ | 1,170 | $ | 1,109 | $ | 1,001 | ||||||
2014 | 2013 | 2012 | |||||||||
Capital Expenditures and Acquisitions | |||||||||||
North America | $ | 837 | $ | 2,106 | $ | 1,303 | |||||
Europe | 319 | 451 | 322 | ||||||||
South America | 373 | 284 | 351 | ||||||||
Asia | 310 | 459 | 431 | ||||||||
Surface Technologies | 56 | 43 | 53 | ||||||||
$ | 1,895 | $ | 3,343 | $ | 2,460 | ||||||
2014 | 2013 | 2012 | |||||||||
Sales by Product Group | |||||||||||
Atmospheric gases and related | $ | 8,623 | $ | 8,451 | $ | 8,104 | |||||
Process gases and other | 2,971 | 2,822 | 2,464 | ||||||||
Surface technologies | 679 | 652 | 656 | ||||||||
$ | 12,273 | $ | 11,925 | $ | 11,224 | ||||||
98
2014 | 2013 | 2012 | |||||||||
Sales by Major Country | |||||||||||
United States | $ | 5,171 | $ | 4,764 | $ | 4,305 | |||||
Brazil | 1,511 | 1,603 | 1,668 | ||||||||
Other – foreign | 5,591 | 5,558 | 5,251 | ||||||||
$ | 12,273 | $ | 11,925 | $ | 11,224 | ||||||
2014 | 2013 | 2012 | |||||||||
Long-lived Assets by Major Country (c) | |||||||||||
United States | $ | 4,817 | $ | 4,723 | $ | 4,255 | |||||
Brazil | 1,344 | 1,376 | 1,535 | ||||||||
Other – foreign | 5,836 | 6,179 | 5,663 | ||||||||
$ | 11,997 | $ | 12,278 | $ | 11,453 | ||||||
________________________
(a) | Sales reflect external sales only. Intersegment Sales, primarily from North America to other segments, were not material. |
(b) | Includes equity investments as of December 31, as follows: |
(Millions of dollars) | 2014 | 2013 | 2012 | ||||||||
North America | $ | 132 | $ | 128 | $ | 135 | |||||
Europe | 207 | 218 | 199 | ||||||||
Asia | 354 | 356 | 320 | ||||||||
$ | 693 | $ | 702 | $ | 654 | ||||||
Changes primarily relate to equity investment earnings, dividends and currency impacts.
(c) | Long-lived assets include property, plant and equipment – net. |
NOTE 19. QUARTERLY DATA (UNAUDITED)
(Dollar amounts in millions, except per share data)
2014 | 1Q | 2Q | 3Q | 4Q (a) | YEAR (a) | ||||||||||||||
Sales | $ | 3,026 | $ | 3,113 | $ | 3,144 | $ | 2,990 | $ | 12,273 | |||||||||
Cost of sales, exclusive of depreciation and amortization | $ | 1,726 | $ | 1,767 | $ | 1,780 | $ | 1,689 | $ | 6,962 | |||||||||
Depreciation and amortization | $ | 285 | $ | 293 | $ | 301 | $ | 291 | $ | 1,170 | |||||||||
Operating profit | $ | 675 | $ | 697 | $ | 711 | $ | 525 | 2,608 | ||||||||||
Net income – Praxair, Inc. | $ | 448 | $ | 467 | $ | 477 | $ | 302 | $ | 1,694 | |||||||||
Basic Per Share Data | |||||||||||||||||||
Net income | $ | 1.52 | $ | 1.59 | $ | 1.63 | $ | 1.04 | $ | 5.79 | |||||||||
Weighted average shares (000’s) | 294,195 | 292,945 | 292,170 | 290,667 | 292,494 | ||||||||||||||
Diluted Per Share Data | |||||||||||||||||||
Net income | $ | 1.51 | $ | 1.58 | $ | 1.62 | $ | 1.03 | $ | 5.73 | |||||||||
Weighted average shares (000’s) | 297,253 | 295,976 | 295,239 | 293,555 | 295,608 | ||||||||||||||
99
2013 | 1Q (a) | 2Q | 3Q (a) | 4Q (a) | YEAR (a) | ||||||||||||||
Sales | $ | 2,888 | $ | 3,014 | $ | 3,013 | $ | 3,010 | $ | 11,925 | |||||||||
Cost of sales, exclusive of depreciation and amortization | $ | 1,638 | $ | 1,710 | $ | 1,697 | $ | 1,699 | $ | 6,744 | |||||||||
Depreciation and amortization | $ | 266 | $ | 275 | $ | 281 | $ | 287 | $ | 1,109 | |||||||||
Operating profit | $ | 600 | $ | 665 | $ | 670 | $ | 690 | $ | 2,625 | |||||||||
Net income – Praxair, Inc. | $ | 391 | $ | 445 | $ | 445 | $ | 474 | $ | 1,755 | |||||||||
Basic Per Share Data | |||||||||||||||||||
Net income | $ | 1.32 | $ | 1.50 | $ | 1.51 | $ | 1.61 | $ | 5.94 | |||||||||
Weighted average shares (000’s) | 296,604 | 295,668 | 295,124 | 294,697 | 295,523 | ||||||||||||||
Diluted Per Share Data | |||||||||||||||||||
Net income | $ | 1.30 | $ | 1.49 | $ | 1.49 | $ | 1.59 | $ | 5.87 | |||||||||
Weighted average shares (000’s) | 299,700 | 298,654 | 298,357 | 298,225 | 298,965 | ||||||||||||||
________________________
(a) | 2014 and 2013 include the impact of the following benefits/(charges) (see Notes 2, 5 & 7): |
(Millions of dollars) | Operating Profit/ (Loss) | Net Income/ (Loss) | Diluted Earnings Per Share | ||||||||
Venezuela currency devaluation - Q4 | $ | (131 | ) | $ | (131 | ) | $ | (0.45 | ) | ||
Pension settlement charge - Q4 | (7 | ) | (5 | ) | (0.02 | ) | |||||
Bond redemption -Q4 | — | (22 | ) | (0.07 | ) | ||||||
Year 2014 | $ | (138 | ) | $ | (158 | ) | $ | (0.54 | ) | ||
Venezuela currency devaluation – Q1 | $ | (23 | ) | $ | (23 | ) | $ | (0.08 | ) | ||
Pension settlement charge – Q3 | (9 | ) | (6 | ) | (0.02 | ) | |||||
Income tax benefit - Q4 | — | 24 | 0.08 | ||||||||
Bond redemption - Q4 | — | (12 | ) | (0.04 | ) | ||||||
Year 2013 | $ | (32 | ) | $ | (17 | ) | $ | (0.06 | ) | ||
100
ITEM 9. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE |
None.
ITEM 9A. CONTROLS AND PROCEDURES
Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures
Based on an evaluation of the effectiveness of Praxair’s disclosure controls and procedures, which was made under the supervision and with the participation of management, including Praxair’s principal executive officer and principal financial officer, the principal executive officer and principal financial officer have each concluded that, as of the end of the annual period covered by this report, such disclosure controls and procedures are effective in ensuring that information required to be disclosed by Praxair in reports that it files under the Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and accumulated and communicated to management including Praxair’s principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.
Management’s Report on Internal Control Over Financial Reporting
Praxair’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Under the supervision and with the participation of management, including the company’s principal executive officer and principal financial officer, Praxair conducted an evaluation of the effectiveness of its internal control over financial reporting based on the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (often referred to as COSO). Based on this evaluation, management concluded that the company’s internal control over financial reporting was effective as of December 31, 2014.
PricewaterhouseCoopers LLP, an independent registered public accounting firm, has issued their opinion on the company’s internal control over financial reporting as of December 31, 2014 as stated in their report in Item 8.
Changes in Internal Control over Financial Reporting
There were no changes in Praxair’s internal control over financial reporting that occurred during the fourth quarter of 2014 that have materially affected, or are reasonably likely to materially affect, Praxair’s internal control over financial reporting.
ITEM 9B. OTHER INFORMATION
None.
101
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Certain information required by this item is incorporated herein by reference to the sections captioned “The Board of Directors”, “Executive Officers” and “Corporate Governance And Board Practices-Section 16(a) Beneficial Ownership Reporting Compliance” in Praxair’s Proxy Statement for the Annual Meeting of Shareholders to be held on April 28, 2015.
Identification of the Audit Committee
Praxair has a separately-designated standing Audit Committee established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934 as amended (the “Exchange Act”). The members of that Audit Committee are Ira D. Hall, Chairman, Nance K. Dicciani, Raymond W. LeBoeuf, Larry D. McVay and Denise L. Ramos.
Audit Committee Financial Expert
The Praxair Board of Directors has determined that each of, Raymond W. LeBoeuf, Ira D. Hall and Denise L. Ramos is an “audit committee financial expert” as defined by Item 407(d)(5)(ii) of Regulation S-K of the Exchange Act and is independent within the meaning of the independence standards adopted by the Board of Directors and those of the New York Stock Exchange.
Code of Ethics
Praxair has adopted a code of ethics that applies to the company’s directors and all employees, including its Chief Executive Officer, Chief Financial Officer, and Controller. This code of ethics has been approved by the Praxair Board of Directors and is named the “Compliance with Laws and Business Integrity and Ethics Policy”. To assist employees and directors in complying with this code of ethics, management, from time to time, develops specific standards implementing certain provisions of the code which standards are contained in Praxair’s “Standards of Business Integrity.” Both documents are posted on the company’s public website, www.praxair.com.
ITEM 11. EXECUTIVE COMPENSATION
Information required by this item is incorporated herein by reference to the sections captioned “Executive Compensation” and “Director Compensation” in Praxair’s Proxy Statement for the Annual Meeting of Shareholders to be held on April 28, 2015.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
Equity Compensation Plans Information – The table below provides information as of December 31, 2014 about company stock that may be issued upon the exercise of options, warrants and rights granted to employees or members of Praxair’s Board of Directors under present and former equity compensation plans, including plans approved by shareholders and one plan which has not been approved by shareholders, the 1996 Praxair, Inc. Performance Incentive Plan ("the 1996 Plan"). The equity compensation plan not approved by shareholders was terminated in March 2001 and directors and officers of the company were not eligible to participate in that plan. Shareholder approval of that plan was not required under applicable NYSE rules. The 1996 Plan provided for granting nonqualified or incentive stock options, stock grants, performance awards and other stock related incentives for key employees. The exercise price under the 1996 Plan was equal to the closing price of Praxair’s common stock on the date of grant. Options that were granted under this plan became exercisable after one or more years after the date of grant and the option term was no more than ten years.
102
EQUITY COMPENSATION PLANS TABLE
Plan Category | Number of securities to be issued upon exercise of outstanding options, warrants and rights (a) | Weighted-average exercise price of outstanding options, warrants and rights (b) | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c) | ||||||
Equity compensation plans approved by shareholders | 12,121,179 | (1) | $ | 80.65 | 7,982,085 | ||||
Equity compensation plans not approved by shareholders | — | — | — | ||||||
Total | 12,121,179 | $ | 80.65 | 7,982,085 | |||||
________________________
(1) | This amount includes 307,159 restricted shares and 832,860 performance shares. Up to an additional 700,345 performance shares could be issued if performance goals are achieved at the maximum specified targets. See Note 15 to the consolidated financial statements. |
Certain information required by this item regarding the beneficial ownership of the Company’s common stock is incorporated herein by reference to the section captioned “Share Ownership” in Praxair’s Proxy Statement for the Annual Meeting of Shareholders to be held on April 28, 2015.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE
Information required by this item is incorporated herein by reference to the sections captioned “Corporate Governance And Board Practices – Review, Approval or Ratification of Transactions with Related Persons,” “Corporate Governance And Board Practices – Certain Relationships and Transactions,” and “Corporate Governance And Board Practices – Director Independence” in Praxair’s Proxy Statement for the Annual Meeting of Shareholders to be held on April 28, 2015.
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
Information required by this item is incorporated herein by reference to the section captioned “The Independent Auditor” in Praxair’s Proxy Statement for the Annual Meeting of Shareholders to be held on April 28, 2015.
103
PART IV
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
(a) | The following documents are filed as part of this report: |
(1) | The company’s 2014 Consolidated Financial Statements and the Report of the Independent Registered Public Accounting Firm are included in Part II, Item 8. Financial Statements and Supplementary Data. |
(2) | Financial Statement Schedules – All financial statement schedules have been omitted because they are not applicable or the required information is shown in the financial statements or notes thereto. |
(3) | Exhibits – The exhibits filed as part of this Annual Report on Form 10-K are listed in the accompanying index. |
104
SIGNATURES
Praxair, Inc. and Subsidiaries
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report on Form 10-K/A to be signed on its behalf by the undersigned thereunto duly authorized on February 27, 2015.
PRAXAIR, INC. | ||||||
(Registrant) | ||||||
By: | /s/ ELIZABETH T. HIRSCH | |||||
Elizabeth T. Hirsch Vice President and Controller (On behalf of the Registrant and as Chief Accounting Officer) | ||||||
105
INDEX TO EXHIBITS
Praxair, Inc. and Subsidiaries
Exhibit No. | Description | |
3.01 | Restated Certificate of Incorporation of Praxair, Inc. as filed with the Secretary of State of the State of Delaware on April 27, 2012 (Filed as Exhibit 3.01 to the Company’s Current Report on Form 8-K dated April 30, 2012, Filing No. 1-11037, and incorporated herein by reference). | |
3.02 | Amended and Restated By-Laws of Praxair, Inc. (Filed as Exhibit 3.02 to the Company’s Current Report on Form 8-K dated April 30, 2012, Filing No. 1-11037, and incorporated herein by reference). | |
3.03 | Certificate of Designations for the 7.48% Cumulative Preferred Stock, Series A (Filed on February 13, 1997 as Exhibit 3.3 to Amendment #1 to the Company’s Registration Statement on Form S-3, Registration No. 333-18141). | |
3.04 | Certificate of Designations for the 6.75% Cumulative Preferred Stock, Series B (Filed on February 13, 1997 as Exhibit 3.4 to Amendment #1 to the Company’s Registration Statement on Form S-3, Registration No. 333-18141). | |
4.01 | Common Stock Certificate (Filed as Exhibit 4.01 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
4.02 | Indenture, dated as of July 15, 1992, between Praxair, Inc. and U.S. Bank National Association, as the ultimate successor trustee to Bank of America, Illinois, formerly Continental Bank, National Association (Filed as Exhibit 4 to the Company’s Current Report on Form 8-K dated March 19, 2007, Filing No. 1-11037, and incorporated herein by reference). | |
4.03 | Copies of the agreements relating to long-term debt which are not required to be filed as exhibits to this Annual Report on Form 10-K will be furnished to the Securities and Exchange Commission upon request. | |
4.04 | Series A Preferred Stock Certificate (Filed on February 7, 1997 as Exhibit 4.3 to Amendment #1 to the Company’s Registration Statement on Form S-3, Registration No. 333-18141). | |
4.05 | Series B Preferred Stock Certificate (Filed on February 7, 1997 as Exhibit 4.4 to Amendment #1 to the Company’s Registration Statement on Form S-3, Registration No. 333-18141). | |
*10.01 | Restated 2002 Praxair, Inc. Long Term Incentive Plan (Filed as Exhibit 10.01 to the Company’s 2003 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.01a | Amendment, dated as of October 24, 2006, to the Amended and Restated 2002 Praxair, Inc. Long Term Incentive Plan (Filed as Exhibit 10.01a to the Company’s 2006 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.01b | Amendment, dated as of January 23, 2007, to the Amended and Restated 2002 Praxair, Inc. Long Term Incentive Plan (Filed as Exhibit 10.01b to the Company’s 2006 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.01c | Form of Standard Option Award under the 2002 Praxair, Inc. Long Term Incentive Plan (Filed as Exhibit 10.01c to the Company’s 2007 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.01d | Form of Transferable Option Award under the 2002 Praxair, Inc. Long Term Incentive Plan (Filed as Exhibit 10.01d to the Company’s 2007 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
106
Exhibit No. | Description | |
*10.02 | Form of Executive Severance Compensation Agreement effective January 1, 2009 (Filed as Exhibit 10.02 to the Company’s 2008 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.02a | Form of Amendment, effective December 31, 2012, to Executive Severance Compensation Agreements that were effective January 1, 2009 (Filed as Exhibit 10.1 to the Company's Current Report on Form 8-K dated December 14, 2012, Filing No. 1-11037, and incorporated herein by reference. | |
*10.02b | Form of Executive Severance Compensation Agreement effective January 1, 2010 (Filed as Exhibit 10.02 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, Filing No. 1-11037, and incorporated herein by reference). | |
*10.02c | Form of Amendment, effective December 31, 2012, to Executive Severance Compensation Agreements that were effective January 1, 2010 (Filed as Exhibit 10.02c to the Company’s 2012 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.02d | Form of Executive Severance Compensation Agreement effective January 1, 2013 (Filed as Exhibit 10.02d to the Company’s 2012 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.03 | Praxair, Inc. Variable Compensation Plan amended and restated effective April 24, 2012 (Filed as Exhibit 10.01 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, Filing No. 1-11037, and incorporated herein by reference). | |
*10.04 | Amended and Restated 1995 Stock Option Plan for Non-Employee Directors (Filed as Exhibit 10.04 to the Company’s 2003 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.04a | First Amendment, dated as of October 24, 2006, to the Amended and Restated 1995 Stock Option Plan for Non-Employee Directors (Filed as Exhibit 10.04a to the Company’s 2006 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.04b | 2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc. amended and restated effective January 26, 2010 (Filed as Exhibit 10.04b to the Company’s 2009 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.04c | Form of Option Award under the 2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc (Filed as Exhibit 10.04a to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2005, Filing No. 1-11037, and incorporated herein by reference). | |
*10.05a | Praxair, Inc. Supplemental Retirement Income Plan A effective January 1, 2008 (Filed as Exhibit 10.05a to the Company’s 2008 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.05b | First amendment to the Praxair, Inc. Supplemental Retirement Income Plan A effective January 1, 2010 (Filed as Exhibit 10.05b to the Company’s 2009 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.05c | Praxair, Inc. Supplemental Retirement Income Plan B amended and restated effective December 31, 2007 (Filed as Exhibit 10.05b to the Company’s 2008 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.05d | First amendment to the Praxair, Inc. Supplemental Retirement Income Plan B effective January 1, 2010 (Filed as Exhibit 10.05d to the Company’s 2009 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.05e | Second Amendment to Praxair, Inc. Supplemental Retirement Income Plan B effective July 1, 2012 (Filed as Exhibit 10.05e to the Company’s 2012 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.05f | Praxair, Inc. Equalization Benefit Plan amended and restated effective December 31, 2007 (Filed as Exhibit 10.05c to the Company’s 2008 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
107
Exhibit No. | Description | |
*10.05g | First amendment to the Praxair, Inc. Equalization Benefit Plan amended and restated effective January 1, 2010 (Filed as Exhibit 10.05f to the Company’s 2009 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.06 | Praxair, Inc. Director’s Fees Deferral Plan amended and restated effective January 26, 2010 (Filed as Exhibit 10.06 to the Company’s 2009 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.07 | Praxair, Inc. Compensation Deferral Program Amended and Restated as of July 15, 2014 (Filed as Exhibit 10.01 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, Filing No. 1-11037, and incorporated herein by reference). | |
10.08 | Transfer Agreement dated January 1, 1989, between Union Carbide Corporation and the registrant (Filed as Exhibit 10.06 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.08a | Amendment No. 1 dated as of December 31, 1989, to the Transfer Agreement (Filed as Exhibit 10.07 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.08b | Amendment No. 2 dated as of July 2, 1990, to the Transfer Agreement (Filed as Exhibit 10.08 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.08c | Amendment No. 3 dated as of January 2, 1991, to the Transfer Agreement (Filed as Exhibit 10.09 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.09 | Transfer Agreement dated January 1, 1989, between Union Carbide Corporation and Union Carbide Coatings Service Corporation (Filed as Exhibit 10.14 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.09a | Amendment No. 1 dated as of December 31, 1989, to the Transfer Agreement (Filed as Exhibit 10.15 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.09b | Amendment No. 2 dated as of July 2, 1990, to the Transfer Agreement (Filed as Exhibit 10.16 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.10 | Additional Provisions Agreement dated as of June 4, 1992 (Filed as Exhibit 10.21 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.11 | Amended and Restated Realignment Indemnification Agreement dated as of June 4, 1992 (Filed as Exhibit 10.23 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.12 | Environmental Management, Services and Liabilities Allocation Agreement dated as of January 1, 1990 (Filed as Exhibit 10.13 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.12a | Amendment No. 1 to the Environmental Management, Services and Liabilities Allocation Agreement dated as of June 4, 1992 (Filed as Exhibit 10.22 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.13 | Danbury Lease-Related Services Agreement dated as of June 4, 1992 (Filed as Exhibit 10.24 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.13a | First Amendment to Danbury Lease-Related Services Agreement (Filed as Exhibit 10.13a to the Company’s 1994 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
108
Exhibit No. | Description | |
10.14 | Danbury Lease Agreements, as amended (Filed as Exhibit 10.26 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.14a | Second Amendment to Linde Data Center Lease (Danbury) (Filed as Exhibit 10.14a to the Company’s 1993 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
10.14b | Fourth Amendment to Carbide Center Lease (Filed as Exhibit 10.14b to the Company’s 1993 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
10.14c | Third Amendment to Linde Data Center Lease (Filed as Exhibit 10.14c to the Company’s 1994 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
10.14d | Fifth Amendment to Carbide Center Lease (Filed as Exhibit 10.14d to the Company’s 1994 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
10.14e | Sixth Amendment to Carbide Center Lease (Filed as Exhibit 10.14e to the Company’s 2004 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
10.15 | Employee Benefits Agreement dated as of June 4, 1992 (Filed as Exhibit 10.25 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.15a | First Amendatory Agreement to the Employee Benefits Agreement (Filed as Exhibit 10.15a to the Company’s 1994 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
10.16 | Tax Disaffiliation Agreement dated as of June 4, 1992 (Filed as Exhibit 10.20 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference). | |
10.17 | Credit Agreement dated as of December 19, 2014 among Praxair, Inc. and the Eligible Subsidiaries Referred to therein, the Lenders listed therein, and Bank of America, N.A., as Administrative Agent, Citibank N.A., Deutsche Bank Securities Inc. and HSBC Securities (USA) Inc., as Syndication Agents was filed as Exhibit 10.1 to the Company’s current report on Form 8-K, dated December 22, 2014, Filing No. 1-11037, and is incorporated herein by reference. | |
*10.18 | Praxair, Inc. Plan for Determining Performance-Based Awards Under Section 162(m) (included as Appendix 3 to the Company’s definitive proxy statement for its 2011 annual meeting of shareholders filed on March 16, 2011 and incorporated herein by reference). | |
*10.19 | Service Credit Arrangement for Stephen F. Angel dated May 23, 2007 was filed as Exhibit 10.20 to the Company’s Form 8-K filed on May 24, 2007 and is incorporated herein by reference. | |
*10.20 | 2009 Praxair, Inc. Long Term Incentive Plan as amended on April 27, 2010, January 25, 2011 and October 23, 2012 was filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K dated December 14, 2012 Filing No. 1-11037, and incorporated herein by reference. | |
*10.21 | Form of Standard Option Award under the 2009 Praxair, Inc. Long Term Incentive Plan (Filed as Exhibit 10.22 to the Company’s 2009 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
109
Exhibit No. | Description | |
*10.22 | Form of Transferable Option Award under the 2009 Praxair, Inc. Long Term Incentive Plan (Filed as Exhibit 10.23 to the Company’s 2009 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.23 | Form of Restricted Stock Unit Award under the 2009 Praxair, Inc. Long Term Incentive Plan (Filed as Exhibit 10.24 to the Company’s 2009 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.24a | Form of Performance Share Unit Award under the 2009 Praxair, Inc. Long Term Incentive Plan for grants made from 2010-2013 (Filed as Exhibit 10.25 to the Company’s 2009 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.24b | Form of Performance Share Unit Award under the 2009 Praxair, Inc. Long Term Incentive Plan for grants made in 2013-2014 with Earnings Per Share performance metrics (Filed as Exhibit 10.24b to the Company’s 2012 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.24c | Form of Performance Share Unit Award under the 2009 Praxair, Inc. Long Term Incentive Plan for grants made in 2013-2014 with Return on Capital performance metrics (Filed as Exhibit 10.24c to the Company’s 2012 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference). | |
*10.25 | Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan (Filed as Exhibit 10.01 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014, Filing No. 1-11037, and incorporated herein by reference). | |
*10.26 | Form of Transferable Option Award under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan for grants made in 2015 and thereafter is filed herewith. | |
*10.27 | Form of Restricted Stock Unit Award under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan for grants made in 2015 and thereafter is filed herewith. | |
*10.28a | Form of Performance Share Unit Award under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan for grants made in 2015 and thereafter with Earnings Per Share performance metrics is filed herewith. | |
*10.28b | Form of Performance Share Unit Award under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan for grants made in 2015 and thereafter with Return on Capital performance metrics is filed herewith. | |
*10.29 | Letter of Clarification of Certain Pension Benefits dated October 26, 2010 between the Company and James T. Breedlove (Filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, Filing No. 1-11037, and incorporated herein by reference). | |
10.30 | Form of Standard Underwriting Agreement Provisions was filed as Exhibit 1.1 to the Company’s Form S-3 filed on August 8, 2012, and is incorporated herein by reference. | |
10.31 | Terms Agreement dated February 1, 2012 among the Company, Citigroup Global Markets Inc., HSBC Securities (USA) Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representatives of the underwriters named therein for the issuance and sale of $600,000,000 2.450% Notes due 2022, was filed as Exhibit 1 to the Company’s Current Report on Form 8-K, dated February 6, 2012, Filing No. 1-11037, and incorporated herein by reference. | |
10.32 | Terms Agreement dated July 30, 2012 among the Company, Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the underwriters named therein for the issuance and sale of $500,000,000 2.20% Notes due August 15, 2022, was filed as Exhibit 1 to the Company’s Current Report on Form 8-K, dated August 2, 2012, Filing No. 1-11037, and incorporated herein by reference. | |
10.33 | Terms Agreement dated November 2, 2012 among the Company, Citigroup Global Markets Inc., Deutsche Bank Securities Inc. and RBS Securities Inc., as representatives of the underwriters named therein for the issuance and sale of $400,000,000 1.05% Notes due 2017, and $300,000,000 3.55% Notes due 2042, was filed as Exhibit 1 to the Company’s Current Report on Form 8-K, dated November 7, 2012, Filing No. 1-11037, and incorporated herein by reference. | |
110
Exhibit No. | Description | |
10.34 | Terms Agreement dated February 13, 2013 among the Company, HSBC Securities (USA) Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and Mitsubishi UFJ Securities (USA), Inc., as representatives of the underwriters named therein for the issuance and sale of $400,000,000 0.75% Notes due 2016, and $500,000,000 aggregate principal amount of its 2.70 % Notes due 2023, was filed as Exhibit 1 to the Company’s Current Report on Form 8-K, dated February 19, 2013, Filing No. 1-11037, and incorporated herein by reference. | |
10.35 | Terms Agreement dated February 27, 2013 between the Company and Citigroup Global Markets Inc., the underwriter named therein for the issuance and sale of $500,000,000 1.200% Notes due 2018, was filed as Exhibit 1 to the Company’s Current Report on Form 8-K, dated March 4, 2013, Filing No. 1-11037, and incorporated herein by reference. | |
10.36 | Terms Agreement dated April 29, 2013 among the Company, Citigroup Global Markets Inc. , Credit Suisse Securities (USA) LLC and RBS Securities Inc., as representatives of the underwriters named therein for the issuance and sale of $475,000,000 1.250% Notes due 2018 and $175,000,000 3.550% Notes due 2042, was filed as Exhibit 1 to the Company’s Current Report on Form 8-K, dated April 30, 2013, Filing No. 1-11037, and incorporated herein by reference. | |
10.37 | Terms Agreement dated November 4, 2013 between the Company and Citigroup Global Markets Inc., the underwriter named therein for the issuance and sale of $500,000,000 1.900% Notes due 2019, was filed as Exhibit 1 to the Company’s Current Report on Form 8-K, dated November 5, 2013, Filing No 1-11037, and incorporated herein by reference. | |
10.38 | Terms Agreement dated March 4, 2014 among the Company and Credit Suisse Securities (Europe) Limited, Deutsche Bank AG, London Branch and HSBC Bank plc, acting on behalf of the several underwriters for the issuance and sale of €600,000,000 1.500% Notes due 2020, was filed as Exhibit 1 to the Company’s current report on Form 8-K dated March 5, 2014, Filing No. 1-11037, and incorporated herein by reference. | |
10.39 | Terms Agreement dated November 21, 2014 among the Company and Citigroup Global Markets Limited, Deutsche Bank AG, London Branch, HSBC Bank plc and Merrill Lynch International, acting on behalf of the several underwriters for the issuance and sale of €500,000,000 1.625% Notes due 2025, was filed as Exhibit 1 to the Company’s current report on Form 8-K dated November 24, 2014, Filing No. 1-11037, and incorporated herein by reference. | |
12.01 | Computation of Ratio of Earnings to Fixed Charges. | |
21.01 | Subsidiaries of Praxair, Inc. | |
23.01 | Consent of Independent Registered Public Accounting Firm. | |
31.01 | Rule 13a-14(a) Certification | |
31.02 | Rule 13a-14(a) Certification | |
32.01 | Section 1350 Certification (such certifications are furnished for the information of the Commission and shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act). | |
32.02 | Section 1350 Certification (such certifications are furnished for the information of the Commission and shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act). | |
101.INS | XBRL Instance Document | |
101.SCH | XBRL Taxonomy Extension Schema | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase | |
101.LAB | XBRL Taxonomy Extension Label Linkbase | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase | |
111
Exhibit No. | Description | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase | |
Copies of exhibits incorporated by reference can be obtained from the SEC and are located in SEC File No. 1-11037.
* Indicates a management contract or compensatory plan or arrangement.
112